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Ancylostomiasis, a disease caused by nematodes (ancylostomes) 
is of great public health Importance, not only in India but in the 
whole of t rop ica l and subtropical regions of the wor ld . 
The l i f e cycle of a l l hookworms is d i rec t . The infective 
stage larvae (L^) enter the host ei ther through skin penetration 
or through mouth. After the entry (skin penetration) the larvae 
migrate through heart, lung, trachea and oesophagus and f inal ly 
sett le down in the intestine as adult parasites. The l i fe span 
of adult hookworms has been estimated to be from one year 
(Ancylostoma duodenale) to f i ve years (Necator americanus). 
Hookworms are voracious blood suckers causing severe anaemia, 
gastrointestinal disorders and creeping eruption. The other symptoms 
include physical and mental retardation and myocardial ailments. 
In pregnancy, these infections may be associated wi th changes in 
renal functions resulting in toxaemia and albuminuria. Chronic hook-
worm infection produces dullness, depression, confusion, poor memory, 
sexual retardation in chi ldren and par t ia l impotency in man. 
In the absence of any suitable control measures against 
ancylostomiasis, chemotherapy attained advantage in combating th is 
parasit ic scourge. But the currently avai lable drugs are either 
not fu l l y effective or have various side effects. Thus, i t is impera-
t i ve that ef fect ive, nontoxic, cheaper polyvalent antihookworm drugs 
be developed for the cure and control of the disease. 
For any biological investigation, the basic requirement 
is to have a rel iable test model. The selection of a test parasite 
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should be based upon the probabi l i ty of s imi lar chemotherapeutic, 
biological and immunological responses in the organisms to that 
of the target parasite. Further, to obtain consistent therapeutic 
responses, i t is necessary to have a host of standard breed with 
minimum genetic variat ions. On the other hand, parasite wi th short 
l i f e cycle is preferred for quick turnover of infected host and 
the parasit ic materials. 
The true human hookworms are A. duodenale and N[. americanus. 
Attempt to adapt 1^. americanus in golden hamsters have been success-
f u l , however, i t necessitates the use of immunosuppressive drug 
and hydrocortisone. The forced parasitism is l i ke l y to change 
the genetic make up of the parasite resulting in altered immunological 
and chemotherapeutic responses and as such should be avoided. 
A. duodenale has been successfully maintained in beagle 
dogs but the model is not suitable for chemotherapeutic investigations 
because of large size and d i f f i cu l ty in handling of the host. 
A. ceylanicum, a hookworm parasite of dog, cat and man, having 
direct and short l i f e cycle and easy adapt ib i l i t y in small laboratory 
host-hamster, is an acceptable test parasite for experimentation 
on ancylostomiasis. Further, the existence of posi t ive correlation 
of chemotherapeutic and immunological responses between A. ceylanicum 
in hamster and target parasite add to i ts selection. 
The thesis has two dist inct aspects of studies: i ) Chemo-
therapy and i i ) Immunology. 
3 
a) CHEMOTHERAPEUTIC INVESTIGATIONS 
In search of highly effective and nontoxic, p lyvalent , an t i -
hookworm agents, a number of newly procured plant extracts and 
rat ional ly synthesized compounds were screened for the i r antihookworm 
ac t i v i t y . 
The synthetic compounds screened, belong to benzimidazole, 
/ i -carbol ine, sa l icy lan i l ide , thiazole, py r ro le , isoxzoline and n i t ro -
imidazole groups. Amongst the benzimidazole series, 29 compounds 
were found effective and of these A have shown good promise and 
hence studied in de ta i l . The members of the /3-carboline, sa l i -
cy lan i l ide , thiazole and pyrro le series showed poor eff icacy. In 
isoxzoline and nitroimidazole groups, none were found effective 
even at the i n i t i a l dose of 250 mg/kg x 1. 
None of the plant extracts showed any a c t i v i t y . I t is 
l i ke ly that inact iv i ty might be due to the process of extraction 
being different from that practiced in Ayurvedic system. 
A l l the four active compounds belonging to benzimidazole 
series, were evaluated against mature and metamorphic forms (L_, 
L, and L^ stages) of A. ceylanicum. 
Their efficacy was also investigated against other helminth 
parasites, Nippostrongylus brasi l iensis ( t r ichostrongyl id) in ra t , 
Syphacia obvelata (•Dxyurid) in mouse, Hymenolepis nana and 
H. diminuta (cestodes) in rats. 
w 
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Among the four active benzimidazoles, Comp. 85-478 had 
eaker action. To achieve 100% clearance of A, ceylanicum, the 
required dose is 50 mg/kg x 1 per os. Developing larvae were 
also affected when the compound was administered in amount of 
100 mg/kg x 1. Even at th is dose a l l L^ were not k i l l e d . The 
compound has marginal ac t i v i t y against, ^ . obvelata and H. nana 
where as no action was observed against N. brasi l iensis and 
H. diminuta even at the i n i t i a l dose of 250 mg/kg x 3. 
Compound 85-479 had better ac t i v i t y and a single oral dose 
of 25 mg/kg x 1 was sufficient to remove a l l adult A. ceylanicum 
worms from treated hamsters. Though, the compound had 95-100% 
efficacy against L. and Lj- stages of the parasite, the efficacy 
against L^ was poor. In case of S^ . obvelata and H. nana, a dose 
of 100 mg/kg x 1 cured the respective host whereas, very l i t t l e 
ac t i v i t y was observed against H. diminuta and no efficacy was found 
against N. brasi l iensis. 
The other compound, 83-148 was found 100% effective against 
adult A. ceylanicum at an oral dose of 12.5 mg/kg x 1. By paren-
tera l route the compound exhibi ted weak ac t i v i t y . This compound 
was though effect ive against a l l developing forms, the minimum 
required dose was 100 mg/kg x 1 to achieve almost 100% efficacy 
aginst the larvae. I t had good ac t i v i t y against ^ . obvelata and 
meager efficacy against cestode (H. nana and H. diminuta). However, 
no anthelmintic action was detected against N. brasi l iensis. 
Among the lo t , compound 87-144 was found to be the most 
effect ive. The ED50 value (based on worm reduction) against 
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A. ceylanicum is approximately 1.53 mg/kg x 1. The compound 
was also effective against a l l the metamorphic forms of th is parasite 
and against other helminths i . e . , Nl. brasi l iensis, ^ . obvelata , 
H. nana and H. diminuta also. However, the compound lacks chemo-
prophylact ic action. The compound has exceedingly high therapeutic 
index as the maximum tolerating dose is above A500 mg/kg x 1. 
b) IMMUNOLOGICAL INVESTIGATIONS 
Various antigens of A. ceylanicum (somatic and ES) were 
evaluated for the i r protect ive potential and the i r immunogenicity 
was assessed wi th challenge and _i]2 v i t ro immunological tests. 
Fractionation of antigens was carr ied out with Sephadex 
G-200 column. The somatic and ES antigens of adult and larva l 
parasites resolved into three major f ract ions. Adult somatic antigen 
engendered weaker immunity compared to ES products. Among somatic 
f ract ions, F_ e l ic i ted better immunity and fraction 1 and 2 producted 
mild effects. Crude larva l antigens also el ic i ted considerable immu-
ni ty at higher doses. 
A def ini te correlation in serum antibody t i t r e and the level 
of protection was observed. Animals immunized wi th somatic antigens 
and the i r fractions showed good antibody t i t r e , but that obtained 
wi th ES antigens was much higher. 
Humoral immune response during the course of A. ceylanicum 
infection was assessed wi th counter Immunoelectrophoresis (CIEP) 
and enzyme l inked immunosorbent assay (ELISA). Precip i t in antibody 
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t i t r e in infected hamster sera could be detected as early as on 
day 30 post infection ( p . i . ) and th is persisted for a longer period 
(250 days p . i . ) - ELISA test could detect serum antibody (IgG) 
as early as on day 3 post infection. A signif icantly high antibody 
level was obtained on day 30 p . i . which fur ther increased on day 
AO p . i . The antibodies persisted throughout the investigational 
period ( t i l l 300 days) wi th sl ight fluctuations at in tervals . No 
cel l mediated immune (CMI) response was observed during the course 
of infection. 
In order to evaluate the impact of drug therapy on the 
immune status of infected hamsters, f i ve anthelmintics (Mebendazole, 
Albendazole, Levamisole, Pyrantel pamoate and CDRI Comp. 81-A70) 
were evaluated for any alteration in serum antibody. Following 
therapy wi th Mebendazole and Pyrantel pamoate, no prec ip i t in an t i -
bodies were demonstrable on day 10 as observed by CIEP whi le 
in sera of Levamisole and Albendazole treated hamsters, the pre-
c ip i t i n antibodies were detectable t i l l day 20 and 30 post treatment, 
respect ively. Thereafter, th is test yielded negative results. The 
hamsters, treated wi th comp. 81-A70, demonstrated prec ip i t in an t i -
body t i l l day AO post treatment ( p . t . ) and after that no antibodies 
were detected. 
ELISA results demonstrate that after Mebendazole therapy, 
there was sl ight elevation of the (IgG) antibody t i t r e on day 3 
followed by gradual decrease t i l l day 60 p. t . In Albendazole treated 
hamsters, there was perceptible reduction in antibody concentration 
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on day 3 post treatment. The antibody concentration was appreci -
abiy low on day 10 and further declined subsequently to a very 
low leve l . Levamisole treated hamsters, showed in i t i a l decrease 
in antibody t i t r e followed by an elevation in the t i t r e which remained 
high t i l l day 60 p. t . 
Pyrantel pamoate sharply lowered antibody concentration 
on day 5 p. t . and th is antibody level was maintained t i l l the end 
of observation (60 days p . t . ) per iod. 
Comp. 81-470 showed remarkable r ise in the serum antibody 
t i t r e after drug therapy (3-5 day p . t . ) . Thereafter a sl ight 
decrease in serum antibody was noticed but the t i t r e remained appre-
ciably higher than the untreated control throughout the observation 
per iod. 
Findings clearly demonstrated that A. ceylanicum is capable 
of evoking humoral response and sufficient antibody t i t res can be 
detected on day 30 p . i . However, the parasite does not stimulate 
CMI response atleast during the active infect ion. The antibodies 
so generated persisted for ' longer per iod. Thus, immunological 
parameters as such cannot serve an indication to evaluate ef fect iv i ty 
of drug against A. ceylanicum in hamster. 
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A B B R E V I A T I O N S 
B.S.A. . . . Bovine serum a lbumin 
CIEP . . . Counter Immunoelect rophores is 
CNS . . . Centra l nervous system 
DID . . . Double immuno d i f f us i on 
DTH . . . Delayed t y p e of h y p e r s e n s i t i v i t y 
EDc^ . . . 50% e f f ec t i ve dose 
ELISA . . . Enzyme l i n k e d immunosorbent assay 
E5 . . . E x c r e t o r y - s e c r e t o r y 
FCA . . . F reund 's complete ad juvant 
PCS . . . Feta l ca l f serum 
GABA . . . Gamma amino b u t y r i c ac id 
GIT . . . Gastro i n tes t i na l t r ac t 
g . . . gram 
h . . . hour 
i , m . . . . In t ramuscular 
i . p . . . . I n t r ape r i t onea l 
Kc/sec . . . K i locyc le /second 
1 . . . l i t r e 
L^ . . . I n f e c t i v e stage l a r v a e 
LDcQ . . . 50% le tha l dose 
M . . . Molar 
mA . . . m i l l i ampere 
N . . . Norma l i t y 
nm . . . nano meter 
N.S. . . . Normal sa l ine 
OD . . . Op t i ca l dens i t y 
OPD . . . Or tho pheny l d iamine 
PBS . . . Phosphate bu f fe r sa l ine 
p . i . . . . Post in fec t ion 
P- t . . . . Post t reatment 
s . c . . . . Subcutaneous 
UF . . . U n i v e r s i t y of F re i be rg 
^ g • . . microgram 
^® • • • E lu t ion volume 
^ ° • • • Void volume 
I N T R O D U C T I O N 
Helminth parasites of man and domestic animals continue 
to be major global public health concern because of the i r very 
high prevalence and the i r adverse effects on the nutr i t ional and 
immune status of the host. Prevalence of these parasites is f r e -
quently overlooked in temperate regions where they are less common 
and the i r effects are less marked than in the t ropics and the sub-
t rop ics . During the past half century, however, there has been 
a serious realization of the extent and gravi ty of human helminthiases 
and of the fact that they are unremittingly corrosive constituting 
a steady drain on the v i t a l i t y of the host and lowering, often fa ta l l y , 
h is resistance to other diseases even though they are hardly sufficient 
to cause death of the host. 
Among the various helminthic infections ancylostomiasis 
is a major disease of mankind from the point of human misery and 
economic losses (Faust and Russell, 1964). Prevalence of the disease 
is very high in agr icul tural areas (Raghawan, 1967) where favourable 
soi l temperature (23 -33°C) and high percentage of humidity are 
condusive to the growth and surv iva l of infect ive larvae. In an 
endemic area, contaminated soi l may continuously or seasonally bear 
large number of infect ive larvae which are found at the surface 
of the ground where the soi l is damp. Lack of sanitation and 
indiscriminate defaecation ensure constant exposure to infect ion. 
People frequently use same places for defaecation and going bare 
footed. This habit provides ample opportunity for larvae to enter 
through uncovered sk in . According to a recent estimate the global 
prevalence of hookworm infection (A. duodenale and N. americanus) 
is 900 mi l l ion (Warren and Mahmound, 198A) and i t is not surpr is ing 
that i t (hookworm infection) out ranks a l l other helminth infections 
of man, wi th the possible exception of Ascaris lumbricoides, in 
the production of human misery, deb i l i t y and economic losses in 
the tropics (Faust and Russell, 1964). 
IMPORTANT PATHOGENIC SPECIES 
Hookworms which are pathogenic to man are Ancylostoma 
duodenale (old world hookworm) and Necator americanus (American 
or new world hookworm). The t h i r d one, Ancylostoma ceylanicum, 
besides infecting dog and cat has also been reported from man. 
The important pathogenic hookworm species which parasit ise 
l ive-stock and wi ld carnivores are: 
Ancylostoma brazil iense 
A. caninum 
A. tubaeformis 
A. kusimaense 
A. paraduodenale 
Bunostomum phlebotomum 
B. trigonocephalum 
Gaigeria pachyscelis 
Unclnaria spp. 
(dog and cat) 
(dog and wi ld carnivores) 
(cat) 
(badger and dog) 
( l ion and related carnivores) 
(ox, zebu and sheep) 
(sheep and goat) 
(sheep and goat) 
(dog, cat, fox , wolf, pig 
and fur seal) 
GEOGRAPHICAL DISTRIBUTION 
The incidence and d is t r ibut ion of hookworm infection is 
world wide being more intense in the rura l parts of the tropics 
and subtropics. Stoll (1962) worked out the d is t r ibut ion of hookworm 
infection in various countries. According to him, 359 mi l l ion infected 
patients reside in Asia, 208 in the USSR, 1.4 in Europe, 49 in 
Afr ica, 42 in t rop ica l America and about 1.8 mil l ion in north America. 
These f igures, though o l d , (against 900 mi l l ion cases, recent estimate) 
(Warren and Mahmound, 1984) give an idea of endemicity in various 
regions. In Asia the high endemic countries are India, Malaysia, 
China and Japan. The disease also frequently occurs in Pakistan 
Burma, Sri Lanka, Bangladesh, Nepal, Turkey, Morocco, Algeria, 
I ran, The Arbian Peninsula, Hong Kong etc. 
In India, the t ropica l cl imate, low hygiene, and poor health 
education provide ideal conditions for growth, mult ip l icat ion and 
dissemination of a l l types of infections including hookworms. The 
incidence of hookworm has been reported to exceed 90% in tea and 
coffee cult ivat ing areas (Arora et^  al^., 1976, Gaitonde and Renapurkar, 
1979). The states wi th heavy infections are Andhra Pradesh (61.7-
81.0%), Assam (42.90%), Kerala (33.5-88%), Bihar (22.0-62%, 100%), 
Karnataka (29.2-76.0%), Orissa (47.7-87.0%), Maharashtra (10.6-60%), 
Madhya Pradesh (7.3-91.7%), Uttar Pradesh (3.9-87.0%), whereas 
mild infections occur in Gujrat (0.42-0.55%), Tamil Nadu (0.2-2.4%), 
Panjab (1.1-9.6%), Rajasthan (0.1-12.0%), Himanchal Pradesh (up 
to 13.5%), West Bengal (2.2-17.91^) (Gaitonde and Renapurkar, 1979). 
A 
GENERAL LIFE CYCLE 
The l i fe -cyc le of a l l hookworm species is d i rec t . There 
is no mult ipl icat ion of worms inside the host. The eggs containing 
segmented ova, are passed out in the faeces of infected host. From 
each egg a rhabdi t i form larva hatches out in about 48 hours. This 
moults twice, the f i r s t moult occurring on day 3 after hatching 
and the second on day 4 or 5 of the f i r s t moult and becomes a 
f i la r i fo rm larva ( infect ive L_ stage l a r va ) . The la rva l forms from 
L. to L , are free l i v i ng . The period for development from eggs 
to f i la r i fo rm larvae is on an average 8 to 10 days. L^ forms enter 
the host ei ther through skin or through mouth. In the former 
case the invasion takes place through barefoot to which f i l a r i fo rm 
juveniles are attracted by the heat of the body. The larvae cast 
off the i r sheaths and gain entrance to the body by penetration. 
The larvae after systemic migration through heart, lungs, trachea 
and oesophagus reach the intestine. L i t t l e growth or development 
takes place before the larvae enter the alveolar spaces. Th i rd 
moult ( f i r s t parasit ic moult) usually occurs after they leave the 
lungs. Fourth stage larvae wi th a provisional buccal capsule are 
f i r s t found in la rynx , pharynx, oesophagus and intestine in a re la -
t ive ly short time after infect ion. The growing larvae settle down 
in small intestine and undergo fourth moulting (second parasit ic 
moult) to develop to adolescent worms. At th is stage a def ini te 
buccal capsule wi th teeth is formed. In 3-4 weeks time the parasites 
mature to adulthood, mate and reproduce. 
Higo (1961) and Okamoto (1961) have demonstrated that 
mature f i l a r i fo rm larvae of A. duodenale when swallowed, w i l l develop 
into mature worms without migration phase. This was also confirmed 
by Hoagland and Schad (1978). The length of time from infection 
to f i r s t appearance of hookworm eggs in the faeces of the host 
i s , wi th in certain l imi ts constant for each species of hookworm. 
The shortest prepatent period (2 weeks) occurs in hookworms of 
dogs and cats and the longest in the hookworms of ungulates and 
Necator americanus of man (8-10 weeks). Yoshida et_ al^. (1968) 
recorded prepatent period of 18 to 26 days for A. ceylanicum in 
six volunteers. 
A. duodenale and N. americanus are comparatively long 
l i v e d . In experimental infection wi th A. duodenale and N. americanus 
maximum egg output was observed between 12-18 months of infection 
and the worms have a maximum l i f e span of A-7 years (Schad and 
Anderson 1985). 
SIGN AND SYMPTOMS 
The hookworms are voracious blood suckers which leads 
severe anaemia (Lorenzi and Jamra, 1978; Akinkugbe, 1980; Areekul, 
1980; Loureiro et^  al^., 1983) and various other associated disorders 
(gastrointestinal ulcerations, nutr i t ional deficiencies, creeping eruption, 
pneumonitis and broncho spasms). 
The other symptoms include physical and mental retardation 
(Watson, 1960) and myocardial ailments. In pregnancy, these infect-
ions may be associated wi th changes in renal function (Faust and 
Russell, 196A) resulting in toxaemia and albuminuria. The disease 
is also known to cause depletion in endocrine secretions, delay 
in puberty and par t ia l impotency in man (Watson, 1960; Faust and 
Russell, 1964). 
PATHOGENIC EFFECTS 
The pathology due to hookworm infections depends upon 
the stage of the parasite and the organ infested. I t may be d iv ided 
into two parts. Primary pathology is associated wi th the penetration 
and migration of infect ive larvae whi le secondary phenomenon is 
related to the pathology caused by adult worms. 
a) Pathogenic effects due to larvae 
At the site of entry (skin penetration) there is re lat ive ly 
l i t t l e mechanical damage to the skin layers but as the larvae burrow 
down the blood capi l la ry beds, considerable local tissue damage 
occurs. I f the pathogenic bacteria are also associated wi th the 
larvae which generally happens, open lesions develop, ending into 
ground i tch (dermati t is or water sore) (Watson, 1960). The f i l a r i -
form larvae of non-human species after entering the human sk in , 
wander aimlessly for long and produce reddish i tchy papules along 
the path traversed by them (Chatterjee, 1967). The condition is 
called creeping eruption (Mayers and Neafie, 1976; Cypers, 1982). 
During migration through the broncho-oesophageal path, microscopic 
damage is produced at each site where the larvae breakout of the 
blood capi l lar ies into airsacs, causing pneumonitis, bronchospasm 
and cough. 
b) Pathology due to adult worms 
The adult parasites inhabit small intestine (jejunum), attach-
ing themselves to the mucous membrane by means of thei r buccal 
armature and suck blood. A single parasite may consume on an 
average, 0.15-0.23 ml of blood each day from i ts host (Hoagland 
and Schad, 1978). A patient on average having 100 worms would 
loose approximately 15 ml of blood per day. The blood loss from 
one mi l l ion cases would be 15,000 l i t r es a day and world blood 
loss from 900 mi l l ion cases would be nearly 12 mi l l ion l i t res per 
day. Riva et a l . (1981) noticed acute massive intestinal bleeding 
in hookworm infections result ing in hypochromic microcytic anaemia, 
the main feature of hookworm infection (Lee, 1975; Areekul, 1979; 
Gupta et^  aJ^., 1980; Foy and Kondi, 1981; Variyam and Banwell, 
1982). The amount of iron loss through intest inal haemorrhage varies 
from 3.9 to 18.1 mg/day, depending upon the intensity of the infection 
(Maspes and Tamigaki, 1980). The body's iron stores are maintained 
by the dai ly absorption of iron from the small intestine. I t is 
estimated that a blood loss of 15-20 ml per day w i l l produce a 
state of negative iron balance as th is has been ascribed to faulty 
absorption from the injured intestine. Because of severe blood 
dra in , the infect ion, at t imes, leads to hypoalbuminaemia and severe 
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impairment of nitrogen balance in heavi ly infected hookworm patients 
(WHO, 1987). 
OBJECTIVE AND SCOPE OF THE PRESENT WORK 
In view of the seriousness of the problem, deep and con-
certed efforts need to be made to combat the hookworm scourge. 
In the absence of any vaccine against hookworms, immediate and 
effective remedy l ies in the successful treatment of the disease 
wi th suitable nontoxic agents. 
In recent past though a number of promising anthelmintics 
have been developed as antihookworm drugs and these are being 
successfully used for the treatment of ancylostomiasis of man and 
domestic animals, none, however, appears to be perfect as they 
have one or the other shortcomings. Bephenium hydroxynapthoate 
(Alcopar; Burrough's Welcome India L td . ) has species specif ic t o x i -
c i ty (Komiya et^  al^., 1960b; Hsieh, 1970), bitoscanate (Zonit; Hoechst 
India L td . ) frequently causes severe digestive disorders (Lammler 
and Saupe, 1969), pyrantel pamoate (Combantrin; Pfizer India L td . ) 
does not exert equal action against the two human hookworms (Huggins 
et^  a]^., 1973) and has many side effects (Kale, 1977), levamisole 
(Vermisole; Khandelwal Laboratories Pvt . L td . ) and tetramisole 
(Decaris; Ethnar India L td . ) are mainly effective against adult 
parasites (Thienpont e;^  aJ,., 1969; 1970). Mebendazole (Mebex; 
Cipla India L td . ) the drug of choice also has l imitat ions since 
the drug exerts embryotoxic and teratogenic effects (Annon, 1975) 
and as such is not prescribed during pregnancy, and in chi ldren 
of tender age (Keystone and Murdoch, 1979). Further the restr icted 
spectrum of ac t iv i ty in majority of the drugs named above l imi ts 
thei r use in mixed helminthic infections, a common feature noticed 
in underdeveloped and developing countries l i ke India. Thus, the 
need of the day is to develop an effective and nontoxic antihookworm 
agent (s) wi th high cure rate. Since polyparasit ism has become 
a rule rather than an exception, a drug wi th wide spectrum of 
anthelmintic ac t i v i t y w i l l be prefer red. The prophylact ic action, 
i f possessed by a drug, would be an added advantage in minimising 
the r i sk of reinfect ion. 
Though, chemotherapy at present is the only control measure 
for ancylostomiasis, th is tool provides only temporary cure because 
of reinfection in endemic population. This necessitates repeated 
drugging, adding not only to the cost but also posing problems 
of drug resistance. Therefore, drugs alone cannot cope wi th wide 
spread incidence of the disease. The current situation demands 
exploration of immunological control measures which w i l l provide 
long lasting protection and ultimate eradication of the disease. 
An ideal immunoprophylactic agent should/be 
a) avai lable in sufficient quantity 
b) provide strong protection in challenge infection 
c) effective in e l ic i t ing strong immunity in the host 
d) free from side effects 
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e) have long self l i f e 
f) of reasonably low cost 
g) have prolong action 
h) suitable for mass use 
For any biological investigation the basic requirement is 
to have a re l iab le test model. In early days the t r i a l for an t i -
ascarid drugs were being conducted on earthworms which have no 
s imi lar i ty wi th Ascaris except the phenotypic appearance. The 
earthworm is a free l i v ing creature and has (altogether di f ferent) 
habitat and nutr i t ional requirement from Ascaris which is an o b l i -
gatory parasite. Hence, the ^ v i t ro screening results obtained 
on earthworm d id not match wi th those obtained in Ascaris in man. 
With the passage of time newer host-parasite systems were developed 
and the drug development programme received a boost and many 
newer anthelmintics were developed. Thus, the selection of exper i -
mental model should be based, as far as possible, on the resemblance 
in the l i f e cycle pattern, pathological, biochemical and chemothera-
peutic reactions to the target parasite. 
The true human hookworms are A. duodenale and N.americanus. 
Attempts to adapt N. americanus in golden hamsters have been success-
f u l , however, i t necessitates the use of immunosuppressive drug, 
hydrocortisone (Sen et^  al^., 1965). The forced parasitism is l i ke l y 
to change the genetic make up of the parasite (Kr isch, 1972) resul t -
ing in altered immunological and chemotherapeutic responses and 
as such should be avoided. 
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A. ceylanicum, a hookworm parasite of man, cat and dog, 
having direct and short l i f e cycle, easy adapt ib i l i t y in a laboratory 
host, hamster (Ray and Bhopale, 1972) is a suitable test parasite 
for experimentation on ancylostomiasis. Further, the existence 
of posit ive correlation of chemotherapeutic responses between 
A. ceylanicum in hamster and target parasite add to i ts selection 
(Misra et^  aJ^., 1981; Katiyar et^  al^., 1982; 1984; 1987). As such 
in the present study A. ceylanicum was used as the test parasite. 
BRIEF OUTLINE OF THE WORK DONE 
The work embodied in the present thesis consists of two 
parts. Part I deals wi th chemotherapeutic studies and Part I I 
wi th immunological investigations. 
Under Part I , attempts have been made to develop new 
antihookworm agent (s) using standard chemotherapeutic techniques. 
For th is a large number of rat ional ly synthesized compounds and 
newly collected plant extracts were screened for the i r antihookworm 
ac t iv i t ies . Compounds showing promise have been investigated in 
de ta i l . Their therapeutic potent ial i ty has also been determined 
against other helminth parasites to ascertain ac t i v i t y spectrum. 
Part I I presents the work carr ied out on the immunological 
aspects. 
With a view to develop an acceptable immunoprophylactic 
agent(s), di f ferent antigenic materials (somatic and excretory-secretory) 
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derived from developing larvae and adult worms of A. ceylanicum 
were assessed for the i r immunoprophylactic potent ial . Further, 
the complex mosaic of the parasite antigen in dif ferent metamorphic 
forms wi th diverse immunogenic potentials are the main hurdles 
in the development of immunoprophylactic agent(s). Thus the iso-
lation and fractionation of immunogens which could afford acceptable 
protection to the host, may be a f ru i t fu l step in the direct ion 
of vaccine development. As such, attempts have been made to 
fractionate somatic and excretory-secretory products of A. ceylanicum 
to isolate the potent antigenic components for beneficial use to e l i c i t 
high order of immunity in hamsters. 
Besides, the immunologic prof i le of hamsters infected with 
A. ceylanicum was studied during the course of infection and after 
successful therapy in a bid to establish a correlation i f any, 
between the drug therapy and immune status of the host. 
PART I 
CHEMOTHERAPEUTIC INVESTIGATIONS 
R E V I E W O F L I T E R A T U R E 
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The existence of helminth parasites of man is as old as 
the history of human evolut ion. These are known since the earl iest 
time of ant iqui ty but i t was not unt i l re la t ive ly recently that the 
idea of modern helminthology took shape and use of anthelmintics 
became anything other than emperical. 
Although, l i f e is not generally threatened by helminth para-
si tes, none can ignore the i r long term i l l effects. Helminths release 
toxins which are pre judic ia l to the carr iers health (Watson, 1960) 
and lower the i r resistance or give a predisposit ion to other infections. 
Since the i l l effects due to these invaders are not as disastrous 
as those caused by bacteria and viruses, re la t ive ly less attention, 
in the past was paid towards control of helminthiases. Thus, i t 
is not surpr is ing that proportionately the number of suitable anthel-
mintics is very small . Hall (1928) in his exhaustive review gave 
a detailed account of early nematodicidal drugs and ascribed the 
lack of effect ive anthelmintics to the absence of c r i t i ca l screening 
models. 
Success in the development of new drugs is largely dependent 
on re l iab le screening models, rational design of molecule, and usage 
of standard screening techniques. Of these the former plays a 
pivotal role and requires better understanding of the host-parasite 
re lat ionship, as insuff icient knowledge regarding parasite biology 
would lead to errat ic and inconsistent resul ts. The f lu id and r u d i -
mentry knowledge on parasit ic models we had in the past, was 
perhaps the main hurdle in the development of effect ive medcaments 
against helminthic diseases. 
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The quali t ies of a good anthelmintic should be: 
a) I t must reach the habitat of the parasite and therefore, 
i t must resist absorption and rapid destruction in the host 's 
system. 
b) The drug must not have harmful effects on the host t issue. 
c) I t must attack the v i ta l organs of the parasite. 
d) I t must destroy the parasite or affect i t s expulsion without 
producing toxic effects in the host. 
e) I t must be cheap and easy to administer and be effective 
in single dose which may be beneficial for mass treatment. 
With the advent of re l iable test models in recent years, 
remarkable success has been achieved and many effect ive and safe 
anthelmintics have been developed as evidenced by several publ ica-
tions on helminth chemotherapy. Exhaustive reviews, on chemothera-
peutic agents developed from time to time against hookworms, have 
been presented by Standen (1963), Cavier and Hawking (1973), Annon 
(1979), Lang (1979), Sharma and Charles (1982) and recently by 
Van den Bossche et^  al^. (1985). 
A l l these give a general account of drug's effectiveness 
against various species of hookworms. This chapter b r ie f l y reviews 
the l i terature on the agents which are active against hookworms 
of man, domestic animals and experimental hookworm models. 
Ancylostoma ceylanicum as a test parasite has been recognized 
recently (Ray et aJ_., 1978; Misra et^  aJ,., 1981; Katiyar e^ a l . , 
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1982; 1984; 1987) and as such only a few chemotherapeutic studies 
on th is parasite have been conducted and very l imi ted l i terature 
is avai lable. Anthelmintics screened/used against other hookworms 
have been reviewed and reference, wherever avai lable on A. ceylanicum 
has also been made. 
SYNTHETIC PRODUCTS 
a) Halogenated hydrocarbons 
The use of halogenated hydrocarbons as anthelmintics dates 
back to 1929 (Wright and Schaffer, 1932). Carbon tetrachlor ide 
was recommended for the treatment of hookworms (Hal l , 1921). 
Later, Hall and Shi l l inger (1925) used tetrachloroethylene against 
human ancylostomiasis which was more active and less tox ic (Migasena 
et a l . , 1978). However, the drug causes depression of the central 
nervous system and is re lat ive ly tox ic . I ts administration may 
prove fatal i f proper care is not exercised. Because of t ox i c i t y , 
the use of carbon tetrachlor ide has been discontinued. 
b) Phenols and their alkylated derivatives 
The- anthelmintic property of a lky lated der ivat ives of phenol 
was studied by Lamson and Brown (1936) and recently reviewed 
by Sharma and Charles (1982). Of these, disophenol (2 ,6 -d i ido-
4-ni t rophenol) , thymol , iodothymol, d isopyro l n i t roxyn i l (4-cyano-
2-iodo-6-nitrophenol) were used as antihookworm agents (Mutalik 
et^  aJ.., 1964). Idothymol and d isopyrol showed moderate ac t i v i t y 
against A, duodenale and N. americanus (Sanghavi and Mis t ry , 1971; 
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Sen et^  al^. ,1974). Phenols cause many toxic effects and as such 
they are no more used in c l in ical pract ice. 
c) Cyanine dyes 
A number of cyanine dyes are known to possess antihookworm 
ac t iv i ty and of these di thiazinine iodide and sti lbazium are of some 
importance. Wright and Brady (1938; 19A0) evaluated the anthel-
mintic property of various dyes. Dithiazinine iodide and stilbazium 
have remarkable ac t i v i t y against hookworm of cat and dog (McCown 
et aJ^., 1957; Burrows and L i l l i s , 1962), but are feebly effective 
against human ancylostomiasis (Wagner et^  al^., 1958; Jaffery et^  a l . , 
1963). These dyes also cause many unfavourable reactions, such 
as nausea, vomit ing, gastric pain, dizziness, headache and fever, 
which l im i t the i r use. 
d) Quaternary ammonium sal ts 
Quaternary ammonium compounds have been shown to posses 
wide spectrum of ac t i v i t y against intest inal nematodes (Copp et_ 
a l . , 1958), and act iv i t ies of th is group have been extensively reviewed 
by Standen (1963), Cavier and Hawking (1973) and more recently 
by Sharma and Charles (1982). In human ancylostomiasis, the early 
t r ia ls carr ied out by Young et^  aJ^ . (1958), were quite encouraging. 
Among the various members of th is series, bephenium hydroxynaph-
thoate is the most act ive member. This is being marketed by 
Burrough's Welcome (India) under the trade name of "Alcopar". 
I t has high efficacy against the experimental infection of hookworms. 
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Young et^  a l . (1960) treated 169 cases of ancylostomiasis (human 
subjects) wi th suspension of bephenium hydroxynephthoate in water, 
f ru i t juice or m i l k . The usual dose is 5 g (= 2.5 g of base) per 
adult (single or mult iple dose) at which i t is h ighly effective 
against A. duodenale and N. americanus (Vaki l and Dalai, 1975; 
Al-Issa and Abdul Wahab, 1978). The drug, however, has species 
specif ic ac t i v i t y , i . e . being more effect ive against A. duodenale 
than N. americanus (Hsich, 1970). 
Against A. caninum in dog, the drug was effective at 50 
mg/kg x 1 b.w. (Larcevicet^^,1972). Against Uncinaria stenocephala, 
1-2 g given in single oral dose cured dogs to the tune of 84.8 to 
100% (Novikov et^  al^., 1971). Ray et^  al^. (1978) have evaluated i t s 
action against A. ceylanicum in hamster. With single dose adminis-
trat ion of 200 mg/kg and 1000 mg/kg the respective efficacy rate 
was 73% and 90%. 
Main disadvantage of Alcopar is i t s very b i t te r taste. Nausea, 
vomiting, stomachache and diorrhoea are the other common side 
effects. 
e) Piperazlne salts 
Piperazine preparations are feebly active against ancylostomes 
and the i r anthelmintic property had been evaluated by Deschiens 
e^ a],. (1954). At a dose, ranging from 63 to 100 mg/kg, the cure 
rate against N. americanus and A. duodenale wi th piperazine c i t rate 
was 81-84%. 
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f) Arylisothiocynates 
i ) Bltascanate (Zonit) 
Hoechst developed th is drug for the treatment of hookworm 
infections. I t was highly effective against A. duodenale and 
N. americanus. At the dose of 50-100 mg/kg (single or mult iple) 
the compound was fu l l y effective against hookworms (Mutalik and 
Gulati, 1975; Vaki l and Dalai, 1975). 
The drug had many toxic side effects (vomit ing, nausea, 
headache, diorrhoea, abdominal pain, weakness and vert igo) and 
as such i t has been withdrawn from the market. 
i i ) Amoscanate 
Developed by Ciba-Geigy (India Ltd) as a n t h e l m i n t i c Amos-
canate has been shown to possess efficacy against a var iety of 
intestinal parasites including hookworms. I ts efficacy against in tes t i -
nal helminths was evaluated by Doshi et^  a]^. (1977). The drug 
is highly efficacious against A. duodenale and hJ. americanus (Doshi 
et^  al^. , 1977; Singh et^  al^., 1981). 
Studies carr ied out in China, revealed that mice treated 
with 50 mg/kg x l of a suspension formulation or 250 mg/kg x 1 
of an o i l formulation developed focal necrosis of the large in t ra -
hepatic and extrahepatic b i le duct and gal l bladder (Batzinger et 
aJ^., 1981). The compound is under c l in ica l t r i a l s and is yet to 
be released for mass use. 
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g) Imldazothiazoles 
Tetramisoles, the new class of anthelmintics, were developed 
by Thienpont and his associates in 1966. The most potent member 
of th is group is levamisole ( levorotatory isomer) which is more 
effective than i t s dextro-rotatory counterparts (Tetramisole). The 
chemotherapeutic efficacy of imldazothiazoles has been reviewed 
by Ferriot (1978) and Lionel (1980). 
i ) 1-tetramlsole (Levamisole) 
Act iv i ty of th is compound against hookworm was studied 
by Haller (1980). A complete picture of the drug efficacy is ava i l -
able in "The levamisole s tory" published by Janssen (1976). A 
dose between 2.5-200 mg/kg (single or mult iple) was 50-100% active 
against A. duodenale and N. americanus (Kuzmicki et^  al^., 1972; 
Rees et^  al^., 1974; Sinniah and Sinniah, 1981). Levamisole is also 
effective against hookworms of cat and dog at respective doses 
of 3.8 to 7.1 mg/kg x 3 and 1.3 mg/kg x 1 (Beck et^  al_., 1971). 
In experimental hookworm infect ion, 30 mg/kg x 1 dose given oral ly 
was 100% effective against A. ceylanicum, Nlppostrongylus brasi l iensis 
and Nematospiroides dubius in the respective hosts. 
Levamisole besides having anthelmintic ac t i v i t y also restores 
the host defence in immuno deficient patients. 
i i ) d-tetramisole (Tetramisole) 
This drug is in fer ior to levamisole against human hookworms 
(Radoev, 1974). However, in mult iple dose schedule, 150 mg/kgx4 
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given at 6 hourly in te rva l , yielded satisfactory results (Vaki l and 
Dalai, 1975). 
Against hookworms of dog and cat the drug was moderate 
to highly effective at mult iple doses of 20 mg/kg x 3 (Lammler 
et^  al., 1970; Kessler and Stoye, 1971). In experimental infection 
of A. ceylanicum in hamster, a dose of 100 mg/kg caused 30% worm 
reduction, however, when the amount was doubled the ac t i v i t y was 
enhanced to 85% (Ray et^  al^., 1978). Contrary to ear l ier reports, 
Misra et^  aJ .^ (1981) have shown 95% cure at single oral dose of 
30 mg/kg. Against the experimental hookworm infections of A. 
ceylanicum, N. brasi l iensis and hJ. dubius the drug is 100% effective 
in respective single oral dose of AO mg/kg, 50 mg/kg and 40 mg/kg 
(Misra et^  al^., 1981). 
h) Tetrahydropyrimidines 
Pyrantel pamoate is the most important member of th is 
group. This was developed by the Medical Research Laboratories 
of Chas-Pfizer and Co. Inc . , U.S.A., in late s ix t ies under the 
brand name of "Combantrin". I ts broad spectrum efficacy was des-
cribed by Desowitz e^ aJ^ . (1970), Pasticier (1975) and Islam and 
Chowdhury (1976). The drug was found more efficacious against 
A. duodenale than against N. americanus (Huggins et a l . , 1973). 
The drug is effective at the dose of 10-20 mg/kg in single or mult iple 
dose administration (Singh e^ al^., 1977a; Al-Issa and Abdul Wahab, 
1978; Schcherbakov et^  al^., 1980). 
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Against experimental infection Nl. dubius and HI. nana, a 
dose of 50 mg/kg x 3 of the drug showed 79% host clearance. 
Against A. caninum and T. canis, of dog 100% efficacy was achieved 
at a single oral dose of 5.0 mg/kg. Similar studies against A. 
brasil iense and U. stenocephala gave 100 and 96.3% efficacy res-
pectively (Robinson et_ al^., 1976b). 
Pyrantel pamoate in combination wi th oxantel exhibi ted 
high efficacy (100% effective) against A. duodenale in man at a 
single oral dose ranging 15-20 mg/kg (Dissanaike, 1978; Rim et^  al^., 
1978; 1981; Cabrera et^  aJ^., 1980). 
Pyrantel pamoate is only s l igh t ly absorbed from the gut 
and is wel l to lerated. A single oral dose of 3500 mg/kg d id not 
produce any side effect whi le a dose 2500 mg for two consecutive 
days resulted in mild side effects l i k e , diorrhoea, gas cramps 
and nausea (Bumbalo et^  al^., 1969). 
i ) Benzimidazole 
Perhaps the most significant break through in the f ie ld 
of modern anthelmintics was achieved in 1961 when Brown and his 
colleagues reported the unusual broad spectrum ac t i v i t y of benzlmi-
dazoles against gastrointestinal helminths of man and animals. Ferriot 
(1978), Sharma and Charles (1982) and Van den Bossche et a l . (1985) 
have reviewed the chemotherapeutic usefulness of dif ferent benzi-
midazoles. 
Among the various members of th is series, thiabendazole, 
mebendazole and albendazole are the most potent members. 
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i ) Thiabendazole (Mintezol) (Merck, Sharp and Dohme, India L td . ) 
This drug was formulated by Brown et^  aJ^ . (1961) and in t ro -
duced by Merck in 1961. Lang (1979) and Lionel(1980) have elabo-
rately reviewed the efficacy of th is drug. I t is a polyvalent and 
versat i le anthelmintic for cure and control of parasit ic infections 
in man (Campbell and Cuekler, 1969; Meoni, 1971; Yalcinkaya, 1975). 
Rees et^  al^. (1974) and Farahmandian et^  aJ^ . (1977) found that 25-
100 mg/kg drug in single or mult iple doses was effective (50-70%) 
against human hookworms. 
The drug has poor efficacy against A. ceylanicum in hamsters. 
A dose of 100 mg/kg x 1 caused only 32% worm reduction. High 
doses from 150-700 mg/kg x 1 caused 83 to 99% worm reduction (Ray 
et_ al^. , 1978). 
Misra et_ al_. (1981) achieved 100% efficacy wi th a dose 
of 150 mg/kg x 3 against A. ceylanicum in hamster. 
Thiabendazole addi t ional ly possesses l a rv i c ida l property 
and hence has been widely used against "creeping erupt ion". Drug 
in 15% aqueous suspension or 50% as paste appl ied top ica l ly cured 
cutaneous larva migrans in 9A to 98% of the cases (Bat t iss t in i , 1969; 
Whiting, 1976; Bardach, 1980). 
The pharmacological propert ies and tox ic i t y of the drug 
were studied by Graessle e^ aJ.. (196A) and by Robinson et^  al.. 
(1965). Major part of the drug in single oral dose administration 
was eliminated in 48 hours, including 75% in the urine and 15% in 
the faeces. 
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Side effects include, nausea, headache, colic musculoskeletal 
pain, giddiness and vomiting (Chuttani and Ghouri, 1969; El-Masry 
et a l . , 1974). In some patients theophyl l ine type t ox i c i t y , toxic 
epidermal necrolysis, intrahepatic cholestatic, p ru r i t i s and jaundice 
have been reported by Robinson and Samorodin (1976) and Sugar 
et^  a][. (1980). 
i i ) Mebendazole 
This is the most promising member of the benzimidazole 
series, synthesized and developed by Janssen Pharmaceutica Research 
Laboratory, Beerse, Belgium in 1972. Lang (1979) has reviewed 
the therapeutic value of mebendazole. The drug is h ighly effective 
against a var iety of helminth parasites. The usual dose recommended 
for human hookworms is 100 mg/kg, given twice dai ly for three 
consecutive days and at th is dose schedule the drug is 100% effective 
against A. duodenale and N. americanus (Gorodner et_ al^., 1977; 
Loria et^  al^., 1977; Bunnag et_ aj^., 1978; Jaroonuerama et_ al^., 1978; 
Cabrera and Cruz, 1980; Sinniah and Sinniah, 1981; Vujosevic et 
a l . , 1981). The drug is also highly effect ive against A. caninum 
in dog, A. tubaeformis in cat and N. americanus in rabbi t model 
at 10-150 mg/kg in single or mult iple doses (Guerrero, 1978; Bhopale 
et^  a l . , 1982). 
Mebendazole was also reported to inh ib i t the development 
of A. duodenale. N. americanus and A. caninum eggs in faecal cultures 
but had no effect on the v i ab i l i t y and in fec t i v i t y of 3rd stage 
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larvae (Banerjee et^  al^., 1971). In experimental infection of A. 
ceylanicum in hamster, i t showed excellent eff icacy. Though, Ray 
et a l . (1978) have obtained 100% clearance of A. ceylanicum in hamster 
at the dose of 100 mg/kg, recent observation made by Misra et_ 
a l . (1981), found that to achieve these results only 1 mg/kg x l 
of the drug is needed. 
The drug does possess minor side effects and causes nausea, 
diarrhoea, headache, cy to tox ic i ty , oesinophi l ia, polatoschisis and 
p ru r i t i s (Gorodner et^  aU, 1977; Bosse and Stoye, 1981). The 
main drawback of th is agent is embryotoxic and teratogenic effects 
(Annon, 1975; Delatour e^ al^., 1976). Hence the drug is contra-
indicated during pregnancy and in chi ldren of tender age (Keystone 
and Murdoch, 1979). 
i i i ) Albendazole 
Albendazole, a new benzimidazole der ivat ive is methyl-5-
prophylthio-1-H-benzimidazole-2-yl-carbamate, and is being used 
as a broad spectrum anthelmintic in veterinary practice (Theodorides 
et^  aJ^., 1976; Georgi et^  aJ^., 1980). Recently, i t has been introduced 
for human use also. In i t i a l f indings suggested that at the dose 
of AOO mg/kg x 1, the drug was highly effective against a var iety 
of nematode and cestode infections (Pene et^  al^., 1982). 
Misra e^ al^. (1983) tested the drug against 56 adult patients, 
having single or mixed infections wi th round worms, hookworms, 
whipworms, pin worms and tapeworms. A single dose of 400 mg 
gave cure rate of 95.7% in ascariasis, 94.1% in ancylostomiasis and 
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57.2% in taeniasis. Jagota (1986) reported 92.2% cure rate (130 
out of 141 cases in hookworm infection at a dose of AOO mg/kg x1.. 
The drug in suspension form (400 mg in 20 ml) has been reported 
to be 100% effective against 8 mild and 6 moderate cases of 
A. duodenale infection (Misra et_ al^., 1985). Rossignol and Maisonneuve 
(1984) have evaluated i ts acute tox ic i t y in mice and rats wi th single 
oral dose of 5000 mg/kg and 1500 mg/kg respect ively and observed 
mi ld side effects i . e . , loss of appet i te and diarrhoea in both the 
species. They also evaluated tox ic i t y in rat and dog with da i ly 
oral administration of 48 mg/kg for 4 weeks. In both the species 
there was diarrhoea, anaemia and loss of appetite and body weights. 
j ) Avermectins 
Avermectins are the newly discovered ant iparasi t ic agents 
(Burg et^  al., 1979) wi th excellent potency and unique spectrum 
of ac t iv i ty against nematode and arthropod parasites. These are 
macrocyclic lectones produced by a new species of actinomycete, 
Streptomyces avermi t i l i s (Burg et^  al_., 1979). The fungus was f i r s t 
isolated in Japan and the anthelmintic efficacy of the fungal con-
centrate was established by Merk, Sharp and Dohme Research Labo-
ratories against N. dubius in mice at a concentration of 0.0002% 
in diet for 6 days (Campbell, 1981). 
Avermectins consist of 4 major components, Ala, A2a, Bla, 
B2a, in varying proportions and equal number of minor components, 
A lb , A2b, Bib and B2b, each of which is a lower homologue of 
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the corresponding major component. The avermectin complex was 
further analysed and found to contain several f ract ions. The most 
potent isolate was 22,23-dihydroavermectin Bla, named " Ivermect in" . 
I t consists of at least 80% of 22,23-dihydroavermectin, Bla and 
about 20% of ' b ' homologue. This combination, being highly effect-
ive and safe, was purused for commercial development (Chabala 
e t ^ a l . , 1980; Egerton et^  al^., 1980). 
Against canine hookworms, Bla component is 82.5% effective 
at 0.003 mg/kg dose level and 90% at 0.005 mg/kg whi le B2a fraction 
is more potent and 100% effect ive at the dose of 0.003 mg/kg (Blair 
and Campbell, 1978). 50 ug/kg dose given subcutaneously showed 
100% efficacy against A. caninum and A. brazil iense (Anderson and 
Roberson, 1982). The drug appears to possess broad spectrum 
of efficacy being effective against a var iety of helminth parasites 
including gastrointestinal (GI) tract nematodes and f i l a r i i d s (Barth 
et^al^., 1980; Campbell et^  aJ[.; 1983). 
The drug paralyses worms by potentiating the inh ib i to ry 
effects on neurotransmitter i . e . , gama-amino-butyric acid (GABA). 
Signals from central nervous system (CNS) are, therefore, not per-
ceived by the motor neurons resulting in the state of para lys is . 
The expanded range of ac t i v i t y , coupled wi th negligible 
tox ic i ty and lack of cross resistance to other drugs, ivermectin 
appears to be the most important contribution as ant iparasit ic agents 
in recent years. 
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PLANT EXTRACTS 
Very l imi ted use of plants against hookworms has been 
made. Among these, o i l of chenopodium (Chenopodium ambrosioides) 
was introduced in Europe in 1881, for the treatment of intestinal 
parasites (Watkins, 1958). The o i l which contains 45-70% active 
constituents is h ighly toxic UT^  v i t ro to Ascaris (Cavier and Hawking, 
1973) and H. nana (Sen and Hawking, 1960). The o i l was exclusively 
used against Ascaris and ancylostomes (Cavier, 1973) but at present, 
i t has no therapeutic value due to i t s high tox ic i t y and ava i lab i l i t y 
of better agents. 
Cashew nut o i l (Anacardium occidentale) is the other 
known plant extract effective against ancylostomes of man and animals. 
Four to six gram (adult dose) given 3-A times at 15 days in te rva l , 
exerted 63.6% cure (1A out of 22) in man (Eichbaum et_ al_., 1950). 
With the advent of better antihookworm agents the use of 
the feebly effect ive plant extracts has been abondoned. 
The anthelmintic drugs currently avai lable have one or 
the other shortcoming which l im i t the i r use. Thus, there is need 
to develop new anthelmintic (s) wi th wide spectrum ac t i v i t y , high 
cure rate, minimum side effects and suitable for population based 
chemotherapy. 
M A T E R I A L S A N D M E T H O D S 
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MAINTENANCE OF PARASITES IN LABORATORY HOSTS 
Ancylostoma ceylanicum (hookworm) 
A. ceylanicum infection ( infect ive larvae) was procured 
from the Sarabhai Research Centre, Baroda in 1978 and since then 
th is is being maintained in th is laboratory in golden hamsters (Visen 
et^  aJ^., 198A), 
A. ceylanicum completes i ts l i f e cycle exclusively in the 
small intestine (jejunum) of the host. The infect ive larvae (L^) 
following oral administrat ion, develop into adult stage in the intestine 
without under going any tissue migration. Mature parasites can 
be seen in the intestine as early as day 12 post infection ( p . i . ) 
but the peak egg count is achieved on day 18 p . i . 
Larval culture 
Faecal pellets were collected from hamsters harbouring 
19-25 day old infection and were made to th in paste wi th d i s t i l l ed 
water. The faecal paste is thoroughly mixed with activated charcoal 
in the rat io of 1:3 and transferred to petr l -d ishes (6" diameter) 
having moist f i l t e r paper at the bottom and sprayed wi th 0.2% 
mycostatin to check fungal growth. Culture plates were maintained 
at 26 -28 C in a humid chamber for 9-12 days (by th is time the 
eggs get transformed to infect ive larvae L_). The developed L-, 
"J 3 
were separated and cleaned by baermannization or by repeated wash-
ing and sedimentation. 
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Preparation of infective inoculum 
The la rva l count was made by Scotts' d i lut ion technique. 
Br ie f l y , the larvae were di luted with appropriate volume of d is t i l l ed 
water and gently s t i r red to make the larvae uniformly d ist r ibuted 
in the suspension. 0.1 ml of the suspension was spread over a 
Scott's s l ide and the la rva l count was made under the dissecting 
microscope. Three la rva l counts were made and the average number 
of larvae present in 0.1 ml of the suspension was assessed, and 
from th is the number of larvae present in 1 ml of mother suspension 
was calculated. 
For experimental work, the stock solution was di luted wi th 
d is t i l l ed water so as to obtain the desired number of larvae in 
0.2 ml of the suspension. 
Infection to hamsters 
Hamsters were kept in plastic cages and maintained under 
standard laboratory conditions. They were fed wi th standard rodent 
food pellets (Lipton India L imi ted, Bangalore) and water ad l ib i tum. 
An inoculum of 60 ± 10 L^ is most appropriate as higher inocula 
are lethal to hamster and lower yielded poor parasite recovery. 
Hamsters weighing 60-70 g used in di f ferent experimental 
work were ora l ly infected wi th 0.2 ml of the larvae suspension 
(60 ± 10 L^) per hamster. Infection was given wi th the help of 
feeding needle (20 gauge). 
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Nipostrongylus brasiliensis (trichostrongylid) 
This parasite was or ig inal ly obtained from Wellcome Labora-
tories of Tropical Medicine, London and is being maintained in 
albino rats in th is inst i tute since 1963. The newly weaned albino 
male rats of U.F. (University of Freiburg) strain (30-40 g) were 
infected wi th 500 L, subcutaneously ( S . C ) . The larvae of 
N. brasi l iensis in rats following subcutaneous inoculation traverse 
through lymph and blood vessels and by 30 h they reach the lungs 
and moult there to become L, . By the 65th h the L, stage (35% 
of the or iginal L_ dose) are carr ied to the lumen of the small 
intestine where they moult once more to L_ and ult imately transformed 
into adults by 6th day. The peak egg discharge is obtained on 
day 9 p . i . (Katiyar and Sen, 1969). 
Syphacia obvelata (oxyurid) 
This parasite has direct l i f e cycle and the mice naturally 
get infected when maintained in the close v ic in i ty of infected colony. 
The mice, which on stool examination found posit ive were used 
in drug test ing. 
Hymenolepis nana (cestode) 
Laboratory raised male Swiss mice (15-20 g) were used 
as the host. 
The adult worms were collected from infected mice harbour-
ing 17-20 day old infect ion. The terminal gravid proglott ids were 
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removed and crushed gently in a beaker containing dechlorinated 
tap water. The crushed material was suspended in a small volume 
of dechlorinated tap water. 
Counting of e ^ s and infection to host 
Egg counts were made wi th the help of haemocytometer. 
Only fu l l y developed eggs wi th moving hooklets were counted. The 
volume of the stock suspension was then adjusted using dechlorinated 
water, containing 0.2 mg/ml of morphine sulphate so that each ml 
of f inal suspension should contain 1000 eggs. Each animal was 
given 0.2 ml of suspension ( i . e . 200 eggs per animal) through a 
feeding needle attached to a one ml tuberculine syr inge. Infection 
matures in the host on day lA-18 post infect ion. The worm remains 
in the host for a period of 30-40 days fol lowing single infection. 
Number of adult worms recovered was var iab le. The size of worms 
is inversely proport ional to the number of worms developed. 
Hymenolepis dimlnuta (cestode) 
This is the parasite of rodents but can infect humans also. 
I t is a large tape worm and has indirect l i f e cycle. 
The parasite was maintained through i ts intermediate host, 
the grain beetle, (Tr ibol ium confusum). B r ie f l y , the beetles were 
maintained at room temperature (28 -30°C) on wheat f lour enriched 
wi th yeast powder (5-10%). Adult beetles developed in th is way, 
were used for propagation of the colony. 
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For infect ion, the technique of Voge and Turner (1956) 
was used. Prior to infection the beetles were starved for A-5 
days. Concentrates of cestode eggs were placed on a small piece 
resin in a one inch standard pe t r i d i sh , the bottom of which was 
covered wi th f i l t e r paper. The starved beetles were then exposed 
for 2A h to the resin containing egg concentrate. The cysticercoids 
develop in beetles in 8-10 days after exposure. 
Infected beetles were dissected to collect required number 
of cyst icercoids. Eight to ten cyst icercoids were given to each 
rat ora l ly with the help of feeding needle and tuberculine syringe. 
The adult worms developed on 17-20 day post infect ion. 
PRIMARY SCREENING AGAINST A. CEYLANICUM 
The primary screening of potential antihookworm compounds 
and plant extracts was carr ied out against A. ceylanicum in hamster. 
After detailed chemotherapeutic evaluation, any compound showing 
promise was tested for i ts spectrum of anthelmintic ac t i v i t y against 
various test parasites. At least two replicates were done for each 
type of study. 
Preparation of test materials 
The plant extracts and synthetic compounds for testing 
were provided by the Medicinal Chemistry Division of th is Inst i tute. 
The water soluble synthetic compounds were made into solu-
tion in requisi te amount of water, whi le the insoluble ones were 
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made into f ine paste wi th tween 80 (polyoxyethylene sarbitan mono-
oleate), before making f ina l suspension in permissible amount of 
water. 
Drug testing 
Drugs were tested as per technique being used in th is 
inst i tute (Misra e^ a^., 1981; Katiyar et_ al^., 1987). Br ie f l y , the 
hamsters harbouring 18-20 day old infection (60 ± 10 L_; per hamster) 
(as confirmed by ovoscopic examination) were used for screening 
purposes. The animals were randomized in various experimental 
and control groups. Animals were starved overnight (to ensure 
closer contact of the drug wi th parasites) and treated with plant 
extracts or synthetic compounds at the i n i t i a l dose of 1 g/kg x1 
and 250 mg/kg x 1 respectively using 2-5 animals. A l l experimental 
and control animals, 48 hours la ter , were sacrif iced under deep 
ether anaesthesia having been starved 24 h before hand. Withdrawal 
of food fac i l i ta ted accurate counting of worms. A l l the parasites 
recovered from ind iv idual hamsters were registered. 
Assessment of therapeutic efficacy 
The therapeutic efficacy was assessed by comparing the 
average number of worms recovered from the treated groups to 
that obtained from untreated control group. The efficacy was assessed 
in terms of percent worm reduction which was determined by the 
formula ^ ; ^ X 100; where ' N ' and 'n 'a re the average number of 
worms recovered from the untreated control and treated animals 
respect ively. 
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The t r i a l s were conducted under optimal experimental condi-
tions to minimize the possible errors in drug test ing. The synthetic 
compounds, found active in i n i t i a l doses, were evaluated at lower 
doses t i l l reasonable ac t i v i t y was retained. 
This exercise helped in selecting the most effect ive compound 
for elaborate studies. 
DETAILED INVESTIGATIONS ON ACTIVE COMPOUNDS 
A. ceylanicum 
Determination of effective dose 50% (ED50) 
A number of hamsters (50-80 g) were infected with SOilOL^. 
On day 18 p . i . they were weighed and randomized in different 
experimental and control groups. As far as possible, large number 
of descending doses of the test compounds were evaluated in the 
same batch of animals to avoid day to day and batch to batch 
variation in chemotherapeutic results in respect of time factor, 
worm load and animal husbandry conditions. Two to 5 animals 
at each dose level were employed. Efficacy was assessed as ment-
ioned ear l ier . A l l the experimental data were pooled and the ED^_ 
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value based on percent worm reduction was calculated by the method 
of Basil (1963). 
Assessment of larvicidal action 
The method of infection and medication to animals were 
the same as described ear l ie r . Animals were d iv ided into several 
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groups, depending on the number of doses and stages of parasite 
against which the action of the drug was to be evaluated. The 
infect ive larva (L^) of A. ceylanicum moults to L, on day 2 and 
L, to Lc on day 5 (Ray et^ al_., 1972). Therefore, the test comp-
ounds and reference drug, mebendazole, were administered on day 
1, 3 and 6 post infection in dif ferent batches to evaluate the action 
on L^, L, and L^ . stages respect ively. The control animals received 
medium only. Treated and untreated animals were necropsied on 
day 18 p . i . , when worms reached maturity in the intestine. The 
efficacy was expressed in terms of absolute clearance of parasites 
from the host, and percent worm reduction compared to control 
group. 
Chemoprophylactic action 
For evaluating chemoprophylactic potent ial , hamsters were 
injected intramuscularly ( i . m . ) wi th the test compounds in a re la t -
ive ly high dose. The treated hamsters were challenged wi th 60±10L^ 
at dif ferent intervals after the treatment. The untreated control 
group, which received only the medium was also challenged s imul-
taneously. 
The hamsters of both the groups were sacri f iced on day 
18 post challenge when worms attained patency in the small intestine. 
The assessment of prophylact ic action was done on the basis of 
absolute worm clearance and percent worm reduction compared to 
untreated controls. 
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Speed of action 
To study the speed of action, a number of male hamsters 
(60-70 g) were infected ora l ly with 60±10L,. Eighteen days post 
infect ion, animals (confirmed by ovoscopic examination) were d iv ided 
into three groups. Group I was treated wi th test compound (87-
1A4) and groupd I I with mebendazole. The t h i r d untreated group 
served as control . The animals of group I and I I were treated 
wi th curative dose of respective drugs (Comp. 87-14A at 12.5 mg/kgxl 
and mebendazole at 1 mg/kgxl) and group I I I received sham treatment. 
Two animals from treated group and one from untreated 
control group were necropsied at intervals of 3, 6, 9, 12, 15, 18, 
21, 25, 27, 30, 32 and 35 h post medication. The number, location 
and condition of parasites were recorded. 
Acute toxicity 
The acute tox ic i t y test was carr ied out in healthy male 
mice (20-25 g) by oral route as described by Bushby (1963). 
Br ie f l y , mice were administered wi th test compounds 87-144 and 
mebendazole, using 10 mice at each dose leve l . Control animals 
received medium only. The animals were kept under close obser-
vation for 48 h. The mortal i ty and adverse effects, i f any noticed) 
were recorded. 
Nippostrongylus brasiliensis 
Male albino rats of UF strain (35-40 g) harbouring 9 day 
old infection (500 L3) , subcutaneously were used for drug testing 
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(Katiyar et^  al^., 1984). The infected animals were div ided into 
various groups, each consisting of 2-5 animals. The compounds 
were administered oral ly on day 9 p . i . (single dose schedule) 
in dif ferent doses. The control animals received medium only. 
The treated and untreated animals were autopsied on day 3 of t reat-
ment and efficacy was assessed as described for A. ceylanicum. 
Syphacia obvelata 
S. obvelata is frequently found in rodents. The mice which, 
on stool examination, were found harbouring natural S^ . obvelata, 
were employed for drug test ing. Two to four animals (20-25 g) 
of ei ther sex were used at each dose leve l . The drug t r ia ls both 
in single and mult iple schedules were carr ied out according to the 
technique of Standen (1963). 
After sacr i f ic ing the experimental and control animals on 
day 3 of last medication, the contents of caecum and rectum of 
ind iv idual mouse, were gently scrapped out in a petr id ish containing 
normal saline. Worms were counted and efficacy evaluation was 
made on the basis of host clearance only because of wide variat ion 
in worm load. 
Hyrnenolepis nana 
The screening technique followed was that of Gupta et a l . 
(1980b). B r ie f l y , male Swiss mice (20-25 g) were inoculated with 
200 viable ova of H. nana. On day 20 p . i . , the mice found posit ive 
for parasite (on ovoscopic examination) were selected for drug 
screening. 
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Drugs were administered in t r i p l e dose schedule. After 
day 3 of the last dose, the animals were sacri f iced and ind iv idual 
intestine was searched for worms/scolices (under dissecting micro-
scope). The cr i ter ion of efficacy was based on absolute clearance 
of parasites along wi th scolices from the ind iv idual mouse at a 
part icular dose. The formula used for percent ac t i v i t y was n/NxlOO, 
where N and n were the number of animals treated and cured res-
pect ively. 
Hymenolepis diminuta 
The parasite has indirect l i f e cycle, having grain beetle 
as the intermediate host. 
Cysticercoids (8-10) obtained from infected beetles were 
oral ly inoculated to rats (35-40 g ) . On day 20 p . i . , the stool 
examination was done for cestode ova under microscope and the 
rats found posi t ive, were employed in drug evaluation. The detai ls 
in respect of number of animals in each group, medication, autopsy 
and cr i ter ion of efficacy were the same as described for H. nana. 
R E S U L T S 
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PRIMARY SCREENING AGAINST A. CEYLANICUM 
Screening results have been summarized in Table 1 . A 
total of 125 synthetic compounds (from different chemical series) 
and A8 plant extracts of di f ferent famil ies were screened. Synthetic 
compounds belong to benzimidazole (AA), p-carboline (A9), sa l i c y l -
ani l ide (8 ) , thiazole (7 ) , pyr ro le (9 ) , isoxazoline (5) and n i t ro -
imidazole (3) series. 
Of the 125 compounds, 37 were found effect ive fuly or p a r t i -
a l ly at the i n i t i a l dose of 250 mg/kg x 1. A sharp decline in 
ac t i v i t y prof i le below the i n i t i a l dose was observed in majority 
of the compounds. 
Among the AA benzimidazole compounds tested, 29 were found 
fu l ly or par t ia l l y efficacious at the dose level of 250 mg/kg x 1. 
Eight compounds (Comps. 87-AlA, 87-381, 87-336, 87-31A, 87-269, 
88-298, 88-1AO and 88-15) were par t ia l l y active at the dose of 250 
mg/kg x 1 and became ei ther inactive or marginally effective below 
th is dose leve l . 
The other eight (87-216, 87-221, 87-301, 87-337, 87-362, 
87-36A, 87-380 and 88-169) were 100 percent effect ive at the i n i t i a l 
dose of 250 mg/kg x 1 but showed par t ia l ac t i v i t y when the amount 
was reduced. 
In the other seven compounds (Comps. 87-338, 87-229, 87-
29A, 87-270, 87-217, 87-1A6 and 88-300), complete efficacy was 
observed at a single dose of 100 mg/kg x 1. At lower doses (50 
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mg/kg x 1) the i r ac t iv i ty dropped remarkably and a l l the agents 
became inactive when a dose of 12.5 mg/kg x 1 was given. Three 
compounds (85-A78, 87-292 and 88-83) showed almost 100% efficacy 
(99-100%) at the dose of 50 mg/kg x 1 and below i t . Compound 
87-292 becomes inact ive. But Comp. 88-83 continued to show par t ia l 
efficacy up to a single administration of 6.25 mg/kg x 1 and become 
completely inactive at 3.12 mg/kg x 1 dose leve l . 
Of the lo t , 4 compounds, 83-148, 85-478, 85-479 and 87-
144 showed good promise and warranted detailed investigations. 
Among these, Comp. 87-144 was the most promising, having 
high cure rate wi th broad spectrum anthelmintic ac t i v i t y . 
The members of the ^^-carboline series showed very poor 
eff icacy. Of the 49 compounds tested, only 1 (Comp. 87-580) was 
found par t ia l ly efficacious at the i n i t i a l dose of 250 mg/kg x 1. 
The compound lost ac t i v i t y when the dose level was reduced to 
100 mg/kg x 1. 
Sal icylani l ides were l i t t l e better than the /3-carboline. Two 
members of th is series (87-513 and 87-514) were fu l l y effective 
at a dose level of 250 mg/kg x 1. Proportionate ac t i v i t y was 
observed at lower doses. They retained var iable ac t i v i t y up to 
50 mg/kg x 1 but became inactive at the dose of 25 mg/kg x 1. 
Of the 7 thiazole der ivat ives, 2 compounds (88-139 and 
88-154) e l ic i ted only par t ia l efficacy at the i n i t i a l dose (250 mg/kgxl) 
and no ac t iv i ty was registered in lower doses. 
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Out of 9 p y r r o l e s , only two (87-494 and 87-495) exer ted 
100% ant ihookworm act ion at the dose l e v e l of 250 mg/kg x 1 . Compound 
87-495 showed dose-dependent a c t i v i t y up to 50 mg/kg x 1 and 
the rea f te r (at 25 mg/kg x 1) became i ne f f ec t i ve whereas compound 
87-494 was i n a c t i v e at the dose of 50 mg/kg x 1. 
In i soxazo l ine and n i t r o im idazo le groups none was found 
e f f ec t i ve even at t he i n i t i a l dose of 250 mg/kg x 1. 
DETAILED INVESTIGATIONS ON ACTIVE COMPOUNDS 
COMPOUND 83-148 (F ig .1 ) 
A. ceylanicum 
Determination of effect ive dose 50% (ED50) 
Table 2 summarizes the resu l t s of _ii2 v i v o screening. The 
compound was 100% e f fec t i ve at the dose of 12.5 mg/kg x 1 and 
above (a l ready repo r ted in p r i m a r y screening - Table 1 ) . Lower 
doses showed cor responding worm reduct ion i . e . , 43.46% and 31.80% 
at the dose l e v e l of 6.25 mg/kg x 1 and 3.12 mg/kg x 1 , r e s p e c t i v e l y . 
Thus, the approx ima te est imated ED^„ value i s 6.92 mg/kg x 1. 
Paren t ra l admin i s t ra t i on ( i n t r ape r i t onea l ) of the compound 
also endorsed ant ihookworm a c t i v i t y but was i n f e r i o r to per os 
rou te . Hundred percent e f f i cacy was observed at 50 mg/kg x 1 
dose l e v e l and lower doses showed dose-dependent e f f i cacy . 
Assessment of l a rv ic ida l action 
Ef f icacy data against deve lop ing paras i tes of A. ceylanicum 
have been summarized in Table 3 . The resu l t s ciemoT^st^ated tha t 
H- jC^ , 0 
1 
H 3 
(Compound 83-148) 
Me thy l [ 5 - ( 2 , 5 - d i m e t h y l - 3 - m e t h o x y c a r b o n y l f u r - 4 y l ) - l H -
b e n z i m i d a z o l e - 2 - y l ] carbamate 
F ig .1 
NHCOOCH, 
(Compound 85-478) 
M e t h y l [ 5 - ( 2 , 5 - d i m e t h y l - 3 - methoxy c a r b o n y l p y r r o l - 4 -
y l ) - 1 H - b e n z i m i d a z o l e - 2 - y l ] carbamate 
F i g . 2 
H-COOCHN 
3 H 
HCOOCH, 
(Compound 85-479) 
2 , 2 ' -D i ca rbome thoxy a m i n - 5 , 5 ' - d i b e n 2 i m i d a z o l y l methanol 
F i g , 3 
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the compound was efficacious against a l l the developing forms by 
oral and intraperitoneal routes. However, parentral administration 
yielded poor results. At lower doses, the compound has propor-
tionate eff icacy. I t seems that L, form is more resistant to the 
the drug action as compared to L, and L^ forms. Oral administration 
of 100 mg/kg x 1, reduced the worm burden to the extent of 82.61%, 
100% and 100%, when assessed against L^, L^ and L^ stages. Lower 
dose i . e . , 25 mg/kg x 1 was found lethal to L^, to the tune of 
62.38% to L, 80.69% and to L^ 67.72%, whereas at 12.5 mg/kg x1 
the respective worm reduction was 4A.7A%, 78.23%, 73.68%. 
Intraperitoneal administration of 100 mg/kg x 1 yielded 
worm reduction to 68.15%, 97.47% and 100% against L^, L^ and L^ 
stages, respect ively. Lower doses showed proportionate eff icacy. 
Chemoprophylactic action 
Compound at 100 mg/kg x 1 dose was found to protect hamsters 
(67.90%) to subsequent challenge of L^ up to day 15 (Table 4 ) . 
When the amount was reduced, the compound fai led to exert any 
prophylact ic action. 
N. brasiliensis 
Against th is parasite Compound 83-148 was ineffective even 
at an i n i t i a l dose of 250 mg/kg x 3, as the worm recoveries were 
almost equal in both treated and untreated control groups (Table 2) . 
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S. obvelata 
Against t h i s o x y u r i d , the compound had cons iderab le e f f i cacy 
as i s ev ident f rom Table 2. A l l the 9 mice admin is te red w i t h com-
pound (100mg/kgxl)were cured. When the amount was ha lved (50 m g / k g x l ) 
the e f f i cacy went down to 44.44% as on ly 4 of 9 mice t rea ted were 
d e p a r a s i t i z e d . 
In m u l t i p l e dose schedu le , 100% host c learance was observed 
at the dose of 50 mg/kg x 3 and 66.66% at 25 mg/kg x 3 (Tab le 2 ) . 
H. nana 
The compound was comple te ly e f f ec t i ve at the dose of 250 
mg/kg x 1 in t he r a t s , but only 25% host c learance was ach ieved 
at the dose of 100 mg/kg x 1. 
In m u l t i p l e dose regimen the cure rates at dose schedule 
of 50 mg/kg x 3 and 25 mg/kg x 3 were found to the tune of 100 
and 83.33% (Tab le 2)-
H. diminuta 
The compound was p a r t i a l l y e f f ec t i ve (50%) at the i n i t i a l 
dose l e v e l (50 mg/kg x 3) and no a c t i v i t y was observed at the 
lower dose (100 mg/kg x 3 ) . 
COMPOUND 85-478 (F ig .2 ) 
A. ceylanicum 
Determination of ef fect ive dose 50% (ED50) 
The compound k i l l e d a l l the paras i tes at a s ing le o ra l dose 
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of 100 mg/kg x 1 (Table 5) . At the lower dose of 50 mg/kg x 1 
the worm reduction was to the tune of 99.39 percent. Further lower 
doses showed proportionate eff icacy. The approximate estimated 
ED value would be around 9.12 mg/kg x 1. By intraperitoneal 
administrat ion, the compound exhibi ted infer ior efficacy than through 
oral route. Complete efficacy was observed at 100 mg/kg x 1 and 
lower doses yielded corresponding ac t i v i t y . 
Assessment of larvicidal action 
A single oral dose of 100 mg/kg x 1 was effective to the 
tune of 72.17%, 97.20% and 100% against L^, L^ and L^ stages of 
the parasites, respect ively. Lower doses had corresponding act iv i ty 
(Table 6) . 
The compound when give intraper i toneal ly, a dose of 100 
mg/kg x 1 showed 53.30%, 97.20% and 100% efficacy against L^, L^ 
and Lg stages, respect ively. Lower dose i . e . , 25 mg/kg x 1 resulted 
in the reduction of worm burden to the tune of 23.30%, 59.89% and 
38.44% against L^, L. and L^ stages, respectively (Table 6) . 
Chemoprophylactic action 
The compound administered at 100 mg/kg x 1 intramuscularly 
d id not exert any prophylact ic action and the worm recovery on 
challenge in treated group, was comparable to the untreated group 
(Table 4 ) . 
N. brasiliensis 
The compound was ineffective even at the in i t i a l dose of 
250 mg/kg x 3 against th is parasite (Table 5) . 
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S. obvelata 
At a dose of 250 mg/kg x 1 , t he compound c leared a l l the 
worms f rom the t rea ted mice (100% e f f i c a c y ) , w h i l e at 100 m g / k g x l 
only 66.66% animals were f ree f rom paras i tes (Tab le 5 ) . 
In t r i p l e dose schedules the respec t i ve host c learance at 
50 mg/kg x 3 and 25 mg/kg x 3, was 77% to 50%, r e s p e c t i v e l y . 
H. nana 
The compound was e f f ec t i ve only at the dose of 250 m g / k g x l 
in r a t s , w h i l e in m u l t i p l e dose regimen (50 mg/kg x 3) 100% ef f i cacy 
was found. Lower doses have e i t h e r p a r t i a l or no ef fect on the 
paras i te (Tab le 5 ) . 
H. diminuta 
The compound was i ne f f ec t i ve against t h i s pa ras i te even 
at the i n i t i a l dose of 250 mg/kg x 3. 
COMPOUND 85-479 (F ig .3 ) 
A. ceylanicum 
Determination of effect ive dose 50% (ED50) 
Detai led a c t i v i t y p r o f i l e of t h i s compound has been presented 
in Table 7. 
A l l t he worms f rom the t rea ted hamsters were c leared at 
the dose of 25 mg/kg x 1 and ha l f of t h i s dose (12.5 m g / k g x l ) 
reduced the worm load to the tune of 97-100%. Lower doses showed 
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dose dependent efficacy i . e . , 83.2%, 66.2% and 24.6% at the res-
pective doses of 6.25, 3.12 and 1.56 mg/kg x 1. As such the ED_^ 
was found to be 2.45 mg/kg x 1 approximately. 
Intraperitoneal administrat ion, also endorsed antihookworm 
eff icacy. However, the ac t iv i ty was infer ior to per os route. 
The compound was 100% effective at the dose of 50 mg/kg x 1 whereas, 
with 12.5 mg/kg x 1 dose, the worm reduction was to the tune 
of 90.6%. Lower doses el ic i ted dose dependent worm reduction 
compared to the control group. 
Assessment of larvicidal action 
Efficacy data against developing forms of A. ceylanicum 
have been summarized in Table 8. The results demonstrated that 
the compound was more efficacious against a l l the stages by in t ra -
peritoneal route compared to per os route. The oral administration 
of 100 mg/kg x 1, k i l led 69.6% L3, 94.8% L^ and 100% L^. While 
th is amount when given intraperi toneal ly the efficacy against L^ 
was 87.04% and against L^ and L^ was 100%. Lower doses showed 
proportionate eff icacy. 
Chemoprophylactic action 
The compound administered at 100 mg/kg x 1 intramuscularly, 
showed no prophylact ic action when challenged on day 7 of post 
treatment (Table 4 ) . 
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N. brasiliensis 
In i t ia l dose of 250 mg/kg x 3 (per os) d id not have any 
efficacy against the t r ichostrongyl id worm, N. brasi l iensis. 
^ . obvelata 
This compound too had considerable efficacy against S^. 
obvelata. A dose of 100 mg/kg x 1 cleared a l l the treated mice. 
Lower doses showed dose dependent efficacy (Table 7) . 
In mult iple dose regimen, 25 mg/kg x 3 the compound was 
fu l ly ef fect ive. The efficacy was retained up to 5.25 mg/kg x3 
where 16.0% host clearance was recorded. 
H. nana 
The respective efficacy at 100 mg/kg x 1 and 50 mg/kgxl 
was found to be 100% and 50%. No ac t iv i ty was recorded when 
amount was fur ther reduced to 25 mg/kg x 1. Three doses each 
of 50 mg/kg given at consecutive days, resulted in 100% host clearance, 
whereas only 55.55% animals were free from the parasites at the 
dose of 25 mg/kg x 3. Lower to th is dose, compound has no e f f i -
cacy (Table 7) . 
H. diminuta 
The compound was fu l l y effective at the dose of 100 mg/kgx3 
and become inactive below th is level (Table 7) . 
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COMPOUND 87-144 (Fig.4) 
Of the four compounds chosen for elaborate investigations, 
Comp. 87-144 appeared most promising as th is has wider act iv i ty 
spectrum. As such the compound has been examined in greater 
detai l i . e . , speed of action against adult A. ceylanicum, acute t o x i -
c i ty and comparison of antihookworm ac t iv i ty (adult and larval) 
wi th reference to mebendazole. (F ig .5) . 
A. ceylanicum 
Determination of effective dose 50% (ED50) 
The efficacy data have been presented in Table 9. The 
compound in single oral dose of 25 mg/kg x 1 and above, removed 
a l l the parasites from the treated hosts. Half of th is dose (12.5 
mg/kg x 1) deparasitized 5 out of 6 treated infected hamsters and 
the worm reduction was 99.4%. At lower doses proportionate act iv i ty 
was recorded. The approximate ED__ value was found to be 1.53 
mg/kg x l . 
Intraperitoneal administration of the compound was infer ior 
to per OS route, as 25 mg/kg x 1 and 12.5 mg/kg x 1 doses caused 
only 94.28 and 61.42% worm reduction, respect ively. The reference 
drug, mebendazole showed better efficacy (Table 9 ) . 
Assessment of larvicidal action 
The compound appears to be more effective by intraperitoneal 
route than by per os. A dose of 100 mg/kg x 1 given ora l l y , was 
87.17% lethal to L3, 88.96% to L, and 90.81% to L, . Similar adminis-
"3^-Y__/N-C 
NHCOOCH, 
(Compound 87-144) 
Methyl 5l5)-l4f-methyl-piperidin-'}-yl) carbonyl-benzimi-
dazo le-2-car bamate 
F i g . 4 
N-^ NHCOOCH, 
Me thy l 5 (6 ) -ben2oy l benz imidazo le-2-carbamate (Mebendazole) 
F i g . 5 
R 
-CO-R 
Cyc l i c guanid ino ske le ton 
X = CO or S 
R = a r y l o r hetero a r y l 
R = a l k y l or a l k o x y groups 
F i g . 6 
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t rat ion by intraperitoneal route deparasitized 93.10% L^, 96.29% 
L^ and 98.76% L^ (Table 10). 
Lower doses by both the routes e l ic i ted proportionate e f f i -
cacy. Reference drug mebendazole appeared better in exerting la r -
v ic ida l action. 
Chemoprophylactic action 
The compound does not possess prophylact ic action, as 
100 mg/kg x 1 administered intramuscularly, 7 days before challenge, 
d id not show any reduction in worm load compared to control group 
(Table 4 ) . 
Speed of action 
The results of speed of action have been shown in Table 
11. 
3rd h 
A mean of 38.20 (range 27-48) worms was recovered and 
a l l of them were act ively moti le. Worms were present in the jejunum 
(small intest ine). 
6th h 
Of the 37.0 (26-40) worms recovered at 6th h 60% were 
actively motile and rest were sluggish in the small intestine. No 
dead worms were recovered. 
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9th h 
42.8 (35-49) worms were recovered from the small intestine, 
out of which only 30% were act ively moti le. A l l , the worms were 
found in the small intestine. 
12th h 
25-46 worms (mean 32.8) were recovered on autopsy and 
only 6.2 parasites (mean) were found act ively motile in the small 
intestine. Of the to ta l , 14.50% of the worms were found in the 
large intestine. 
15th h 
A total of 30.80 (25-35) worms was recovered and only 
5.4 parasites were present in the small intestine and were act ively 
moti le. Rest of the worms 25.4 (mean) were present in the large 
intestine which were sluggishly moti le. 
18th h 
Of the total of 28.8 parasites a mean of 1.2 parasite was 
present in the small intestine and these parasites were act ively 
motile. The rest of the worms (27.4) were found in the large 
intestine of which 21.6 were sluggishly motile and 6 were dead. 
21st h 
About 56% of worms were eliminated as compared to the 
control group. Out of 18.00 (9-27) worms, only 7 were found slugg-
ishly motile in the large intestine. A mean of 10.40 (7-13) worms 
were found dead in the large intestine. 
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25th h 
An average of 6.80 (3-9) worms only was recovered from 
the large intestine and only 0.60 (0-2) was found sluggishly moti le. 
28th h 
An average of 2.60 (0-A) parasites was recovered from 
the large intestine and a l l were dead. 
30th h 
Only 2.30 (0-5) dead worms were present in the large intes-
tine and the rest (about 95% worms) were eliminated as compared 
to the control group. 
32nd h 
About 98.5% worms were eliminated as compared to the control 
group. 
35th h 
A l l worms were eliminated as compared to the control group. 
In simultaneous t r i a l s , mebendazole appeared more efficacious than 
Comp. 87-144. 
Acute toxicity 
In simultaneous t r i a l s , both Comp. 87-144 and reference 
drug mebendazole had more or less s imi lar range of safety (Table 
12). On examination at 24 h after the administration of Comp.87-
1A4, 9 of the 10 mice surv ived. Observations recorded at 24 h 
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revealed that 9 of the 10 mice treted wi th Comp. 87-14A at 4500 
mg/kg x 1 dose surv ived. However, there was no death at dose 
level of 2500 mg/kg x 1. 
In case of mebendazole at both dose levels death of an 
addit ional mouse occurred. 
N. brasiliensis 
The compound was fu l l y effective at the dose of 100 mg/kgxl . 
Half of th is dose (50 mg/kg x 1) e l ic i ted 88.5% worm reduction 
compared to control group. Below th is dose, efficacy sharply declined 
(Table 13). 
^ . obvelata 
Single oral administration of 50 mg/kg x 1 and above exerted 
100% efficacy whi le 25 mg/kg x 1 cured 50% of the treated mice 
(Table 13). 
In t r i p l e dose schedule the compound cured a l l the infected 
mice at the dose of 25 mg/kg x 3 whereas, half of th is dose (12.5 
mg/kg x 3) was effect ive to the tune of 75%. Lower doses were 
ineffect ive. 
H. nana 
The compound was 100% effective at the i n i t i a l dose of 250 
mg/kg x 3 but no ac t i v i t y was witnessed in lower doses (Table 13). 
H. diminuta 
The compound was ineffective even at the i n i t i a l dose of 
250 mg/kg x 3 (Table 13). 
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Table 1 : Results of p r i m a r y screening of syn the t i c compounds and plant 
ex t r ac t s against A. ceylanicum in hamsters . 
S.No. Compound 
code No. 
Chemical name Dose 
(mg/kg) 
A c t i v i t y 
(percent 
worm 
reduc t ion ) 
BENZIMIDAZOLE 
83-U8 
85-478 
85-479 
87-141 
87-142 
87-144 
87-146 
M e t h y l [ 5 - ( 2 , 5 - d i m e t h y l - 3 - m e t h o x y 
ca rbony l f u r - 4 y l ) - l H - b e n z i m i d a -
zo le-2 y l ] carbamate 
M e t h y l [ 5 - ( 2 , 5 - d i m e t h y l - 3 - m e t h o x y 
ca rbony l p y r r o l - 4 y l ) - l H - b e n z i -
midazo le-2 y l ] carbamate 
2 , 2 ' d i ca rbomethoxy amino-5 ,5 ' -
d i b e n z i m i d a z o l y l methanol 
2 - t r i f l u o r o a c e t y l - 5 - b e n z o y l 
benzimidazole 
2 - ace tamido-5- ((?(acetox y -
pheny l me thy l ) benzimidazole 
Me thy l 5 - ( 6 ) - ( 4 - m e t h y l -
p i p e r i d i n - 1 - y l c a r b o n y l -
benz imidazo le-2-carbamate 
2 - d c e t a m i d o - 5 - p h e n y l t h i o -
benz imidazole 
12.5x1 
6.25x1 
3.12x1 
1.56x1 
0.78x1 
100x1 
50x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
1.56x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
1,56x1 
0.78x1 
250x1 
250x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
1.56x1 
0.78x1 
100x1 
50x1 
25x1 
100.0 
43.4 
31.8 
17.51 
Inact ive 
100.0 
99.3 
80.7 
69.4 
27.5 
26.3 
Inact ive 
100.0 
97.1 
83.2 
66.2 
24.6 
Inact ive 
Inact ive 
Inact ive 
100.0 
99.4 
88.4 
68.5 
55.6 
29.4 
100.0 
85.4 
Inact ive 
[Table 1: con td . . . ] 
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11 
87-148 2-( l -pyroamidino acetyl amino)-5-
(6) benzoyl benzimidazole 
87-216 N,N'-di(5-benzoyl benzimidazole-
2-y l ) urea 
87-217 2-amino-5-phenylthiobenzimi-
dazole 
87-220 2-(2-methyl p iper id ino-acety l 
amino)-5-(6) benzoyl benzi-
midazole 
250x1 
250x1 
100x1 
50x1 
100x1 
50x1 
25x1 
250x1 
Inact ive 
100.0 
78.2 
Inact ive 
100.0 
68.3 
Inact ive 
Inact ive 
12 87-221 5-(6)-benzoyl-2-(carboxamido 
methyl p iper id ino) benzimidazole 
13 87-269 2-(1-morpholino acetylamino)-
5-(6) benzoyl benzimidazole 
14 87-270 2-(1-4-methyl p iper id ino 
acetyl aminc^-5-(6) benzoyl 
benzimidazole 
15 87-291 Methyl 5-acetyl-1H-benzi-
midazole 2-carbamate 
16 87-292 Methyl 5-(i?<-hydroxy)ethyl-1H-
benzimidazole-2-carbamate 
17 87-293 Methyl-5-propionyl-1H-
benzimidazole-2-carbamate 
18 87-294 Methyl 5- (K-hydroxy) p ropy l - IH-
benzImidazole-2-carbamate 
250x1 
100x1 
50x1 
25x1 
250x1 
100x1 
50x1 
25x1 
100x1 
50x1 
25x1 
12.5x1 
250x1 
50x1 
25x1 
12.5x1 
250x1 
100x1 
50x1 
25x1 
100.0 
86.9 
28.6 
Inact ive 
87.0 
81.6 
25.7 
Inact ive 
100.0 
84.4 
56.0 
Inact ive 
Inact ive 
100.0 
55.2 
Inact ive 
Inact ive 
100.0 
83.5 
Inact ive 
[contd. . ] 
[Table 1: con td . . . ] 
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19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
87-299 2- ( l -3 methyl piper idino acetyl 
amino)-5-(6)-benzoyl benzimidazole 
87-301 2-(N-methyl piperazino acetyl 
amino)-5-(6)-benzoyl benzimidazole 
87-314 3-e thy l -8 -methy l -1 ,3 ,8- t r iazab i -
cyclo (4,4,0 decan-2-onium 2-
carbmethoxy amino)-1H-benzi-
midazole-5 carboxylate 
87-336 5-(6)-phenyl thio-2-(carboxamino-
methyl piperadino) benzimidazole 
87-337 5-(6)-phenyl thio-2-(carboxamino 
methyl amino) benzimidazole 
87-338 2-(1-p iper id ino-acety l amino)-
5-(6)phenyl th io benzimidazole 
87-362 2-(1-pyro l id ino acetyl amino)-
5-(6) phenyl th io benzimidazole 
87-363 2-(1-2-methyl piper idino acetyl 
aminc^5-(6)-phenyl th io benzi-
midazole 
87-364 2-(1-morpholino acetylamino)-5-(6)- 250x1 
phenyl th io benzimidazole 100x1 
50x1 
25x1 
12.5x1 
87-365 2-(carbethoxy methyl amino>-5-(6)- 250x1 
phenyl th io benzimidazole 
100x1 
50x1 
25x1 
2.5x1 
250x1 
100x1 
50x1 
250x1 
100x1 
100.0 
84.7 
52.1 
Inact ive 
100.0 
87.2 
Inact ive 
61.1 
Inact ive 
250x1 
100x1 
250x1 
100x1 
50x1 
25x1 
100x1 
50x1 
25x1 
12.5x1 
250x1 
100x1 
50x1 
25x1 
12.5x1 
250x1 
66.1 
Inact ive 
100.0 
95.1 
56.2 
Inact ive 
100.0 
78.1 
62.7 
Inact ive 
100.0 
91.3 
76.2 
66.0 
Inact ive 
Inact ive 
100.0 
82.6 
56.5 
42.6 
Inactive 
Inactive 
[Contd. . .J 
[Table 1: con td . . . ] 
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29 
30 
31 
32 
33 
3A 
35 
36 
37 
38 
39 
AO 
87-380 
87-381 
87-414 
87-415 
88-15 
88-80 
88-81 
88-82 
88-83 
88-128 
88-140 
88-141 
2-(1-4-methyl piper idino acetyl 
amino)-5-(6)-phenyl th io 
benzimidazole 
2-(1-3 methyl piper idino acetyl 
amino)-5-(6)-phenyl th io 
benzimidazole 
2-acetamido-5-phenylsulfono 
benzimidazole 
2-acetamido-5- (6) - (3-nit ro-5-
phenyl) sulfono benzimidazole 
9-phenyl-10H-pyrido [3,4-b] imidazo 
[^>5-g] indole 2-carbamate 
5(6)-benzoyl-2-benzoylamino-
benzimidazole 
5(6)-benzoyl -2-(p-chloro-
benzoyl) amino benzimidazole 
5(6)-benzoyl-2-cyclohexyl 
carbonyl amino benzimidazole 
5(6)-benzoyl-2-propionylamino 
benzimidazole 
2-(benzimidazole-2-yl)amino-5-
phenyl-1,3,4 thiadiazole 
2-acetamido-5-(2-thenylcarbony])-
IH-benzimidazole 
2-acetamido-5-acetyl-1 H-
benzimidazole 
250x1 
100x1 
50x1 
250x1 
100x1 
50x1 
25x1 
250x1 
100x1 
250x1 
250x1 
100x1 
250x1 
250x1 
250x1 
50x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
250x1 
250x1 
100x1 
50x1 
250x1 
100.0 
86.4 
Inact ive 
92.6 
91.3 
63.1 
Inact ive 
75.1 
Inact ive 
Inact ive 
50.0 
Inact ive 
Inact ive 
Inact ive 
Inact ive 
100.0 
95.9 
78.3 
65.5 
Inact ive 
Inact ive 
88.7 
80.6 
Inact ive 
Inact ive 
41 88-155 2-(5-benzoyl benzimidazole-2-
y l ) amino-4-(4-chlorophenyl) 
thiazole 
250x1 Inactive 
(Contd. . . ) 
[Tab le 1 : c o n t d . . . ] 
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42 88-169 2 - t h i a 2 o l e - 1 - y l - 5 - b r o m o 
benzimidazole 
43 88-298 Sodium 2-carbmethoxy a m i n o - I H -
benz im idazo le -5 -ca rboxy la te 
44 88-300 M e t h y l - 5 - ( 6 ) - ( 2 - a m i n o t h i a z o l e -
4 - y l ) benz imidazo le-2-carbamate 
250x1 
100x1 
50x1 
250x1 
100x1 
50x1 
100x1 
50x1 
25x1 
100.0 
85.0 
Inact ive 
81.1 
40.0 
Inact ive 
100.0 
76.2 
Inact ive 
/G-CARBOLINE 
45 87-576 6 - a c e t a m i d o - 9 H - p y r i d o [ 3 , 4 - b ] 
indo le 
250x1 Inac t i ve 
46 87-577 6 -ca rbe thoxyam ino -9H-py r i do • 
[ 3 , 4 - b J indo le 
47 87-578 6 - a c e t a m i d o - 7 - n i t r o - 9 H - p y r i d o 
[ 3 , 4 - b ] i n d o l e 
48 87-579 6 - a m i n o - 7 - n i t r o - 9 H - p y r i d o 
[3 ,4 -b ] indo le 
49 87-580 6 -ch lo roace tam ido -9H-py r i do 
[ 3 , 4 - b ] i ndo le 
50 87-581 l - p h e n y l - 9 H - p y r i d o 
[ 3 , 4 - b ] indo le 
51 87-639 6 - n i t r o - 1 - p h e n y l - 9 H - p y r i d o 
[ 3 , 4 - b ] i n d o l e 
52 87-640 8 - n i t r o - 1 - p h e n y l - 9 H - p y r i d o 
[ 3 , 4 - b ] i ndo le 
53 87-641 6 - a m i n o - 1 - p h e n y l - 9 H - p y r i d o 
[ 3 , 4 - b ] indo le 
54 87-642 8 - a m i n o - 1 - p h e n y l - 9 H - p y r i d o 
[3,4-b] indole 
250x1 Inactive 
250x1 Inactive 
250x1 
250x1 
100x1 
50x1 
250x1 
Inact ive 
93.6 
45.2 
Inact ive 
Inact ive 
250x1 Inactive 
250x1 Inactive 
250x1 Inactive 
250x1 Inactive 
[contd...] 
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55 87-643 8-acetamido-1 -phenyl-9H-pyr ido 
[3,4-bJ indole 
250x1 Inactive 
56 87-644 6-acetamido-1 -phenyl-9H-pyr ido 
[3,4-bJ indole 
250x1 Inactive 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
87-645 6-carbethoxy amino-1-phenyl-9H- 250x1 Inactive 
pyr ido [3,4-bJ indole 
87-646 8-carbethoxy amino-1-phenyl-9H- 250x1 Inactive 
pyr ido [3,4-b] indole 
87-667 8-chloro acetamido-1-phenyl-9H- 250x1 Inactive 
pyr ido [3 ,4 -b ] indole 
87-668 6-chloroacetamido-1-phenyl-9H- 250x1 Inactive 
pyr ido [3 ,4 -b ] indole 
87-669 6-acetamido-7-nitro-1-phenyl- 250x1 Inactive 
9H-pyrido [3,4-bJ indole 
87-670 8-acetamido-7-nitro-1-phenyl- 250x1 Inactive 
9H-pyr ido[3,4-b ] indole 
87-671 6-amino-7-nitro-1-phenyl-9H- 250x1 Inactive 
pyr ido [3,4-b] indole 
88-10 6-[/3-(4-methyl p iperazine-1-yl) 250x1 Inactive 
acetamido]- l -phenyl-9H-pyr ido 
[3,4-b ] indole 
88-11 8-amino-7-nitro-1-phenyl-9H- 250x1 Inactive 
pyr ido [3 ,4 -b ] indole 
88-12 8-^3-{4-methyl piperazine-1-yl) 250x1 Inactive 
acetamido]-1-phenyl-9H-pyrido 
[3 ,4-b ] indole 
88-13 6-[/3-(4-phenylpiperazine-1-yl) 250x1 Inactive 
acetamido]-1-phenyl-9H-pyrido 
[3,4-bJ indole 
88-16 8-[X3-(4-phenylpiperazine-1-yl) 250x1 Inactive 
acetamido]-1-phenyl-9H-pyrido 
[3,4-b J indole 
(contd..) 
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69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
88-18 
88-19 
88-20 
88-21 
88-23 
88-110 
88-111 
88-112 
88-113 
88-11A 
88-115 
88-116 
88-117 
8-phenyl- [9H-pyr ido (3,4-b) 250x1 Inactive 
imidazo] [A,5- f ] indole 2 carba-
mate 
6-[ /3-(A-phenyl piperazine-1-yl) 250x1 Inactive 
acetamido]-9H-pyrido[3,A-b] 
indole 
6-[ / 3 - (p i pe r i d i n - l - y l ) acetamido] 250x1 Inactive 
9H-pyrido [3,A-b] indole 
8-[ /3 - (p iper id in -1 -y l ) aceta- 250x1 Inactive 
mido]-1-phenyl-9H-pyr ido 
[3 ,4-b ] indole 
6-[ / 3 - (p ipe r id in -1 -y l ) aceta- 250x1 Inactive 
mido]-1-phenyl-9H-pyr ido 
[3,A-b] indole 
6- [2-n i t ro benzoyl]-amino-1- 250x1 Inactive 
phenyl-9H-pyrido 
[3,A-b] indole 
6- [2-n i t ro benzoyl] amino-9H- 250x1 Inactive 
pyr ido [3 ,4-b ] indole 
8- [2-n i t ro benzoyl] amino-1- 250x1 Inactive 
phenyl-9H-pyrido [3,A-b] indole 
6-[2-amino benzoyl] amino-1-
phenyl-9H-pyrido [3 ,4-b ] indole 
250x1 Inactive 
6- [2,A-din i t rophenyl ] amino-1- 250x1 Inactive 
phenyl-9H-pyrido [ 3,A-b] indole 
8-[2-aminobenzoyl] amino-1- 250x1 Inactive 
phenyl-9H-pyrido [3 iA-b] indole 
6-[2-aminobenzoyl] amino-9H- 250x1 Inactive 
pyr ido [ 3 , A - b ] indole 
6-[2-(carbethoxy amino) benzoyl] 250x1 Inactive 
amino-1-phenyl-9H-pyrido 
[3,A-b] indole 
(contd. . . ) 
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82 
83 
8A 
85 
86 
87 
88 
89 
90 
91 
92 
93 
88-118 
88-120 
88-163 
88-164 
88-165 
88-166 
88-168 
88-208 
88-209 
88-439 
88-442 
88-443 
8-[2-(carbethoxy amino benzoyl)] 250x1 Inactive 
amino-9H-pyrido [3 ,4-b ] indole 
6- [N-(2,4-d in i t rophenyl )amino]- 250x1 Inactive 
1-phenyl-9H-pyrido [ 3 ,4 -b ] 
indole 
6-[N-(2-methyl-5-acetamido) 250x1 Inactive 
benzimidazolyl ]-1-phenyl-9H-
pyr ido [3 ,4-b ] indole 
6-[ [ (2-carbomethoxy amino)-5- 250x1 Inactive 
(N N'-dicarbomethoxy)guani-
dino) benzimidazole-1-yl ] -
1-phenyl-9H-pyrido [3 ,4-b ] indole 
8-[N-(2,4-diamino phenyl)amino] 250x1 Inactive 
l -pheny l -9H-pyr ido[3,4-b] 
indole 
6- [2 ,4-d in i t rophenyl ] amino- 250x1 Inactive 
9H-pyrido [3 ,4-b ] indole 
6- [2,4-dioxo qu inazo l i n -3 -y l ] - 250x1 Inactive 
l -phenyl-9H-pyr ido [3 ,4-b ] 
indole 
8-[ 2,4-dioxoquinazol in-3yl ] - 250x1 Inactive 
l -phenyl-9H-pyr ido [3 ,4-b ] 
indole 
8 - [N ' - (2-methyl-5-acetamido) 
benzimidazoly l ] -1-phenyl-
9H-pyrido [3 ,4-b ] indole 
250x1 Inactive 
6 - [N ' - ( 2-methyl-5-acetamido) 250x1 Inactive 
benzimidazoyl -9H-pyr ido[3 ,4-b ] 
indole 
2-methyl-9-phenyl-10H-pyrido 250x1 Inactive 
[3 ,4-b ] imidazo [4 ,5-g ] indole 
9H-pyrido [3 ,4-b ] imidazo 250x1 Inactive 
[4 ,5 - f ] indole-2-carbamate 
(contd . . . ) 
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94 87-A92 E t h y l - 3 - [ 1 - ( 1 , 2 - d i m e t h y l - 3 -
methoxy c a r b o n y l - A - p h e n y l ) 
m e t h y l i d e n e j h y d r a z i n e ca rbo -
d i t h i o a t e 
250x1 Inac t i ve 
95 
96 
87-493 E t h y l - 3 - [ 1 - ( 1 , 2 - d i m e t h y l - 3 -
m e t h o x y - c a r b o n y l - 4 - 3 , 4 -
d imethoxy p h e n y l ) m e t h y l i d i n e ] 
hyd raz ine ca rbod i t h i oa te 
87-494 E t h y l - 3 - [ l - ( l , 2 - d i m e t h y l - 3 -
methoxy c a r b o n y l - 4 - 3 , 4 -
methy lene d i o x y p h e n y l ) m e t h y l -
i d i n e ] h y d r a z i n e c a r b o d i -
th ioa te 
250x1 Inac t i ve 
250x1 
100x1 
50x1 
100.0 
55.0 
Inact ive 
97 
98 
99 
87-495 E t h y l - 3 - [ 1 - ( 1 , 2 - d i m e t h y l - 3 -
methoxy c a r b o n y l - 4 - 4 , 5 -
d i m e t h o x y - 2 - n i t r o p h e n y l ) 
m e t h y l i d i n e ] hyd raz ine 
ca rbod i t h i oa te 
87-544 Bis [ l , 2 - d i m e t h y l - 3 - m e t h o x y 
c a r b o n y l - 4 - p h e n y l - 5 -
p y r r o l y l ] me thy l e ther 
87-545 Bis [1 , 2 -d i r ne thy l - 3 -me thoxy 
c a r b o n y l - 4 - ( 3 , 4 - d i m e t h o x y 
p h e n y l ) - 5 - p y r r o l y l ] me thy l 
e ther 
250x1 
100x1 
50x1 
25x1 
250x1 
100.0 
89.3 
69.4 
Inact ive 
Inact ive 
250x1 I nac t i ve 
100 
101 
87-546 3-methoxy c a r b o n y l - 1 , 2 , 5 -
t r i m e t h y l - 4 ( 3 , 4 -d ime thoxy 
pheny l ) p y r r o l e 
87-608 Bis [ l , 2 - d i m e t h y l - 3 - m e t h o x y 
c a r b o n y l - 4 - p h e n y l ) - p y r r o l y l 
methane 
250x1 Inac t i ve 
250x1 Inac t i ve 
102 87-609 B i s [ l , ' 2 ^ d i m e t h y l - 3 - m e t h o x y 
c a r b o n y l - 4 - 3 ,4 -d ime thoxy 
phenyl] pyrrolyl methane 
250x1 Inac t i ve 
( c o n t d . . . ) 
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103 87-108 
SALICYLANILIDE 
3,5 d i i o d o - A ' - c a r b o x y s a l i c y l -
a n i l i d e 
250x1 Inac t i ve 
104 
105 
87-512 3,5 d i i o d o - 3 ' - n i t r o - 4 ' -
(morpho l i n 1 -y l ) s a l i c y l a n i l i d e 
87-513 3,5 d i i o d o - 3 ' - n i t r o - 4 ' -
(phenoxy) s a l i c y l a n i l i d e 
250x1 Inac t i ve 
250x1 
100x1 
50x1 
25x1 
100.0 
89.6 
-87.5 
Inac t i ve 
106 87-514 3,5 d i i o d o - 3 ' - n i t r o - 4 ' -
( p - c h l o r o p h e n o x y ) s a l i c y l a n i l i d e 
250x1 
100x1 
50x1 
. 25x1 
100.0 
85.0 
39.1 
Inac t i ve 
107 87-522 3,5 d i i o d o - 4 ' - c h l o r o s a l i c y l -
an iod ide 
250x1 Inac t ive 
108 87-647 3,5 d i i o d o - 4 ' - p h e n y l t h i o 
s a l i c y l a n i l i d e 
109 87-648 3,5 d i i o d o - 4 ' - ( p - m e t h y l -
pheny l ) t h i o s a l i c y l a n i l i d e 
110 87-675 3,5 d i i o d o - 3 ' - n i t r o - 4 ' - ( l -
me thy l p i p e r i 2 i n - 4 y l ) s a l i c y l -
a n i l i d e 
250x1 Inac t i ve 
250x1 Inac t ive 
250x1 Inac t i ve 
THIAZOLE 
111 87-569 2 - a c e t a m i d o - 4 - ( 4 - c h l o r o -
3 - n i t r o p h e n y l ) t h i azo le 
112 87-658 2 - ' ca rbomethoxy a m i n o - 5 - ( 4 -
c h l o r o - 3 - n i t r o p h e n y l ) th iazo le 
113 88-86 2 - a c e t a m i d o - 5 - n i t r o - 6 - c h l o r o -
benzthiazole 
250x1 Inactive 
250x1 Inactive 
250x1 Inactive 
114 88-138 2 -ace tamido-6-carboxy benz-
th iazo le 
115 88-139 Sodium 2-acetamido benzth iazole-
6 - ca rboxy la te 
250x1 Inactive 
250x1 64.5 
100x1 Inact ive 
( c o n t d . . . ) 
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116 
117 
88-154 2 - (N -e thoxy ca rbony l t h i o -
ca rboxamido )amino -5 - (4 -ch lo ro -
3 - n i t r o p h e n y l ) t h i azo le 
88-301 2 - ( t e t r a h y d r o p y r i m i d i n e - 2 - y l ) 
amino-A- (A-ch loropheny 1) 
t h iazo le 
250x1 
100x1 
65.5 
Inac t i ve 
250x1 Inac t i ve 
ISOXAZOLINE 
118 87-A83 3 -me thy l -A - (A -me thoxypheny l 
m e t h y l ) - A - [ A ' (A-methoxy 
pheny l m e t h y l ) - 3 ' - m e t h y l - 5 ' -
o x o i s o x a z o l y l ] i soxazo l i ne -
5-one 
250x1 Inac t i ve 
119 87-507 2-methoxy c a r b o n y l - 3 - m e t h y l -
A- (3 ,A-methy lene d i o x y -
pheny l ) me thy l i soxazo l i ne -
5-one 
250x1 I nac t i ve 
120 87-508 2-methoxy c a r b o n y l - 3 - m e t h y l -
A ( A - h y d r o x y - 3 - m e t h o x y 
p h e n y l ) - m e t h y l i soxazo l i ne -
5-one 
250x1 I nac t i ve 
121 
122 
87-509 2 - m e t h o x y c a r b o n y l - 3 - m e t h y l - 250x1 Inac t i ve 
A ( A - a m i n o - 3 - n i t r o p h e n y l ) -
me thy l i soxazo l ine-5-one 
87-510 2-methoxy c a r b o n y l - 3 - 250x1 Inac t i ve 
m e t h y l - A - ( 3 , A - d i c h l o r o p h e n y l ) 
me thy l i soxazo l ine-5-one 
NITROIMIDAZOLE 
123 87-111 5 - a z i d o - 1 - m e t h y l - A - n i t r o -
im idazo le 
250x1 Inac t i ve 
12A 87-190 5 - c y a n o - 1 - m e t h y l - A - n i t r o -
im idazo le 
250x1 Inac t i ve 
125 87-191 5 - e t h o x y - 1 - m e t h y l - A - n i t r o -
im idazo le 
250x1 Inac t i ve 
( c o n t d . . . ) 
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S.No. 
1 
Name of plant 
2 
(Dose: Ig/kg X 1) Ac t i v i t y 
3 
Family: Euphorbiaceae 
Mallotus phi l l ippenensis 
(entire plant) 
Trigonostemon aurantiacus 
(entire plant) 
Macaranga pustulata 
(entire plant) 
Glochidion el l ipt icum 
(plant without root) 
Euphorbia rotheine 
(entire plant) 
Breynia rhamnoidae 
(plant without root) 
Inactive 
10 
11 
12 
13 
Family: Celastraceae 
Maytenus ovatus 
(entire plant) 
Microtropis microcarpa 
(entire plant) 
Family: Cucerbitaceae 
Luff a echinata 
(plant without root) 
Mukia maderaspatana 
(plant without root) 
Trichosenthis palmata 
(plant without root) 
Family: Loranthaceae 
Taxi l lus cuneatus 
(entire plant) 
Dendrophthae falcata 
(stem) 
(contd..) 
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14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Pemphis acidula 
(entire plant) 
Taxi l lus cuncatus 
(entire plant) 
Family: Poaceae 
Arundinaria falcuta 
(entire plant) 
Arundinaria hookeriane 
(flower and stem) 
Miscanthus nepalensis 
(entire plant) 
Famil y: My rtaceae 
Syzygium occidentalis 
(entire plant) 
Syzygium densiflorum 
(entire plant) 
Syzygium megacarpum 
(entire plant) 
Family: Salicaceae 
Salix wall ichiana 
(entire plant) 
Salix oxycarpa 
(plant without root) 
Family: Cornaceae 
Tor icel l ia t i l l i ae fo l i a 
(entire plant) 
Family: Caesalpinaceae 
25 Acrocarpus f rax info l ius 
(Stem, bark and f ru i ts ) 
(contd . . . ) 
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26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
Family: Boraginaceae 
Arnebia euchroma 
(stem and f lower) 
Lycopsis arvensis 
(entire plant) 
Cynoglossum microglochin 
(entire plant) 
Lindelofia longifol ia 
(entire plant) 
Family: Combretaceae 
Combretum decandrum 
(stem and leaf) 
Lunitzera racemosa 
(plant without root) 
Terminalia crenulata 
(stem, bark) 
Family: Cruciferae 
Caprella barsa 
(entire plant) 
A l l i a r ia of f ic inal is 
(entire plant) 
Famil y: Gramineae 
Paspalidium f lar idum 
(entire plant) 
Dendrocalamus str ictus 
(plant without root) 
Family: Liliaceae 
37 Smilex elegans 
(plant without root) 
(contd . . . ) 
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38 
39 
40 
Family: 
41 
42 
43 
44 
Family: Malvaceae 
Abutilon hir tumi 
(plant without root) 
Thespesia populnea 
(stem) 
Family: Pafjaveraceae 
Papaver dubium 
(entire plant) 
Pol y pod iaceae 
Pteris cretica 
(entire plant) 
Adiantum capil lus 
(entire plant) 
Rubiaceae 
Rubia card i fo l ia 
(entire plant) 
Rosaceae 
Prunus wa l l i ch i i 
Family: 
Family: 
Family: 
45 
46 
47 
48 
(entire plant) 
Um belliferae 
Forula jaeschkeana 
(entire plant) 
Suim latijugam 
(entire plant) 
Family: Vitiaceae 
Cissus repanda 
(entire plant) 
Vi t is pervifol ia 
(plant without root) 
Inactive 
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The anthelmintic drugs currently avai lable are s t i l l re la-
t i ve ly few. Many have l imitat ions in the i r usefulness because of 
narrow spectrum of action, low margin of safety and high cost. 
Some of these might be discontinued because of potential tox ic i ty 
(as was the case with Zonit) and other unforeseen problems such 
as occurrence of drug resistance which needs part icular attention 
since the cases of drug resistance are on the increase. Hence, 
there is a continuous thrust to develop new anthelmintic(s) wi th 
wide spectrum of ac t iv i ty and high cure rate, minimum side effects 
and suitable for population based chemotherapy. 
In recent past, quite a number of broad spectrum anthel-
mintics from benzimidazole series have emerged and they appear 
to be more effective against gastrointestinal helminths (Pawlowski 
and Chodera, 1975; Chevis, 1975). Mebendazole - the most effective 
member of th is series (Banerjee et^  al^., 1971; Gorodner et_ al^., 1977; 
Borda et^  aJ^., 1978; Bhopale et_ al^., 1982) too possess some serious 
l imitat ions owing to i ts teratogenic and embryotoxic action. The 
drug is contraindicated during pregnancy and in chi ldren of tender 
age (Annon, 1975; Keystone and Murdoch, 1979). Since mebendazole 
is poorly absorbed due to i ts low so lub i l i ty in water, i t is feebly 
effective against tissue dwell ing parasites. 
The basic requirement for the development of chemotherapeutic 
agents is to have suitable test parasite. The selection of a test 
parasite is based upon the probabi l i ty of s imi lar chemotherapeutic, 
biological and immunological responses in the organisms to that of 
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the object ive parasite. The host should be small enough for mani-
pulative handling to afford greatest economy in terms of space and 
food. Further, to obtain consistent therapeutic responses, i t is 
necessary to have a host of standard breed with minimum genetic 
variat ions. Parasite wi th short l i f e cycle is preferred for quick 
turnover of infected host and the parasit ic mater ial . Keeping in 
view these considerations, var iety of parasites in the i r natural 
or adapted small laboratory hosts have been used from time to 
t ime. But the chemotherapeutic responses of such natural host-parasite 
systems cannot always be equated to the response of the target 
parasite. Thus, as a compromise i t would be advisable to have 
a target parasite adapted in laboratory animals. A drug showing 
efficacy on such a host-parasite combination is l i ke l y to provide 
fa i r l y good idea about the efficacy of a compound in human or animal 
situation. 
In the past for screening of antihookworm compounds, 
Ni. brasi l iensis and N. dubius (in the i r natural hosts, v i z . rat 
and mouse respectively) have been extensively used (Standen, 1963; 
Cavier and Hawking, 1973). N. dubius was stated to be more sus-
ceptible to anthelmintics than N[. brasi l iensis (Standen, 1963). 
Duwel (1972) studied the suscept ib i l i ty of N[. dubius against various 
standard drugs. They found that the drugs showing high efficacy 
against N. dubius give variable results wi th human ascarids and 
hookworms. Several other compounds showing efficacy against hook-
worms and ascarids do not show any activity against N. dubius 
infect ion. Misra et^  al^. (1981) have also found that N. dubius gives 
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inconsistent results and is resistant to antihookworm drugs. As 
such th is parasite is not a good test model for antihookworm chemo-
therapy. Duwel (1975) also stated that the primary screening results 
obtained wi th NJ. dubius cannot always be extrapolated in hookworms 
of man and animals. Ni. brasi l iensis though showed better response 
to some standard drugs, has been found highly resistant to mebenda-
zole which is the drug of the day in hookworm chemotherapy. 
Since both the parasites, mentioned above, are t r ichostrongyl ids 
and do not represent true hookworms, the low translatory effect 
against hookworms is not surpr is ing. Therefore to obtain better 
correlation between c l in ica l and experimental situations, i t is 
necessary to have a true hookworm parasite in an experimental 
host. 
Ray et_ al^. (1972) were successful in infecting golden hamsters 
wi th A. ceylanicum. Subsequently in 1978 Ray and his associates 
confirmed the i r ear l ier findings and suggested that A. ceylanicum 
would be a suitable test parasite for various experimental studies 
while studying the biology of th is parasite, they observed that 
A. ceylanicum reaches adulthood in hamster by 13-17 days post 
infect ion. They i n i t i a l l y used 1000 larvae for infect ion. The number 
of larvae for infection were subsequently reduced to 200-300 (Ray 
et a l . , 1978). Contrary to the above f indings, our observation 
showed that an inoculum of 200 to 300 L- for each hamster was 
lethal and a l l the infected hosts died before 21 day p . i . (Visen 
et^  al^. , 1984). We standardized the inoculum size and a dose of 
60 larvae ± 10 per animal was sufficient for optimal in fec t iv i ty 
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and reasonable worm recovery, though, some mortal i ty did occur 
at th is inoculum size also. A. ceylanicum has wider host range 
being capable of infecting dog, cat and man. A l l the standard 
drugs have excellent efficacy against th is parasite but surpr is ingly 
i t is resistant to thiabendazole. In comparative studies the action 
of standard drugs under simi lar conditions was assessed on three 
test parasites being frequently used for antihookworm chemotherapy 
v i z . , N. brasi l iensis, N[. dubius and A. ceylanicum (Misra et^  a l . , 
1981). They concluded that N_. dubius requires more drug to achieve 
100% clearance and the results are inconsistent in comparison to 
N. brasi l iensis, a f inding contrary to Standen (1963) but agreeing 
with those of Broome and Greenhalgh (1961). N. brasi l iensis was 
re lat ively resistant to mebendazole which is the drug of choice 
for ancylostomiasis of man and animals. A. ceylancium being a 
hookworm parasite of economic importance and highly susceptible 
to antihookworm drugs, Misra et^  a]^. (1981) recommended the use 
of A. ceylanicum as the test parasite for antihookworm chemotherapy. 
Later Katiyar and his associates (Katiyar et^  aJ^., 1982; 1984; 1987) 
inducted th is model for routine screening of antihookworm agents. 
Among the various synthetic compounds and plant extracts 
tested during the present work, many synthetic compounds showed 
good antihookworm ac t iv i ty whi le no plant material was found to 
possess any effect in spite of the fact that they were used at 
considerably higher doses. This is not surpr is ing, as Ayurvedic 
Materia Medica prescribes specif ic ways of making decoctions and 
the i r usage. The modern concept, however, is to isolate active 
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ingredients by modern technology. This exercise is jus t i f ied since 
most of the inactive and unwanted components are sieved out by 
selective fractionation and only the active and nontoxic constituents 
are picked up re la t ive ly in pure form. This exercise has a serious 
disadvantage as the chemical treatment during the fractionation 
causes denaturation/inactivation of the active ingredients resulting 
in the loss of ac t i v i t y . This is amply proved from the fact that 
the active plant extracts which are s t i l l used in Ayurvedic system 
when subjected to chemical fractionation lose the i r ac t iv i ty 
(Catheranthus rosusus, Thymas vulgaris and Colchicum autumnale) 
(Norman et a l . , 1985). This may be one of the reasons of not 
getting ac t iv i ty in any of the plant extracts tested. 
As is evident from the l i te ra ture , there are some potential 
groups of anthelmintics. Members of some of which have very 
good antihookworm ac t i v i t y . During the present study, leads were 
obtained from previous experiences and analogues were rat ional ly 
synthesised in order to optimise the efficacy of the exist ing molecule. 
As such a number of synthetic compounds showed good ac t i v i t y . 
Of these, benzimidazole 2-carbamates are reputed for anthelmintic 
action (Kumar et^ al^., 198A; Katiyar e^ al^,, 1984; Visen et_ a l . , 
1987). The compounds of th is configuration were screened wi th 
the hope that some or many may possess better anthelmintic ac t i v i t y 
than the exist ing molecule or w i l l provide a base l ine data to 
the chemists to design and synthesize more rational and potent 
antihookworm compounds. The other approach was to modify known 
existing molecules by the i r structural maneuvering in an attempt 
93 
to remove the i r drawbacks. Since benzimidazoles are well knwon 
for the i r very high inso lub i l i t y , the development and synthesis 
of thei r der ivat ives may be an advantage over other series as 
they w i l l be fu l l y avai lable to gastrointestinal helminths. 
Among the benzimidazoles, four compounds v i z . , 83-1A8, 
85-478, 85-479 and 87-144 showed good adul t ic idal efficacy against 
A. ceylanicum and feebly effective against other parasites. As 
such the expanded studies were carr ied out in A, ceylanicum only. 
A l l the four compounds mentioned above exerted better efficacy against 
adults than against the la rva l forms and i t seems that L_ form 
is more resistant to the drug than L, and L^ stages. 
Since benzimidazoles are notoriously insoluble in water 
and feebly absorbed from the gastrointestinal t rac t , most of the 
drug administered oral ly is available to the parasite in the intestine. 
This may explain the detection of better ac t iv i ty in benzimidazoles 
by oral routes. The parenteral administration in general, resulted 
in poor eff icacy. I t is l i ke l y that because of the binding of these 
test compounds to blood proteins during intraperitoneal administrat-
ion, these are not avai lable at the site of infection in effective 
concentrations resulting into infer ior efficacy than the per os route. 
Of the four benzimidazole compounds which were found 
reasonably effective against A. ceylanicum, 87-144 seems highly 
efficacious both on adults and against larvae of A. ceylanicum, 
has reasonably effects against other parasites and possess high 
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therapeutic index. This compound needs to be investigated 
thoroughly. I f the compound holds promise in secondary tests 
also, th is may be a good substitute to mebendazole which has certain 
serious l imi tat ions. 
STRUCTURE ACTIVITY RELATIONSHIP 
Although a number of human and veterinary anthelmintics 
have emerged out from 2,5-disubsti tuted benzimidazoles, the drug 
with optimal anthelmintic action and no side effects is yet to come 
out. The work carr ied out in the present study is complimentry 
to the observation made earl ier (Van den Bossche et^  al^., 1982; 
Sharma and Abuzar, 1983). The substituent at 2 and 5(6) position 
of the benzimidazole play v i ta l role in determining the biological 
ac t i v i t y . In a l l AA substituted benzimidazoles which have been 
screened against A. ceylanicum in hamster, the anthelmintic ac t iv i ty 
obtained by dif ferent benzimidazoles indicate that the benzimidazole 
nucleus having substitution at 2 and 5 positions play crucial role 
for optimal ac t i v i t y . The most s t r ik ing ac t iv i ty was achieved 
when the 2 position of the benzimidazole is attached to an amino 
group thereby forming a guanidino skeleton whose two nitrogen atoms 
are involved in a cycl ic structure. As such the presence of 2-
amino usually leads to inactive molecule however substitution of 
one of the hydrogen of the amino group by methoxycarbonyl (Comps. 
83-1A8, 85-A78, 85-A79 and 87-221) or acetyl (Comps. 87-1A6, 88-
lAO, 88-15A) brings out anthelmintic ac t iv i ty in the compounds. 
Another factor which governs the ac t i v i t y of 2-methoxycarbonyl 
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amino/acetylamino benzimidazoles is the nature of substituents present 
at the 5-posit ion. In general an a ry l or heteroaryl function l inked 
at the 5-position of benzimidazole through a carbonyl (Comps. 83-
1A8, 85-478 and 87-14A) or a hydroxymethyl (Comp. 85-A79) bridge 
gives high ac t i v i t y . Presence of phenylthio group at 5-position 
(Comp. 87-1A6) of benzimidazole carrying an acetamide function 
at 2-position has also been observed to possess anthelmintic ac t i v i t y . 
The salient structural requirements for optimal ac t i v i t y in 2,5-
disubstituted benzimidazole are depicted in Fig. 6. 
/3-carbolines are comparatively less explored class of hetero-
cycles in the chemotherapy of intestinal helminthiases. Most of 
the compounds of th is series have been found to be inactive against 
A. ceylanicum up to a dose of 250 mg/kg x 1 except for one compound 
(Comp. 87-580) which showed marginal ac t i v i t y against the above 
parasite at a dose of 100 mg/kg x 1. This indicates that the 
/3-carbolines, though representing a benzimidazole nucleus fused 
with a nitrogen heterocycle, are not essential for biological ac t i v i t y . 
This further supports our SAR finding in the benzimidazole where 
i t has been shown that attempts to deviate from structural require-
ments given in Fig. 6 may lead to lowering or loss of anthelmintic 
ac t i v i t y . 
Among the other groups of compounds, no def ini te structure 
ac t iv i ty relat ionship could be established as none of them showed 
any appreciable ac t i v i t y . Secondly, the number of compounds tested 
belonging to isoxazolin (5) , pyrroles (9 ) , thiazoles (7) , n i t ro imida-
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zoles (3) , is too less to draw any def ini te correlation between 
structure and ac t iv i ty in the above classes of heterocycles. 
In the present study, the detailed biological ac t iv i ty prof i le 
provides some interesting information on the changes in molecular 
architecture and the spectrum of ac t i v i t y . Change in the heteroatom 
in the active benzimidazole compounds made a significant effect 
on the ac t iv i ty prof i le against intestinal parasites. Since benzi-
midazole-2-carbamates are knwon to exh ib i t the i r biological efficacy 
by inhib i t ing tubulin polymerization (Sharma and Abuzar, 1983; 
Bhaduri, 1985), the binding studies of these compounds with parasit ic 
tubulin would help to map the topography of parasite receptor 
for evolving the compounds wi th desired biological response. In 
view of the significant difference of ac t iv i ty against nematodes 
and cestodes, these compounds would serve as a better tool for 
understanding the differences of tubulins of cestodes and nematodes. 
It would also be interesting to study the b ioava i lab i l i ty of these 
compounds to ascertain the effects of the changes made in th is 
class of compounds. 
PART II 
IMMUNOLOGICAL INVESTIGATIONS 
R E V I E W O F L I T E R A T U R E 
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The development of parasite control measures based on induct-
ion of immune responses constitute a large and vigorous research 
f i e l d . Progress in th is direct ion has been frustrat ingly slow as 
compared to the development of vaccines for microbial pathogens. 
The reasons for that were slow awareness of the importance of para-
s i t ic diseases, marginal levels of acquired immunity developed in 
the host against many parasit ic helminths and the nature of the 
host parasite re lat ionship, an interaction which is the product of 
a long evolutionary association. Unlike bacteria and viruses the 
major d i f f icu l t ies involved in obtaining desired results in parasit ic 
infections are, the complicated nature of parasites which often require 
intermediate host(s) during the l i f e cyc le. Developmental stages 
i . e . , embryonic la rva l and mature forms, include many morphological, 
biochemical and physiological changes, a l l these make the antigen 
mosaic more and more complex. 
History of immunization is quite old as the f i r s t attempt 
to immunize against small pox dates back to 18th Century. Later 
in 1880s Pasteur's discovery of simple methods for attenuating 
bacteria, including culturing under abnormal conditions, opened the 
way for development of a l i ve vaccine against anthrax. In the 
same per iod, Wright and Pasteur pioneered the use of k i l l ed bacteria 
in vaccines against t ypho id , cholera and plague. These methods 
formed the basis for nearly a l l subsequent vaccines against bacterial 
and v i ra l diseases. The exceptions are the d ip ther ia and tetanus 
vaccines developed in early twentieth century and these involved 
the immunization wi th inactivated forms of the exotoxins released 
by the bacteria during the culture. 
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The advances in the f ie ld of active immunization against 
pathogenic organisms took place as the time passed but not significant 
success was achieved in vaccination programme against metazoan 
helminths. The reason for that might be that the helminths rarely 
cause acute disease and seldom prove fatal either to man or to l i ve 
stock. 
The f i r s t attempts to vaccinate against parasit ic helminths 
wi th dead whole worm extracts were made in 1930s and although 
a few results seem to have been promising enough to warrant fur ther 
investigations, most were rather disappointing and the interest waned 
unti l the 1950s. Thorson (1953b) carr ied out successful vaccination 
against N. brasi l iensis in rats using antigenic material secreted 
by l i v ing worms. The f i r s t metazoan helminth vaccine based on 
attenuated organisms was developed soon afterwards. Larvae of 
the catt le lung worm were X- i r radiated at a level which prevented 
fu l l development but allowed induction of a high degree of resistance 
to challenge wi th normal larvae (Jarrett et^  ai^., 1960a). This success-
ful achievement followed the rapid work on development of both 
l i ve and dead vaccines based on attenuation by i r rad iat ion and ant i -
gens secreted into culture media. Unfortunately these advances did 
not material ize. The attenuated vaccines have been tested wi th 
some success wi th a range of helminths, but so far only few attained 
practical u t i l i t y i . e . vaccine against Dictyocaulus v iv iparus and 
A. caninum. Mulugeta et^  al^. (1985) suggested several reasons for 
i r radiated vaccines not coming into greater use. The most important 
of these is the l imi ted se l f l i fe of the vaccine and the fact that 
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a l i ve vaccine is l i ke ly to be applicable only in those diseases 
in which a high level of immunity can be induced by a natural 
infection. Further, some i r radiated larvae may escape desired attenu-
ation and are l i ke l y to reach matur i ty. These w i l l make the vacci-
nated host silent car r ie rs . Moreover, inoculation of l i ve pathogens 
(attenuated larvae) to humans is against the ethics and therefore 
such vaccines cannot be used in man. 
From the l i terature i t is evident that many efforts have 
been directed towards solving the mechanism of immunity against 
parasit ic helminths rather than to develop vaccine(s). The former 
approach is understandable, since many questions in helminth immunity 
are s t i l l unsolved. 
Despite the demonstration of acquired immunity against many 
parasites and remarkable advances made in recent past to understand 
the immune responses in the hosts, protection against parasit ic d i s -
eases by vaccination has proved an elusive goal (StoU, 1961; WHO, 
1965; Ter ry , 1968; Silverman, 1970). I t is well known that animals 
develop considerable and often marked degree of acquired resistance 
against helminth (Chandler, 1936; Urquhart et_ al^., 1962; Ogilvie 
and Jones, 1973; Wakelin, 1978). Based on these evidences attempts 
were made to immunize animals with various antigen(s), crude or 
puri f ied ones (Thorson, 1956; Mi l le r , 1965; Miller,1965. ; 1971;1978; 
Urquhart e^ aJ^ . , 1966; Rothwell and Love,, 1974; Ogilvie et^  a]^. ,1978; 
Stromber,1978; Mitchel l and Anders, 1982;Silverman and Despommier,1984), 
More exhaustive and comprehensive reviews have been writ ten 
on helminth immunity (Clegg and Smith, 1978; L loyd, 1981; Lightowlers 
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and Rickard, 1988). A l l these give a general account of work done 
on immunity. 
In the following pages work on th is aspect has been br ie f ly 
reviewed with special reference to the experimental hookworm infect-
ion. At places other helminths have also been re fer red, in order 
to l ink various attempts on helminth immunity. 
DEVELOPMENT OF PROTECTIVE IMMUNITY EMPLOYING VARIOUS ANTIGENIC 
MATERIALS 
a) By living parasites 
The l i ve parasites are known to stimulate considerable, 
often sol id immunity in natural conditions. In experimental models 
fa i r l y good examples are avai lable, showing strong protect ive immunity 
in various forms. Haemonchus contortus and N_. brasi l iensis are 
the typ ica l examples of the demonstration of natural immunity in 
the form of "self cure" (Stewart,1950b; Stoll,1958; Mulligan et_ al_. ,1965; 
Ogilvie and Jones, 1971; Govila et_ al^., 1973). Protective immunity 
has been adequately demonstrated in Nematospiroides muris in rats. 
Ancylostoma caninum also e l ic i ts protective immunity in dogs 
as repeated infection lowers the worm burden and egg output (McCoy, 
1931). In case of A. ceylanicum, Gupta and Katiyar (1985) demons-
trated high level of protection against challenge infection of L_ 
in hamster previously infected with A. ceylanicum infect ion. Str ik ing 
effects of vaccination were evident wi th mult iple doses of larvae. 
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These observations were similar to that of Bart lett and Ball (1974) 
and Hurley £t^ al_. (1980) against N. dubius in rats. 
b) By irradiated attenuated l ive parasites 
Controlled attenuation of l i v ing pathogens by i r radiat ion 
or chemical treatment is of immense value in the production of immu-
nity against a var iety of infections. Liv ing parasites when exposed 
to optimum dose of X-rays or u l t ravoi let rays, are attenuated to 
the extent that they are unable to mature and do not cause pathology 
in the host. I r radiat ion interferes wi th the physiological process 
and inh ib i ts normal developments of the parasite. But the larvae 
survive long enough to give out required amount of metabolic products 
to produce protective immunity. Based on these basic factors,attempts 
have been made to develop i r radiated vaccines to control and/or 
prevent helminth diseases of man and domestic animals (Mulugeta 
et a]^., 1985). However, t i l l date the only commercially available 
vaccine against helminth parasite is 'DICTOL' against Dictyocaulus 
v iv iparus (Jarrett et^  al^., 1960a). Allen and Hanbury L t d . , London, 
produced 'DIFIL ' along the same l ine to protect sheep against D. f i la r ia . 
Vaccine is under t r i a l on small scale in some endemic areas including 
India. Studies are in progress in Ethiopia and Argentina to determine 
the efficacy of the vaccine for a possible large scale production 
and use. 
Protection against other helminths following the administration 
of i r radiated larvae has been achieved in a var iety of nematode 
infections. In case of N[. brasi l iensis a marked degree of reduction 
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in the larval growth, ova production and worm burden was obtained 
when rats were inoculated with larvae i r radiated wi th 10 to 15 k r . 
However, Prochazka and Mulligan (1965) fai led to stimulate immunity 
when high doses of i r rad iat ion (180 k r ) were used, but the larvae 
receiving lower doses (50 kr and 100 kr ) of i r rad iat ion conferred 
strong immunity. Katiyar et^  al^. (1968) using u l t ravoi le t treated 
larvae of h^ . brasi l iensis obtained high degree of protection in rats 
to subsequent challenge. I r radiated larvae of t r ichostrongyl ids 
{H. contortus and Trichostrongylus colubri formis) provided effective 
immunogens to sheep (Urquhart et^  al^., 1966; Gregg and Dineen, 1978). 
In schistosomiasis much attention has been paid to the effect 
of radiation attenuated vaccine and a considerable degree of immunity 
can be induced in mice, rats and rhesus monkey (Bickle et_ a l . , 
1979; Webbe et_ al^., 1982; Damian et^  aJ^., 1984) but t i l l now i t is 
doubtful whether a l i ve attenuated schistosome vaccine w i l l ever 
reach the level of efficiency for human use. Such a vaccine may 
have a future in veterinary f ie ld (Majid et_ al^., 1980; Hsu et_ a l . , 
1984). 
In cestodes the administration of i r radiated eggs and oncho-
spheres have been shown to induce protection against infection 
(Urquhart et^  al^., 1963). Similar observations were made by 
Movsesijan et_ a]^. (1968) who obtained encouraging protection against 
Echinococcus granulosus when the dogs were immunized wi th i r radiated 
brood capsules. Herd et^  al^. (1975) found th is approach to be potent-
ia l l y dangerous since X- i r radiated worms regenerated in some animals 
reaching f u l l maturity and shedding large numbers of infect ive eggs. 
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The dose of i r rad iat ion seems to be an important factor 
for successful immunization which should not be too high to k i l l 
the parasite or not too low to allow the parasite to reach maturity 
and to produce pathology. There i s , however, strong objection 
to i r radiated vaccines, f i r s t l y , on ethical ground since the hosts 
are administered with l i ve parasites and secondly, such vaccine 
may produce pathology in the subjects. 
c) Whole worm homogenate 
Attempts to vaccinate against parasit ic nematodes with dead 
worms homogenate or extracts began in 1930 (Mi l le r , 1932; Campbell, 
1936). Although a few results seem to have been promising enough 
to warrant fur ther investigations (Sheldon, 1937), most were rather 
disappointing and interest waned (Kerr , 1938), unt i l the 1950s. 
Thorson (1956) demonstrated that injections of extracts of the oeso-
phagus of adult hookworm (A. caninum) resulted in a significant 
reduction in worm count compared to control groups in dogs. 
Clegg and Smith (1978) reviewed variable success in the 
immunization wi th crude somatic extracts of helminths. Most of 
the experiments have been conducted in laboratory models and in 
many cases such immunogens have yet to be examined for the i r e f f i -
cacy in domestic animals and primates. 
Against nematodes the immunization of the host wi th homo-
genate and soluble extracts of various stages of parasites proved 
ineffective (Kerr , 1938; Kagan, 1958; Ogi lv ie, 1967; Bindesi l , 1969; 
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RothweU, 1978). In contrast, Stromberg and Soulsby (1977a) demons-
trated a significant level of resistance in guinea pigs immunized 
against Ascaris suum with a soluble extract of adult worms. Despommier 
and MuUer (1976) isolated alpha and beta granules from homogenate 
of the larvae of Tr ichinel la sp i ra l i s and have been shown to be 
highly protective in rats and mice. 
Significant progress has been made in the evaluation of 
functional antigens from J . colubri formis (RothweU and Love, 1974; 
RothweU, 1978). According to them, a single injection of 
J . colubri formis whole worm extracts stimulated high level of res is-
tance against challenge infection in guinea pigs. Recently Carrol l 
and Grove (1985) have achieved considerable protection in dogs, 
with somatic antigen of adult A. ceylanicum. 
In trematodes protective immunization has largely been con-
fined to Schistosoma s p p . , and Fasciola hepatica (Clegg and Smith, 
1978). Earl ier vaccination attempts wi th Schistosoma spp . , were 
unsuccessful in experimental models (Ozawa, 1930; Vogel and Minning, 
1953; Lin et^  £ l . , 1954; Sadum and L in , 1959; Ritchie et^  aJ^., 1962; 
Murrel l et_ al^., 1975). Contrary to these Watts (1949) achieved 
some success in immunizing the mice wi th homogenate of S^ . mansoni. 
Few experiments conducted against F_^  hepatica also yielded variable 
results (Smithers, 1976). 
Many attempts have been made to immunize animals with 
somatic antigens of cestodes (Mi l le r , 1932; Campbell, 1936; Turner 
et a l . , 1936; Gemmell, 1962; Gallie and Sewell, 1976; Heath, 1976; 
105 
Kwa and Liew, 1977; Ayuya and Will iams, 1979 and L loyd, 1979) 
but they proved either ineffective or only marginally effective in 
e l ic i t ing protection. Further, Rajasekariah et^  al_. (1980a) showed 
some degree of protection with homogenate of metacestodes against 
cysticercosis in mice. 
The fa i lure or atmost marginal success of the majority of 
vaccination attempts gave r ise to the view that the antigens needed 
to stimulate an effective immune response (functional antigen) were 
not present in sufficient quantity in homogenate of dead worms but 
might be act ively secreted by the l i v ing parasites. On the other 
hand, the whole worm homogenate contains mixture of various antigenic 
materials where some potentiate production of antibodies and others 
suppress the immune responses (Rothwell and Love, 1974; Clegg 
and Smith, 1978). 
T i l l now the ident i f icat ion of relevant protective component 
by latest methodology (electrophoresis, electroblott ing, probing 
wi th antisera) has been d i f f i cu l t . This has now become possible 
that major protective antigens can be par t ia l ly ident i f ied (O'Donnel 
et a l . , 1985). A more precise characterization of those antigens 
may be achieved by raising monoclonal antibodies. 
d) By excretory-secretory products (ES antigens) 
Helminths are not known to produce toxins which e l i c i t 
formation of anitbodies. Exsheathing f lu ids have been considered 
more important antigens (Thorson, 195A; Soulsby, 1963). I t is widely 
held that the antigens which stimulate the immune mechanism in 
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host are the substances released by the l i v ing worms. The concept 
that protective antigens are secreted during active metabolism of 
the parasite was established from the work of Sarles (1938) who 
f i r s t demonstrated in case of N. brasi l iensis that the plugs of p rec i -
pitates appeared at the o ra l , excretory and anal openings, when 
the larvae were incubated in antiserum obtained from hJ. brasi l iensis 
infected rats. Similar view was later presented by Denham (1969a), 
who demonstrated high degree of protective immunity in laboratory 
animals wi th excretory-secretory products. I t has been suggested 
that antibodies produced in response to these products are more 
closely related to active infection than the antibody e l ic i ted by somatic 
antigens. 
The complexity of the parasites and the i r l i f e cycle is re -
flected in the variety of molecules excreted or secreted by them 
in the i r hosts (St i rewalt , 1963). These ES products frequently s t i -
mulate or modulate the immune responses of the host (Thorson, 1953b; 
Campbell, 1955). The importance of moulting f lu id as antigens of 
nematodes was demonstrated in many helminthic infections and when 
used as immunizing agents they el ic i ted high protect ive immunity 
(Chipman, 1957; Rothwell and Love, 197A; Stromberg and Soulsby 
1977a; Stromberg, 1978). Contrary to these claims, the excretory 
and secretory products of Nl. dubius fa i led to give any protection 
to mice against the homologous challenge (Day et^  al^., 1979). Protective 
antigens have also been ident i f ied in the stichosome cells of T. sp i ra l is 
and N. muris (Clegg and Smith, 1978). Puri f ied products from s t i -
chosome cells of T. sp i ra l i s muscle larvae are highly immunogenic 
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(Silberstein and Despommier, 198A). One such antigen has recently 
been pur i f ied to homogeneity and has been shown to be a glycoprotein 
of high al lergenici ty (Durham et^  al^., 198A). 
Hookworm derived ES-antigens showed good protect ive immunity 
in the hosts. Parasites have an intr icate glandular apparatus in 
the i r oesophageal region (McLaren et^  al^., 197A). In N. americanus 
these glands excrete proteolyt ic enzymes and acetylcholinesterase. 
I t is well known that these enzymes are immunogenic and probably 
of great importance to the surv iva l of the parasite. Recently, various 
antigens of N. americanus from ovum to adult have also been described 
and of which the predominant one was 3KDA molecule present in adult 
homogenate and ES-products. 
In trematodes, var iable results of immunizations have been 
obtained (L loyd , 1981). Vaccination against Schistosoma spp . , has 
been reviewed by Smithers (1976), Clegg and Smith (1978), Dean 
(1983), Taylor and Bickle (1986) and James and Sher (1986). Studies 
so far conducted on the use of ES antigens of schistosomes for vacci-
nation, have not been encouraging and inconsistant results were obtained 
(Murrel l et^  al^., 1975; Minard et^  al^., 1977). 
The recent descript ion of induction of a strong cytotoxic 
and protect ive IgE response in rats immunized wi th schistosomula 
released products (Damonneville at_ al_., 1986) indicates that the ES 
products of schistosomula include major targets of protect ive IgE 
and are potential ly protect ive (James, 1985). 
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With ES products of £ . hepatica inconsistent results were 
obtained (Lang, 1976; Lang and Hal l , 1977; Rajasekariah et^  a l . , 1979). 
A detailed analysis of these antigens was given by I r rv ing and Howell 
(1982). 
In cestodes the f i r s t clear demonstration of protect ive immunity 
due to ES antigens was made by Rickard and Bell (1971a and b ) . 
They showed that antigen collected from jin v i t ro culture of Taenia 
ovis onchosphere and given wi th FCA gave very high level of pro-
tection against the challenge infect ion. Later protect ive immunization 
using onchosphere ES antigen has been demonstrated in many cestodes 
of sheep, cat t le, rabbi t and mice e.g. T_. ov is , J . saginata, T. 
taeniaeformis (Wil l iams, 1979; Rickard and Will iams, 1982; Rickard, 
1982; Rickard and Howell, 1982). 
e) Nonspecific immunization 
Adjuvants have been shown to potentiate immune responses 
and they, nonspecifically increase protection against infections with 
a var iety of helminths. The use of adjuvants as an adjunct to antigens 
have produced very varied results, depending on the type of adjuvant 
used and the species of animal immunized (WHO, 1976). For instance 
FCIA was an effective adjuvant for J . taeniaeformis antigens used 
in albino mice and rats (Kwa and Liew, 1977; L loyd, 1979). Conversely, 
Ayuya and Williams (1979) found that rats when immunized with antigen 
emulsified in FCA, d id not develop resistance to infection wi th 
T. taeniaeformis. 
109 
A difference in the efficacy of adjuvants by various routes 
was seen when guinea pigs were immunized against infection wi th 
J . colubr i formis. The antigen was effective when given subcutaneously, 
intraper i toneal iy, intradermaliy or intraduodenally. But no effect 
was observed when given o ra l l y . 
In mice, the trematode (_S. mansoni) antigens when administered 
with BCG, increased protection against infect ion. However, very 
high doses of BCG, which produced a disseminated granulomatous 
responses, were required. But variations are knwon to occur as 
when rhesus monkeys were given high doses of BCG challenge wi th 
S. mansoni, no protection was found (Maddison et^  al^., 1978a and 
b ) . Variable results were also obtained in cestodes (L loyd , 1980; 
Clegg and Smith, 1978). I t is evident that extensive studies are 
required in immunization t r i a l s to examine the efficacy of a variety 
of adjuvants or also the i r route of immunization. 
I t would be thus evident that helminth parasites often generate 
sol id immunity, which can be el ic i ted or induced a r t i f i c i a l l y . Work 
on th is aspect is mainly based on i r rad ia t ion technique, dead worm 
antigen and ES antigens. Further^ i t is clear from the review of 
l i terature that th is aspect is s t i l l poorly understood in case of hook-
worm infections because of host speci f ic i ty and lack of suitable exper i -
mental models. 
M A T E R I A L S A N D M E T H O D S 
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PARASITE (A. CEYLANICUM) 
The a c q u i s i t i o n o f p a r a s i t i c s t r a i n , p a r a s i t e c u l t u r e 
and ma in tenance o f i n f e c t i o n i n hamsters ^ r e t he same as 
d e s c r i b e d e a r l i e r (Page 28-29). 
EXPERIMENTAL ANIMALS 
Laboratory bred, parasite free male hamsters weighing 60-
70 g served as experimental animals. Worm recovery on autopsy, 
thei r count and the cr i ter ion of worm reduction have already been 
described elsewhere (Page 33-34). 
PARASITE MATERIAL 
Collection of adult A. ceylancium and preparation of soluble somatic 
antigen 
Adult A. ceylanicum worms were harvested from the hamsters 
which had been ora l ly inoculated wi th eOilOL^ each 18 days before 
(Katiyar et^  al^., 1984). 
Freshly collected worms were washed thoroughly in normal 
saline and were f ina l ly washed in s ter i le normal saline added with 
antibiot ics (Penici l l in 500 un i ts /ml , Alembic Chemical Works Co. L t d . , 
Baroda, India and Streptomycin 300 yug/ml, Sarabhai Chemicals, Baroda, 
India) and stored at -20°C t i l l used. For antigen extract ion, the 
required number of worms were homogenized in normal saline (pH 
7.2) under ch i l led condition using Potter Elvi jhm tissue grinder f i t ted 
with teflon pestle. The homogenate, thus obtained, was sonicated 
I l l 
at 10 kC/sec for 20 min (Soniperp 150, U.K.) . The duration of soni-
cation was 5 beats each of four minutes duration and with intervals 
of two minutes in between the two beats. Sonicated homogenate was 
extracted with isotonic saline for 12 hours at A°C and then centrifuged 
at 10,000 r . p . m . , for 30 min at 4 C (Janetzki, K_,). The supernate 
was aspirated and i ts protein content was determined by the method 
of Lowry et^ ^ . (1951) and th is soluble somatic antigen was used 
in various immunological studies. 
Collection of excretory-secretory (ES) antigens of adult A. ceylanicum 
Selection of the culture medium 
For the maintenance/culture of adult A. ceylancium in v i t r o , 
different defined culture media were tested in a b id to select the 
best which would support the l i f e of the adult parasites for longer 
period . Culture media tested were normal saline (NS) phosphate 
buffer saline (PBS), Hank's balance salt solution supplemented with 
0.5% lactalbumin hydrolysate (HLAC), minimum essential medium (MEM), 
MEM + 10% hamster serum, Novy McNeal and NicoUe (NNN) medium, 
Leibovi tz 's (L-15) medium, pH 7.2, Mitsuhoshi Maramorosch medium 
(MM), MM medium+1C^faetal calf serum (PCS), Roswell Park Memorial 
Institute (RPMI)-1640 medium, RPMI-1640 medium + 10% PCS, RPMI-
1640 medium + 10% hamster serum, medium -199. 
Thoroughly washed adult worms were incubated in antibiot ics 
added saline for 1 hour and f ina l ly rinsed in the medium to which 
they were to be t ransferred. Worms (100 of both the sexes) were 
112 
transferred aseptically to each of the culture tubes containing 10 
ml of medium. The culture tubes were incubated at 37°C and at 
every 12 h and fresh medium was replenished asept ical ly . 
The cultures were examined under the dissecting microscope 
at different in terva ls . The contaminated cultures were discarded. 
Assessment of surv iva l of worms was made by counting them as act ive, 
sluggish and dead. Dead worms were removed from the culture tubes 
during the transfer of fresh medium. 
Collection of ES antigens 
RPMI-1640 medium without any supplement supported the l i f e 
of adult parasite for 192 h and was found most sui table. Worms 
(150-200 males and females) were transferred to culture vessel con-
taining 20 ml of RPMI-16A0 medium and incubated at 37 C. After 
12 h of incubation, incubating medium was aspirated and the culture 
was added wi th fresh medium. From a l l the culture vessels the 
ES products were pooled and stored at -20 C t i l l used. For exper i -
mental purposes the process, for collecting ES antigens, was repeated 
several times t i l l sufficient material was avai lable. The pooled 
antigenic material was concentrated by lyoph i l i za t ion. On the day 
of immunization, the powdered material was reconstituted in normal 
saline (N.S.) and protein content was determined (Lowry et_ a l . , 
1951). 
The prel iminary immunization t r i a l s revealed that ES antigens 
collected in RPMI-1640 medium when used for immunization purposes 
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did not e l ic i t good immunogenic response. However, s imi lar ly collected 
ES antigens in NS engendered reasonable to excellent immunity to 
challenge infection. I t appeared that the medium RPMI-16A0 containing 
various amino acids and other nutrients masked the antigenic epitopes, 
thus further immunization t r ia l s were carr ied out wi th ES antigens 
collected in saline only. 
Collection of larvae (L^) and preparation of soluble somatic antigen 
The larvae were harvested from faecal cul ture as stated 
in page 28. Larvae were rigorously washed in NS and were processed 
for extraction of somatic antigen exactly in the manner as described 
for adult worm antigen preparation. The antigen was stored at 
-20°C t i l l used. 
GEL CHROMATOGRAPHY 
When a mixture of molecules is passed through a column 
of porous gel granules, the molecules may appear in the effluent 
in order of decreasing size. Fractionation is believed to occur when 
diffusion of the molecules into the gel pore is restr ic ted but not 
prevented because of the i r size and because they pass through the 
column at rates that are related inversely to the f lu id volume access-
ib le to them wi th in the column. Based on th is p r inc ip le , the agar 
gel column can be used to separate proteins over very wide molecular 
weight range (Andrews, 1964; 1970). Better separation can be obtained 
with gel f i l t ra t ion media composed of cross l inked dextrans (Sephadex 
manufactured by Pharmacia, Uppsala, Sweden). Andrews (1964) showed 
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that gel f i l t ra t ion can be used as a comparative method to give use-
ful estimates of the molecular weights of proteins. 
Keeping these in view, fractionation of parasite material 
was done on Sephadex column f i t ted in an automatic fract ion collector 
(LKB minocold Lab model 2023 Bromma equipped wi th per is ta l t ic pump, 
U.V. card (analyser), recorder and fraction collector. 
Preparation of Sephadex column 
Four grams of Sephadex G-200 (dry weight) was heated in 
750 ml phosphate buffer, pH 7.2 in a boi l ing water bath for 5 h. 
After sufficient swelling of the gel (confirmed microscopical ly) ,mater ial 
was cooled down to operating temperature (10 C). Excess water was 
removed and gel was suspended in approximately A volumes of equ i l i -
bration buffer. Smallest part ic les (Sephadex) were removed by decan-
tation (3-4 t imes). At optimum temperature, the gel was degassed 
under vacuum. To prepare the column, degassed gel (a s lu r ry ) of 
approximately equal volume of buffer and gel was poured into a v e r t i -
cal column (1,6 x 80 cm) through a glass rod to avoid a i r bubbles. 
A l l the required gel was poured to the optimal level at one t ime. 
The column outlet was then opened and the gel was allowed to settle 
down uniformly. 
Continuous addit ion of gel s lur ry was made unt i l a bed height 
of 80 cm was obtained . The top of the column was then connected 
with buffer reservoi r . Complete packing of the column normally 
took 5-6 h. 
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Three column volume of the buffer was run through the column 
using per is ta l t ic pump regulated at 8 beats (10 ml /h flow rate) for 
washing and f inal setting of the gel bed. 
Gel f i l t ra t ion was carr ied out on sephadex G-200 column (LKB, 
Bromma, Sweden) wi th bed dimensions of 1.6 x 80 cm. Equi l ibrat ion 
and elution were done wi th phosphate buffer, pH 7.2, at a constant 
flow rate of 10 ml /h and 3.5 ml fractions were collected using a 
LKB 2112 Radirac Fraction Collector under continuous monitoring at 
280 nm (LKB 2238 Unicord SII with LKB 2210 automatic 1-channel Recorder). 
Blue dextran dye (5 mg/ml) (high molecular weight protein) 
was passed through the column and an eluant of 3.5 ml was col lected. 
I f a single sharp peak was obtained without any disturbance in the 
base l ine only then the column was considered suitable for f ract ion-
ation of antigenic materials. 
Proper application of the sample on the packed column is 
important for better and sharp fract ionation. To avoid disturbance 
on the gel surface the sample was charged wi th the help of per is ta l t ic 
pump and three way valves. This provided uniform layering of test 
sample over the gel surface. 
Void volume (Vo) determination 
Blue dextran dye (5 mg/ml) was applied to the column avoiding 
disturbance of the gel bed surface. Immediately after applying the 
sample, eluent was col lected. Total volume including leading peak 
indicates the void volume of the column which was followed by reading 
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at 280 nm. Thus Vo is the volume of effluent collected from the 
point of sample application to the center of effluent peak. 
Elution volume (Ve) determination for protein standards. 
Various standard proteins (cytochrome C, carbonic anhydrase, 
bovine serum albumin, alcohol dehydrogenase and beta amylase) having 
concentration of 5 mg/ml protein were loaded separately on the column 
previously equi l ibrated wi th phosphate buffer (pH 7.2) . Elution 
volumes for various standard proteins were determined by measuring 
the volume of effluent collected from the point of sample application 
to the center of effluent peak. 
Standard curve 
A graph was plotted in respect of molecular weights of standard 
proteins versus Ve/Vo for each respective protein standards on semi-
log paper. 
Fractionation of antigens 
Protein samples were fractionated and eluted fractions were 
collected in 3.5 ml volumes (as obtained on graph by recorder) . 
Fraction of each peak was pooled and dial ized against d is t i l l ed water, 
lyophi l ized and stored at -20 C t i l l used. Protein content of each 
was determined by the method of Lowry £t^ ^ . (1951). 
Elution volume (Ve) determination for unknown proteins 
Different antigenic samples of A. ceylanicum . (adu l t , ES and 
larval ) were applied to the column separately at a concentration 
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of 10 mg/ml. Determination of Ve for each fraction (peak) of each 
antigenic material was made as described for standard proteins. 
Molecular weight estimation of antigen fractions 
Estimation of molecular weight of various parasite proteins 
was made by comparing the ratio of Ve/Vo for the protein in question 
to the Ve/Vo of standards of known molecular weights wi th the help 
of cal ibrat ion curve. 
IMMUNIZATION OF NAIVE HAMSTERS 
The crude somatic antigen (adult and larva l ) and ES products 
and thei r different fractions were evaluated for protect ive capabi l i t ies. 
Hamsters in different groups were immunized wi th these antigens in 
different dose schedules (single or mul t ip le ) , given intramuscularly 
with or without Freund's complete adjuvant (FCA) (Difco Laboratories, 
Detroit, Michigan, U.S.A.) . The antigen and FCA in equal volume 
were emulsified and injected in volumes of 0.1 ml to 0.2 ml . The 
f i r s t injection consisted of antigen wi th or without FCA and the sub-
sequent injections were of aqueous boost(s), of 0.1 ml , administered 
by the same route. Each injection was spaced at 10 days. Control 
hamsters received sham administration of normal saline wi th or without 
FCA. 
Immunized and control hamsters were challenged wi th 60±10L-
each, 7 days after the last booster dose and the animals were auto-
psied 18 days later. The intestines were opened longitudinal ly, 
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adult worms were removed and counted and efficacy of vaccination 
was determined as described elsewhere (Page 33-34). Larval antigens 
were also s imi lar ly used for immunization purposes. 
Assessment of protection 
Protective efficacy was assessed by comparing the average 
number of worms recovered from the immunized groups to that obtained, 
from unimmunized controls. (Page 33-34). 
Fecundity potential of femcile worms recovered from immunized hamsters 
Ten act ively motile female worms from immunized and control 
groups were selected for the study. Each female worm was put in 
a separate v ia l containing 1 ml of s ter i le nutrient broth to which 
antibiot ics (Penici l l in 500 units/ml and Ambistryn 300 xjg/ml) had 
been added. The via ls were incubated at 37 C for 24 h. At the 
end of the incubation per iod, the eggs released in the media were 
counted in 0.1 ml al iquots. Three such counts were made. From 
the data obtained, the total number of eggs released (during 24 h) 
were calculated (Visen et^  £l^., 1984). 
SEROLOGICAL STUDIES 
Preparation of hyperimmune sera 
Hamsters were immunized with escalating doses of 100, 200 
and 400 of A. ceylanicum. After 21 days of each la rva l inoculation 
the resultant worms were removed by anthelmintic treatment (Mebex, 
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1 mg/kg x 1). Blood was collected from re t ro-orb i ta l plexus of 
the immunized hamsters 7 days after the last immunizing dose. Sera 
were separated as mentioned ear l ier , pooled and stored at -20°C 
t i l l used. This pooled serum sample was used for standardization 
of immunological assays. 
Antigen 
The soluble somatic antigen (crude) of A. ceylanicum (adult) 
was di luted or concentrated as per demand of the experimental design 
and used in immunological tests. 
COUNTER IMMUNOELECTROPHORESIS (CIEP) 
The technique is based on the ab i l i t y of antigen and antibody 
to move towards each other, in agar gel at a faster rate, in the 
presence of an electr ic f i e l d . The antigen migrates towards anode 
and the antibody towards the cathode (in opposite direct ion) as a 
results of electroendosmosis and a prec ip i t in l ine is formed where 
they meet opt imal ly . 
The advantages of the CIEP technique over double immune 
diffusion (DID) are the s impl ic i ty of the test, rap id i ty in obtaining 
results and a ten fo ld increase in sensi t iv i ty (Gocke and Howe, 1970; 
Alter et al^., 1971). 
In the present study CIEP was performed according to the 
method described by Bhopale e^ aJ,. (1981) wi th s l ight modifications 
which are described b r ie f l y as under -
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Agarose preparation 
One gram agarose (B.D.H.) was dissolved in 100 ml of d ie thy l 
barbitone acetate buffer(0.1M, pH 8.4; autoclaved at 15 lbs for 15 min) 
in a boil ing water bath t i l l a transparent solution of the agarose 
was obtained. 
Slide preparation 
Clean glass s l ides, measuring 25x75 mm, were kept on an 
even surface and 3.5 ml of molten agarose was spread on each s l ide . 
Slides were kept at room temperature t i l l the agarose set t led. Slides 
with settled agarose were then transferred to moist chamber at 20 C 
for further sett ing. To ensure good contacts between gel and glass 
s l ide, the sl ide was precoated with a th in layer of agarose solution. 
After the gel hardened, the wells were made in one step 
with the wel l punchers and the cut gel was sucked up without d is tu rb-
ing the rest of the layer . The capacity of each wel l was 10 All wi th 
an interspace of A mm in between the two wel ls . 
Immunoelectrophoresis 
To carry out CIEP the following procedure was fo l lowed: 
1) Buffer compartment was f i l l ed wi th d ie thy l barbitone acetate, 
buffer pH 8.A and the level of the buffer in the two chambers 
was equalized. 
2. Agarose sl ides were arranged in electrophoretic chamber 
and connected to the buffer wi th Whatman-3 f i l t e r paper 
wicks. 
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3. Pre-run of 15 minutes was made at a constant current of 7.5 
mA per s l ide (before the application of the sample). 
4. Power supply was disconnected and the test samples were 
applied (antigen in the cathodic well and antibody in the 
anodic we l l ) . 
5. Electrodes were connected to the power supply and electro-
phoresis was run for A5 minutes at a constant current of 
5 mA per s l ide . 
6. After the run, the power was disconnected and sl ides were 
incubated in a humid chamber at room temperature for 12h. 
7. Slides, there after were observed for prec ip i t in bands and 
stained for improved sensi t iv i ty in Coomassie b r i l l i an t blue. 
Staining of the sl ides 
Slides wi th prec ip i t in l ines, as visualized by naked eye, 
were stained as fol lows: 
1. Unprecipitated proteins and other unwanted materials attached 
to the sl ide were washed by keeping sl ides in normal saline 
for several hours wi th change of saline at each hour for 
fast cleaning. 
2. The washed gel s l ide was dr ied at room temperature by 
keeping the wet Whatman-3 f i l t e r paper over i t without t rapp-
ing air between the f i l t e r paper and the gel . After complete 
dry ing, f i l t e r paper was removed from the gel surface by 
sl ight moisturing and sl ides were immersed in Coomassie 
b r i l l i an t blue for 15 min. 
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3. In case of over staining, the s l ide was destained in destaining 
solution (methanol and glacial acetic ac id ) . Depending on 
the intensity of stain, changes of the destaining solution 
were made to make the prec ip i t in bands clean and sharp. 
Interpretation of results 
A posit ive result was inducted by the presence of one or 
more prec ip i t in l ines between the serum samples and antigen (Mahajan 
et^  aJ^., 1975). 
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 
ELISA was f i r s t described by Engvall and Perlmann in 1972. 
In the assay, antibodies or antigens are conjugated to enzymes 
in such a manner that the immunological and enzymatic act iv i t ies 
of each moiety are maintained. The degradation of a substrate by 
the enzyme, measured spectrophotometrical ly, is proportional to the 
concentration of the unknown "antibody" or "antigen" in the test solution. 
The technique of heterogenous enzyme assay (non competitive 
direct ELISA) is used as described by Engwall and Perlmann (1972). 
The pr inc ip le of the assay may be summarized as fol lows: 
1. An antigen or antibody is adsorbed to a sol id phase. 
2. The addit ion of test sample to the sensitized sol id phase. 
3. The addit ion of an enzyme-labelled ant iglobul in. 
A. The incubation and washing steps. 
5. The addit ion of the enzyme substrate. 
6. The measurement of the amount of substrate being degraded 
by the enzyme. 
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The advantages of using ELISA for detecting antigen and/or 
antibody are as fol lows: 
a) I t is convenient to use. 
b) I t is very sensitive and rel iable technique. 
c) The labelled immuno reagents are stable for long periods. 
d) The precautions and disposal procedure required for radio-
isotopes are not required. 
e) The use of chromogenic substrates for the enzyme labels 
permit visual interpretat ion of test results. 
Procedure as adapted in the present study 
Plate coating 
Polystyrene microt i ter plates (V i r ion, Germany) were coated 
with 150 All of antigen (crude, adult somatic antigen 15 Ajg/ml) in 
carbonate buffer (pH 9.6; 0.05 M) except wells A-1 and B-1 which 
were used as blanks. Plates were incubated at 37 C for 3 h. After 
coating, plate was stored at 4 C (not more than A days) . Plates 
were covered t igh t l y during incubation and storage. 
Blocking of unbound sites 
In order to block nonspecific bindings, antigen coated plate 
was f i l l ed wi th 0.05% Bovine Serum Albumin in PBS/Tween 20 buffer 
(250 All in each wel l previously coated wi th antigen). Plate was 
incubated for 1 h at 37 C and washed with PBS/Tween 20, 3 times. 
The washing solution should s i t , in the wells for 5-8 minutes during 
each wash. 
124 
Sera dilutions 
Reference and control sera di lut ions were made in PBS Tween 20 
buffer in the rat io of 1:100 to 1:800. 
The reference and control sera consisted of -
i ) Pooled reference posi t ive to assess reproduc ib i l i ty of test 
measurements, 
i i ) Pooled negative to check for nonspecific background reactions. 
Assay method 
a) Prior to inoculation of test samples, in the wel ls, plate 
was washed 3 times wi th 250 / j l PBS /Tween 20. The washing 
solution should s i t in the wells for 5-8 min during each 
wash. 
b) Reference and control sera (150 / j l / w e l l ) were added to the 
plate in appropriate wel ls. 
c) Plate was incubated at 37 C for 2 h keeping t igh t l y covered. 
d) The plate was washed 3 times wi th PBS Aween 20 as described 
above, after incubation. 
e) During the washing cycle, appropriate d i lut ion of enzyme 
conjugate (1:2,000) (goat antihamster IgG conjugated with 
horse radish peroxidase j Kirkegaard and Perry-Laboratories 
Inc, Gaithersburg, Maryland, U.S.A.) was prepared in incubat-
ion buffer (PBS/Tween 20). 
f) Diluted enzyme conjugate (150 AJI) was added to each wel l 
and plate was again incubated for 2 h at 37 C. 
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g) On completion of incubation, solution was discarded and plate 
was washed wi th PBS/Tween 20 as stated above. 
h) During washing cycle appropriate substrate, orthophenyl diamine 
(OPD; Sigma) in c i t rate buffer, pH 5.0, 8 mg/20 ml of buffer 
wi th 20 Ail H^Og) was prepared. 
i ) Immediately after the substrate preparations, 150 /ul of the 
enzyme substrate solution was added to each well and plate 
was incubated at room temperature unt i l the proper color 
was v i s ib le . During incubation, strong l igh t was avoided. 
j ) Reaction was stopped after 20 min of incubation by adding 
50 iUl 5-N H2SO, solution to each we l l . 
k) Color reaction was quantitated spectrophotometrically on the 
auto micro ELISA reader (V i r ion, Germany) at A90 nm. 
Interpretation of results 
Results were expressed in terms of O.D. values. Where values 
greater than a certain reference value were posit ive and below that 
were considered negative. 
DELAYED TYPE OF HYPERSENSITIVITY REACTION (DTH) 
Delayed type of hypersensi t iv i ty (DTH) was done as per 
method of Kwa and Liew (1975). 
Br ief ly the test was carr ied out by using adult somatic antigen 
of A- ceylanicum In different concentrations. Delayed type of hyper-
sensi t iv i ty reaction was measured after injesting somatic antigen into 
the lef t hind foot pad and saline as a control into the r ight hind 
foot pad. 
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The hypersensi t iv i ty reaction at 2A h after sensitization 
was a typ ica l delayed one. Increase in foot pad thickness was 
measured at 2A h after the injection with the help of a d ia l cal iper 
(Mitutoyo, Japan). The degree of DTH reaction was expressed as 
the increase in foot pad thickness over the control values (Thoung 
and Ferrante, 1980). 
CORRELATION BETWEEN SERUM ANTIBODY AND THE LEVEL OF PROTECTION 
INDUCED BY DIFFERENT ANTIGENS OF THE PARASITE 
From each hamster immunized wi th dif ferent antigens of 
A. ceylanicum, blood collection was made from re t ro -orb i ta l plexus 
on day 7 after last immunizing dose (before challenge). Simi lar ly 
blood samples were also made from unimmunized controls. Blood 
samples were incubated at 37 C for 1 h and thereafter stored at 
A°C for 12 h. Serum samples were separated from the clots and 
centrifuged at 1500 rpm for 10 min at A C. They were pooled group-
wise and kept at -20 C t i l l fur ther use. 
The groups which e l ic i ted protection ( in terms of % worm 
reduction) were only evaluated for the antibody t i t r e by counter 
Immunoelectrophoresis (CIEP) and enzyme l inked immunosorbant assay 
(ELISA) as stated ear l ier . The blood samples from 10 hamsters were 
collected and sera were separated. Sera were pooled and used in 
both the assay. 
HUMORAL RESPONSE DURING THE COURSE OF INFECTION 
Twenty hamsters were infected wi th 60±10L^ and the i r antibody 
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p r o f i l e dur ing the course of in fec t ion was inves t iga ted by CIEP and 
ELISA. 
The b lood f rom each s u r v i v o r s was co l lec ted at d i f f e ren t 
i n t e r v a l s 3, 9, 12, 20, 30, AO, 50, 60, 70, 80, 90, 100, 110, 125, 
150, 200, 250 and 300 and the tes ts (CIEP and ELISA) were per formed 
as stated on page (119-122 and 122-125). 
CELL MEDIATED IMMUNE RESPONSE DURING THE COURSE OF INFECTION 
S ix t y hea l thy male animals (60-70 g) were in fec ted each 
w i t h 60±10L and d i v i d e d in to s i x groups of 10 an imals . DTH test 
was c a r r i e d out on day 3, 5, 10, 20, 40 and 60 post i n f e c t i o n , each 
t ime using 10 an ima ls . Antigen was in jec ted in foot pad of l e f t h ind 
l i m b (LHL) and sa l ine in r i g h t h ind l i m b (RHL) . Results were read 
at 24 h l a te r as desc r ibed on page (125-126) , 
ALTERATIONS IN SERUM ANTIBODY AFTER DRUG THERAPY 
In o r d e r to evaluate the impact of chemotherapy on immune 
status of A. ceylanicum in fec ted hamster , var ious reference a n t h e l -
min t ics (Mebendazole, A lbendazo le , Levamiso le , Py ran te l pamoate) 
inc lud ing one new broad spectrum compound f rom CDRI; Comp. 8 1 -
470 was t e s t e d . F ive groups of hamsters each contain ing 10 animals 
were o r a l l y in fec ted w i t h 60±10 (L_) l a r vae and a f te r 30 days post 
in fec t ion each group was t rea ted w i t h cu ra t i ve dose of the an the lmin t i cs 
i . e . , Mebendazole (1 mg/kg x 1 ) , Albendazole (10 mg/kg x 1 ) , Leva-
misole (30 mg/kg x 1 ) , Pyrante l pamoate (25 mg/kg x 1) and Comp. 
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81-A70 (6.25 mg/kg x 1). Blood from each animal was collected from 
the re t ro-orb i ta l plexus at intervals of 3, 5, 10, 20, 30, and 
60 days post treatment. Sera were separated as described ear l ier 
and stored at -20 C t i l l used. 
Counter Immunoelectrophoresis and enzyme l inked immunosorbent 
assay were carr ied out to evaluate antibody response after drug 
therapy. 
R E S U L T S 
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IN VITRO MAINTENANCE OF ADULT A. CEYLANICUM 
For collection of ES antigen, various l i f e supporting defined 
culture media were t r i e d . The details of the surv iva l of the parasite 
in each culture/maintenance medium have been depicted in Table 14. 
Of the thirteen media tested, RPMI-16A0 without any supplement supp-
orted the l i f e of worms for longest period (192 h) and was found 
most suitable. The prel iminary immunization t r i a l s carr ied out with 
ES products collected in RPMI-1640 medium d id not e l i c i t encouraging 
protection whereas s imi lar ly collected ES antigens in normal saline 
engendered good protection against the challenge infect ion. 
I t appeared that medium RPMI-16A0 which is highly enriched 
with amino acids and other nutrients masked the antigenic epitopes, 
hence l i t t l e success was achieved in immunization. Therefore, further 
studies were carr ied out wi th ES antigens collected in normal saline 
only. 
GEL CHROMATOGRAPHY 
Fractionation of antigens 
Isolation and characterization of antigens are the pre-requisi tes 
for immunoprophylaxis, immunodiagnosis and immune-monitoring in 
control of helminthic infections. Hookworm parasites possess several 
antigenic components of which a l l are not immunogenic and some may 
be responsible in e l ic i t ing high antibody t i t r e of considerable immuno-
prophylact ic importance. Some of the antigens may again perform 
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destructive function through stimuiation of antibodies mediating immuno-
pathological reaction or through induction of delayed hypersensi t iv i ty 
reactions. 
Efforts were made in the present study to fractionate soluble 
somatic antigen of adult , la rva l and ES (adult) products of A. ceylanicum 
wi th the main objective of elucidating the i r use in immunoprophylaxis 
of the disease. 
Antigenic materials of adult (somatic and ES) and larval 
parasites were fractionated through Sephadex G-200 column as stated 
ear l ier and the results were as fol lows. 
Adult somatic antigen 
Fig. 7 shows the elution prof i le of soluble somatic antigen 
of A. ceylanicum in terms of absorbance (280 nm). Somatic antigen 
f i l te red through the column resolved into three major fractions ( F . , 
F„ and F^) wi th the respective volumes of 10 ml , 59 ml and 31 ml . 
Total protein recovery was 8.94 mg which consist of l.AA mg of F^  
2.66 mf of F„ and 4.84 mg of F_. 
ES antigens 
The elution prof i le of ES antigens of adult worms has been 
depicted in Fig. 8. Here also three fractions F. , F„ and F_ were 
obtained, having the respective protein values of 1.875 mg, 2.310 
mg and 4.465 mg. Of the 10 mg sample topped, protein recovery 
was 8.650 mg. In th is case, F„ was the main fraction in terms of 
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pro te in concent ra t ion , whereas F-1 and F-2 f rac t i ons contained low con-
cent ra t ion of p r o t e i n . 
Larval ( L 3 ) somatic antigen 
F i g . 9 shows e lu t ion p r o f i l e of l a r v a l somatic ant igen. Three 
major f rac t i ons hav ing p ro te in values of F. 0.957 mg, F„ 3.328 mg 
and F_ 4.1A5 mg were o b t a i n e d . To ta l p ro te in recovery was 8.A30 
mg of the 10 mg p ro te i n a p p l i e d . 
Molecular weights of antigen fractions 
Molecular weight detemr inat ions of d i f f e ren t f rac t i ons were 
made by compar ing t he r a t i o of Ve/Vo fo r t he p ro te in in quest ion 
to tha t of p ro te i n s tandards of known molecular we igh t . 
A c a l i b e r a t i o n curve was p repared by p l o t t i n g the molecular 
we ights of t he known p ro te in s tandards versus t h e i r respec t i ve Ve/Vo 
values on a semi log paper (Andrews , 1964) ( F i g . 10) . F ive standard 
p ro te ins i . e . , cy tochrome (12 ,400 ) , carbonic anhydrase (29 ,000) , 
bov ine serum a lbumin (66 ,000) , a lcoho l dehydrogenase (150,000) and 
/Q-amylase (200,000) were employed to c a l i b r a t e the column. The 
r a t i o of Ve/Vo of d i f f e ren t antigens and t h e i r est imated molecular 
weights range were g iven in Table 15 . 
Molecular weight range of fractionated proteins 
The adu l t somatic f rac t i ons were i n the range o f : 
F^ 150,000 to 220,000 
Fg 16,000 to 66,000 
F^ 12,400 to 16,000 
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ES antigens wh ich have reso lved in to t h ree f rac t i ons have 
the fo l l ow ing molecular weight range: 
'^ 
'2 
'3 
200,000 
150,000 
100,000 
to 
to 
to 
220,000 
180,000 
150,000 
Fract ions of l a r v a l somatic antigens were in the fo l l ow ing 
molecular weight range. 
^ 
^2 
'3 
170,000 
17,000 
14,000 
to 
to 
to 
220,000 
60,000 
17,000 
PROTECTION INDUCED BY DIFFERENT ANTIGENS AND THEIR FRACTIONS 
Somatic antigen 
Dif ferent immunizat ion schedules adapted w i t h c rude somatic 
antigen f rom adu l t paras i tes and p ro tec t ion ach ieved the re f rom have 
been presented in Table 16. 
Somatic antigen alone engendered weaker immuni ty than when 
admin is te red w i t h FCA. Single dose schedule even when g iven in 
cons iderab ly h igh amounts, produced m i l d p r o t e c t i o n . Among the 
var ious schedules t r i e d cons iderab le worm reduc t ion (A8.69%; P4.0.01) 
was obta ined when the f i r s t dose of 100 AJg ant igen was admin is te red 
w i t h FCA fo l l owed by two aqueous boosts of 200 / jg and 400 /ug antigen 
p ro te in spaced at 10 days a p a r t . 
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Al l the three fractions of adult somatic antigen yielded v a r i -
able results (Table 17 ). Fraction 3 was found most potent. Animals 
receiving th is fract ion in dose regimen of 100 Ajg protein with FCA 
followed by 200 >tig and 400/jg protein alone harboured 59.50% (P^O.Ol) 
less worms compared to unvaccinated challenged control . A higher 
dose schedule (250 wi th FCA followed by 500 and 1000 AJg antigen 
protein) also caused more or less simi lar worm reduction (62.92%; 
P^O.Ol) though i t was much higher than obtained wi th crude somatic 
extract . 
Fraction 1 and 2, however, produced only mild prophylact ic 
effect. 
ES antigens 
ES products of adult A. ceylanicum showed better immuno-
prophylact ic effects than that obtained wi th somatic antigen (Table 1 8 ) . 
ES products when administered in dose schedule of 30 Ajg protein 
with FCA followed by two aqueous boosts of 60 Ajg and 120 /jg protein 
spaced at 10 days resulted in significant worm reduction (72.32%; 
P<0.01). Vaccination wi th lesser amounts of protein fai led to afford 
any protection. 
Fractions of ES antigens also afforded better protection than 
the unfractionated] ones (Table 18 )• Of the three major fract ions, 
F^  was found most protect ive. This fract ion when used in the dose 
I I 
I 
schedule of 10 xj'g protein wi th FCA followed by two aqueous boosts 
20 Ajg and 40 ^igl protein^ reduced the worm count of the challenge 
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dose to 64.59% (P<.0.01) compared w i t h unvaccinated con t ro l g roup . 
In the same dose regimen, f r ac t i on 2 and 3 d i d not e l i c i t any p ro tec t -
i on . Other dose regimens showed ve ry m i l d immunoprophy lac t i c ac t ion . 
Larval somatic antigen 
The p ro tec t ion obta ined f rom l a r v a l somatic ant igen has been 
depc i ted in Table 19 . Of the var ious dose schedules adapted fo r 
the immunizat ion of hamsters , dose regimen of 250 / jg p ro te in w i t h 
FCA fo l l owed by two aqueous boosts of 500 Ajg and 1000 yug p ro te in 
caused 62.89% (P<0.01) worm reduct ion on chal lenge compared to un-
vaccinated con t ro l g roup . However, only s l i g h t p ro tec t ion was obtained 
when antigen was in jec ted w i thou t FCA (29.41%; P<.0.05). Lower doses 
showed v a r i a b l e r e s u l t s . Ant igenic f rac t i ons of l a r v a l ex t rac t s could 
not be eva lua ted , s ince the p ro te in contents obta ined were ve ry l ow . 
Fecundity potential of female worms recovered from immunized hamsters 
The egg ' lay ing capac i ty of worms recovered f rom immunized 
group of animals (somatic and ES) was found cons ide rab ly reduced 
(35-40%) as compared to worms of the con t ro l g roup . The s ize of 
worms was also reduced ( h a l f i n s ize compared to worm in con t ro l 
group) (not shown' i n T a b l e ) . 
SEROLOGICAL STUDIES 
STANDARDIZATION OF IMMUNOLOGICAL TESTS 
Counter immunoelectrophoresis (CIEP) 
For op t ima l p r e c i p i t a t i o n , p rope r concentrat ion of antigen 
p ro te in and ant iserum i s necessary. D i f fe rent ant igenic concentrat ions 
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(100, 200, 500, 1000, 2000, 5000 and 10,000 /Ug/ml) were allowed 
to react with undiluted antiserum in counter immunoelectrophoresis. 
The best resolution was obtained wi th antigen solution having the 
protein concentration of 1000/ jg/ml.(Fig. 11). 
Enzyme linked immunosorbant assay (ELISA) 
ELISA test was performed as per method of Engvall 
and Perlmann (1972). 
Standardisation of antigen concentration 
For the standardization of optimal concentration of antigen, 
various concentrations (5, 10, 15, 25, 50, 100 and 200 /(jg/ml) of 
antigen were employed. Of these, 15 / jg/ml concentration was found 
most appropriate for plate coating, hence a l l the studies were carr ied 
out with th is antigen concentration. 
Standardisation of optimal dilutions of antiserum and conjugate by 
chequer board method 
To f ind the optimum di lut ion of antiserum and conjugate (ant i -
hamster IgG raised in goat) a reference posit ive serum (immune serum) 
and a reference negative serum (normal control serum) were taken 
and ser ia l ly di luted (1:25 to 1:800) in phosphate buffer saline (PBS/ 
Tween 20) pH 7.4. Precoated microt i t r te plates, with optimum con-
centration of adult somatic antigen (15 -ug/ml), were washed three 
times wi th PBs/Tween 20 and different di lut ions of antisera (150 
/ j l / w e l l ) were added in a manner that each di lut ion (1:25 to 1:800) 
Fig. 11: Typical appearance of prec ip i t in band(s) in CIEP. 
Fig. 12: Typical appearance of ELISA by using different di lut ions 
of serum and enzyme conjugate. Dark purple color shows 
presence of serum antibody (IgG) and fade color i n d i -
cates negative results. 
Conjugate 
di lut ions 
1:8000 
1:4000 
1:2000 
A 
B 
C 
D 
E 
F 
G 
H 
different controls 
reference posi t ive 
reference negative 
reference posi t ive 
reference negative 
reference posi t ive 
reference negative 
1 2 3 
1:25 1:50 1:100 
A 
1:200 
5 
1 :400 
6 
1:8( 
Serum dilutions 
11 
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would react with a l l di lut ions of enzyme conjugate (1:500 to 1:8,000) 
in the standard assay conditions. The di lut ion of antiserum which 
gave a strong reaction wi th highest d i lut ion of conjugate and weak 
reaction wi th control serum was considered optimum. 
From the results presented in Table 20, i t is evident that 
1:100 di lut ion of antiserum and 1:2,000 di lut ion of conjugate were 
found optimum. Hence further studies were carr ied out at 1:100 di lut ion 
of antiserum and 1:2000 di lut ion of conjugate. The dist inct ion between 
posi t ive and negative can also be visual ly d i f ferent iated, as chromogenic 
reactions provide a dist inct color to interpret resul ts . (F ig.12) . 
Delayed type of hypersensitivity reaction (DTH) 
Of the various antigen concentrations (10, 20, 30, 50, 100 
/ jg/hamster) , t r i e d , 10 /jg antigen protein/hamster was found suitable 
for DTH response and hence further studies were carr ied out with 
th is concentration. 
CORRELATION BETWEEN SERUM ANTIBODY AND THE LEVEL OF PROTECTION 
INDUCED BY DIFFERENT ANTIGENS OF THE PARASITE 
In order to evaluate the impact of immunizing dose of different 
antigen on humoral antibody response, sera from highly protected 
animals were tested by CIEP and ELISA. 
A definite correlation was observed in the level of protection 
and serum antibody l i t r e (Table 21 ) . 
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With CIEP 
Somatic antigen (adult) 
Sera obtained from hamsters immunized with protect ive dose 
(100 + FCA, followed by 200 and 400 /jg protein) e l ic i ted posit ive 
antigen antibody reaction. In control serum no prec ip i t in band was 
found. (Table 21). 
Among the chromatographic fract ions, F^ gave posi t ive results 
and the other two (F. and F,) demonstrated no prec ip i t in bands. 
ES antigens (adult) 
The sera of animals immunized wi th highly protect ive dose 
of 30 /ug + FCA, followed by 60 ug and 120/ug protein showed sharp 
prec ip i t in lines (Table 21). 
Among the ES fract ions, F. in the dose schedule of (10+FCA, 
20 and AO Ajg protein which resulted in 6A.6% worm reduction (P<0.01) 
showed posit ive antibody response only and the other two fractions 
(F2 and F^) gave negative results (Table 21). 
Somatic antigen (larval) 
Animals immunized wi th larva l somatic antigen in the dose 
schedule of 250+FCA, followed by 500 and 1000 /ug protein(62.9% worm 
reduction; P<0.01) showed posit ive perc ip i t in antibodies only (Table 
21). 
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With ELISA 
Somatic antigen (adult) 
Sera obta ined f rom hamsters immunized in the dose schedule 
of 100 / j g p ro te i n w i t h FCA fo l l owed by two aqueous boosts of 200 
and AOO Ajg worm p ro te i n (48.69% worm reduct ion) showed increase 
in serum an t ibody t i t r e (1:800) as compared w i t h unimmunized con t ro l 
(Tab le 21) . 
Hamsters immunized w i t h f r ac t i on 3 i n dose regimen of 100 
yug p ro te in fo l l owed by two booster doses of 200 and AOO ug (59.50% 
pro tec t ion) demonstrated cons iderab le an t ibody t i t r e (1:600 compared 
to cont ro l g roup. 
ES antigens 
The h i g h l y p ro tec ted dose regimen (30+FCA, 60 and 120 
Aig p ro te in ) of c rude ES antigen also increased serum an t ibody t i t r e 
(1:1600). 
Among the f r a c t i o n s , F1 at the dose schedule of 10/ug p ro te in 
along w i t h FCA fo l l owed by two booster doses of 20 / j g and AO / j g 
p r o t e i n , showed remarkab le increase in serum an t ibody t i t r e (1 :3200) . 
Somatic antigen ( l a r v a l ) 
A h i g h l y p r o t e c t i v e dose (250 / jg p ro te in + FCA fo l l owed 
by 500 and 1000 yUg p ro te in ) demonstrated serum an t ibody upto the 
d i l u t i o n of 1:600 (Tab le 21) . 
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HUMORAL AND CELL MEDIATED IMMUNE RESPONSE DURING THE COURSE 
OF A. CEYLANICUM INFECTION 
In o rde r to understand a l te ra t ions in immune status of hamsters, 
dur ing the course of A. ceylanicum in fec t ion CIEP and ELISA were 
c a r r i e d out fo r assessing humoral an t ibody response and DTH for 
c e l l mediated immune response. 
HUMORAL RESPONSE 
With CIEP 
The resu l t s of CIEP c a r r i e d out at d i f f e ren t i n t e r v a l s of 
3, 9 ,12, 20, 30, 40, 50, 60, 70. 80, 90, 100, 110, 125, 150, 200, 
250 and 300 days post in fec t ion have been r e c o r d e d . 
No p r e c i p i t i n an t ibody could be detected on day 3 to 25 
post in fec t ion ( p . i . ) . The ant ibod ies s ta r ted appear ing f rom day 
30 p . i . , and remained prominent in serum t i l l day 250 p . i . On day 
300 p . i . , no p r e c i p i t i n l i ne was o b s e r v e d . 
With ELISA 
The test was c a r r i e d out as desc r ibed on page 122-125 and 
resu l ts are shown in F i g . 13 . B r i e f l y no remarkab le an t ibody t i t r e 
was detected t i l l day 20 post i n f e c t i o n . On day 30, post i n f ec t i on , 
a marked increase in serum an t ibody t i t r e was not iced and even a 
d i l u t i o n of (1:6,400) showed p o s i t i v e an t ibody reac t i on . The an t ibody 
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persisted throughout the investigational period with s l ight deviation 
at interval of 60 days. I t was noticed that though only a few worms 
(1-A) were present on day 300 post infect ion, suff ic ient ly high antibody 
t i t r e was maintained. 
CELL MEDIATED IMMUNE RESPONSE 
With DTH 
The test was carr ied out by the method of Kwa and Liew 
(1975). No DTH response was recorded during the course 
of A. ceylanicum infection (Table 22). 
ALTERATIONS IN SERUM ANTIBODY AFTER DRUG THERAPY 
In order to evaluate the impact of chemotherapy on the immuno-
logical response of A. ceylanicum, sera samples of hamsters treated 
wi th dif ferent drugs were evaluated for any alteration in serum antibody 
by CIEP and ELISA. 
With CIEP 
The sera from mebendazole treated hamsters showed prec ip i t in 
lines on day 3, 5 and 10 post treatment. After that , no prec ip i t in 
l ine was seen. (Table 23). 
Sera of albendazole treated hamsters showed prec ip i t in lines 
up to day 30 post treatment and thereafter no prec ip i t in antibody 
was demonstrated. 
U 1 
Levamisole treated sera demonstrated prec ip i t in lines up 
to day 20 post treatment and beyond th is day, the reaction was not 
detectable. 
The sera collected from hamsters treated with pyrantel pamoate 
on day 3, 5 and 10 post treatment showed posit ive results and there-
after the test was negative. 
The sera from hamsters treated wi th CDRI compound 81-470 
(Methy l -5 - [A - (2 -py r id iny l ) - l -p ipe raz iny l ) carbonyl]- lH-benzimidazole-
2-y l carbamate) had antibody t i t r e for longer periods compared to 
other drugs. The antibody disappearance was evidenced only after 
day 40 of treatment. 
With ELISA 
Various standard drugs and CDRI Comp. 81-470 were given 
oral ly in curative doses on day 30 post infection. Blood and sera 
from different groups were collected as stated in materials and 
methods. Serum antibody t i t r e of infected hamster after treatment 
with drugs have been presented (F ig. 14) . 
Mebendazole treatment lowered the antibody t i t r e on day 
3 post treatment, whereas in infected non-treated controls the antibody 
level had an increasing t rend. On day 5 the OD value was 0.898 
against the control value of 0.825. Later the level of antibody t i t r e 
showed a downward trend in treated hamsters sera whereas almost 
a constant level of antibody was observed in infected untreated sera. 
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No appreciable change in antibody t i t r e was observed in th is group 
of animals. 
Albendazole treated sera showed a decline in antibody t i t r e 
on day 3 and sl ight r ise on day 5 post treatment in comparison to 
untreated controls. On later dates (10, 20, 30 and 60 days post 
treatment) t i t r e fe l l down appreciably in comparison to control animals. 
Sera of animals treated with levamisole showed increase in 
antibody t i t r e on day 3 post treatment as compared with control 
group. Later the t i t r e declined on day 5 post treatment and further 
increased on day 10, thereafter reached a plateau t i l l the end of 
the observation per iod. 
Pyrantel pamoate treated sera showed an increase in antibody 
t i t r e on day 3 post treatment which f e l l down on day 5 post treatment 
and gradually decreased fur ther t i l l day 60 post treatment as compared 
to untreated infected control . Antibody t i t r e was highest in sera 
of animal, treated wi th Comp. 81-470 from day 3 post treatment. 
The level fur ther increased on day 5 post treatment as compared 
to infected untreated controls. The OD values were higher to any 
of the drug tested. On day 10 post treatment the t i t r e started decl in-
ing with a gradual f a l l in ODs t i l l day 60 post treatment (Fig.13). 
Among a l l the drugs tested, Comp. 81-470 showed a remarkable 
r ise in serum antibody t i t r e after drug therapy on day 3 and 5 post 
treatment, whereas other compounds showed a s l ight increase in compari-
son to infected untreated controls. 
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Table 2 2 : Delayed type of hypersensi t iv i ty (DTH) reaction following 
the injection of 10 / jg protein of adult worms antigen 
during the course of A. ceylanicum infection in hamsters. 
Days post 
infection 
3 
5 
10 
20 
30 
40 
60 
Mean foot ; pad 
LHL 
(Antigen) 
3,26 ± 
2.70 ± 
2.90 + 
2.70 ± 
2.61 ± 
2.46 ± 
2.26 ± 
0.20 
0.21 
0.39 
0.14 
0.20 
0.20 
0.12 
thickness in i mm ± S.D. 
RHL ^ 
(Normal saline) 
3.03 
2.62 
2.64 
2.66 
2.33 
2.32 
2.25 
± 
+ 
+ 
± 
± 
+ 
± 
0.23 
0.17 
0.23 
0.15 
0.23 
0.24 
0.15 
Significance 
(a vs b) 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. : Not signif icant. 
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Table 23 : Demonstration of prec ip i t in antibody in infected hamsters 
after drugs therapy. 
Drugs used with 
controls 
Observation after post treatment ( in days) 
10 20 30 AO 60 
Mebendazole 
Albendazole 
Levamisole 
Pyrantel pamoate 
Compound 81-A70 
Infected control 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
D I S C U S S I O N 
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I t was widely held that the control of ancylostomiasis 
by drugs was so successful that no fur ther measures would be re -
qui red. This view, however, has been sharply challenged because 
of reinfection in endemic population which requires repeated chemo-
therapy, adding not only to the cost but also posing logist ical 
probl.evY\s of ava i lab i l i t y of drugs. The edivicatio'r\ of people to 
the use of anthelmintics and resistance to drugs are the main hurdles 
in implementation of chemotherapeutic control measures. 
Drug resistance in neamtodes is wel l established in case 
of strongyl id and t r ichostrongyl id parasites. Resistance against 
phenothiazene and thiabendazole in Haemonchus contortus (sheep) 
has been wel l documented (Drudge et_ al^., 1957; Drudge et^  aU, 
1964). Further, resistance to levamisole, thiabendazole and moranetal 
have also been reported (Jambre et^  aJ^., 1976; 1977; 1978). Occurrence 
of cross resistance against various drugs l imi ts the possib i l i t ies 
of substituting wi th alternative anthelmintics to combat parasit ic 
scourge (Geerts, 1986). Therefore, the ultimate control of the 
disease depends on the development of effective prophylact ic measures 
which can ensure long lasting protection and may provide an ultimate 
answer to the eradication of the disease. 
Unlike microbial diseases, there has been genuine hurdles 
in the development of effective vaccine against helminthic infections. 
The complexity in the l i f e cycle, antigenic d ivers i t y of dif ferent 
developmental stages, the weak immunogenicity of antigens and in ter-
fe-rence by other proteins w i th functional antigenic components are 
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some of the problems which have hampered the development of 
vaccine(s) against helminth parasites. 
A re t r ieva l of the l i terature on parasit ic immunity reveals 
that most of the work carr ied out in helminth immunity was either 
a fa i lure or only par t ia l l y successful. Work on helminth immunity 
is mainly based wi th i r rad iat ion techniques, dead worm antigens 
and excretory-secretory products and as far as hookworm immunity 
is concerned, i t has been elaboratory studied in nonhuman hookworm 
species, i . e . , N. brasi l iensis and N. dubius. 
But immunological responses of human hookworms are poorly 
studied because of the i r host spec i f i c i ty . N[. americanus has no 
closely related animal species and is highly specif ic to man in 
contrast to A. duodenale which could be maintained in dogs (Schad, 
1979). High speci f ic i ty of N. americanus towards i ts host has 
restr icted the ava i lab i l i t y of parasite materials for biological , 
analyt ical , immunological and biochemical studies and hence the 
parasite is s t i l l poorly understood (Behnke and Pr i tchard , 1987; 
Wells and Behnke, 1988). Further on the basis of infection in 
volunteers and epidemiological surveys in endemic areas, i t is 
widely believed that host protective mechanism operates very weakly 
because human volunteers could be reinfected several times without 
any apparent reduction in worm establishment (Ogilvie et a l . , 1978). 
Several attempts have been made to infect a var iety of 
laboratory animals wi th these worms. A. duodenale infections have 
been described in chimpanzees (Mi l le r , 1968), but these animals 
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are scarce and costly to use. Schad (1979) infected puppies (dogs) 
wi th th is parasite but immunosuppression with cort icosteroid was 
necessary for constant maintenance of infect ion. Some success has 
been claimed for infecting infant rabbits wi th A. duodenale and 
N. americanus (Bhopale et^  aJ^., 1980) but the necessity for infecting 
neonatal animals has inh ib i ted wide use of these models. Simi lar ly 
only l imi ted development of N^ . americanus occurred in infant hamsters 
(Sen and Seth, 1967). A. duodenale and NJ. americanus are pr imar i ly 
human pathogens, whereas A. ceylanicum has a wider host range 
infecting humans (Lane, 1913; Joe and Slag, 1959; Yoshida et^  a l . , 
1968; Chowdhury and Schad, 1972), dogs (Lane, 1913; Ito and Tongkoom, 
1962; Rohde, 1962; Yoshida et^  al^., 1968) and cats (Looss, 1911; 
Lane, 1913; Rohde, 1962; Yoshida et^  a]^., 1968) in nature. Although 
A. ceylanicum is the most infrequently occurring hookworm in humans, 
i ts ab i l i t y to infect a number of animal hosts makes i t the only 
human hookworm species that can be studied easily in experimental 
conditions. As such A. ceylanicum in golden hamster (Ray and 
Bhopale, 1972) has extensively been used for chemotherapeutic studies 
(Ray et^  al^., 1978; Misra et_ a]_., 1981; Katiyar et^  ai_. , 1982; 198A; 
1987). Though a few prel iminary reports on the immunological 
response of hamster to l i ve parasites have appeared (Gupta and 
Katiyar, 1985; Kamath et^  ^ . , 1985a and b) no concrete information 
is avai lable on the ab i l i t y of dead antigens which could be used 
for inducing protect ive immunity. The meager information, so far 
available on the immunological aspects of A. ceylanicum have pro-
voked interest to understand the immunoprophylactic potential of 
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somatic and ES antigens to the subsequent challenge infections in 
hamster. Thus in the present study, the immunogenicity of dead 
antigens and the i r fractions were evaluated in a bid to generate 
considerable amount of antibodies to resist challenge infect ion. 
The ab i l i t y to stimulate protection by dif ferent immunogens (somatic 
and ES) was judged by challenging the immunized animals and serum 
antibody demonstration. 
ES products were found to be more immunogenic than somatic 
ones (adult and larva l ) as the former are avai lable re la t ive ly in 
pure form and are closely related to active infections. These f i n d -
ings are in confirmation wi th ear l ier investigators (Rothwell and 
Love, 1974; Clegg and Smith, 1978; Day et^  aJ^., 1979). The abrupt 
fa l l in prophylact ic potential of these antigens in lower doses could 
be due to possession of restr ic ted amount of effect ive immunogens. 
In order to enhance the i r protective capabi l i t ies , the an t i -
gens (somatic and ES) were fractionated on Sephadex G-200 column. 
Both the crude somatic antigen of A. ceylanicum (adult and larva l ) 
and ES products yielded 3 major f ract ions. 
Fraction 3 of adult worms having lower molecular weight 
range (12,400-16,000) protected the hamsters to a significant leve l . 
This was not in conformation with other investigators (O'Donnell 
et a l . , 1985; Monroy and Dobson, 1986) where immunogenicity was 
correlated with higher molecular weight proteins. However, such 
a correlation was noticed with ES products. Results indicated 
that pur i f ied antigens are more accessible to immune system of 
the host rather than the unfractionated crude antigens. 
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Serological studies showed that hamsters immunized wi th 
protective doses of somatic and ES antigens (crude and pur i f ied) 
demonstrated high antibody t i t r e (IgG). A def ini te correlation 
was obtained in the level of protection and serum antibody demons-
t ra t ion. 
The stimulation of a high level of immunity to infection 
by vaccination wi th non-l iving worm materials was not consistent 
and th is agrees wi th the t radi t ional view that these materials are 
incapable of stimulating significant immunity in the i r crude forms 
(Ter ry , 1968; Silverman, 1970; Clegg and Smith, 1978; Day e^ aJ_., 
1979). 
Further the crude worm homogenate consists of various 
antigenic components and only a small fract ion bears the protective 
potential whi le the bulk is ei ther inactive or suppresses the immune 
response of the host (Clegg and Smith, 1978). Moreover, the immu-
ni ty induced by crude antigens wanes out rap id ly (Murray et^  a l . , 
1979). As such in the present study there was hardly any corre la-
tion between the immunizing dose and the level of protective immu-
n i t y , endorsing the views of Rothwell and Love (1974). The low 
response wi th large immunizing doses could also be explained on 
the basis of immune paralysis (Sercarz and Coons, 1959; Weir, 
1978). The high level of protection e l ic i ted by ES antigens are 
probably due to the fact that these antigens are re la t ive ly simple 
and pure as compared wi th crude somatic antigens and are closely 
related wi th active infections. 
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Freund's Complete Adjuvant (FCA) was found to enhance 
protective ab i l i t y of antigens. FCA binds wi th antigens and makes 
a sort of depot, releasing antigenic material slowly and making 
a constant source of antigenic stimulus. As such better protection 
was achieved when the antigen was used in combination with FCA 
rather than when used alone. 
The study denotes that the protect ive immunogens are often 
masked by the nonfunctional components in crude antigens. Fraction-
ation and puri f icat ion of these may help in indenti fying the most 
protective antigenic epitope(s) which may ult imately be able to 
e l i c i t formore protection against the infect ion. 
The existence of an immunological cr i ter ion to assess effect-
i v i t y of chemotherapy in parasit ic infections has long been fe l t 
(Ambroise-Thomas, 1974). Almost a l l the parasites promote antibody 
production but the phenomenon is more pronounced in parasites 
which have close contact with the host t issue. The antibody t i t r es , 
therefore, are signif icant ly high in tissue dwell ing parasites or 
in such intestinal worms which have somatic migration. A. ceylanicum 
is exclusively a parasite of gastrointestinal tract and the worms 
remain f i rm ly attached wi th the mucosa of the intest ine. As such, 
they stimulate reasonably good humoral response in hamsters (Gupta 
and Katiyar, 1985). The antibody level (by ELISA and CIEP) and 
CMI response (by DTH) were investigated in A. ceylanicum infected 
hamsters during the course of infection as wel l as after successful 
therapy. 
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ELISA revealed that antibodies persisted longer than what 
was observed in CIEP. This was obvious since, ELISA is a very 
sensitive test and could detect even traces of antibodies. The 
result showed that sufficient antibody was avai lable in the serum 
on day 30 post infect ion, and high t i t r e of antibody was noticed 
for a considerable period after infect ion. 
Earl ier studies (Gupta and Katiyar, 1985) indicated that 
A. ceylanicum is highly immunogenic to hamsters and immediately 
after gaining adulthood on day 18 post infection the parasite could 
mount considerable immunogenic responses. I t has been observed 
that worms remain a l ive for more than 100 days (Visen et_ a l . , 
1984) and continue to supply antigenic stimulus to the host. This 
would explain the persistance of high t i t r e t i l l day 250. Though, 
a l l worms were expelled from hamsters by day 200 (personal obser-
vat ions), the t i t r e seen up to day 250 would indicate the presence 
of circulating antibodies since the immunoglobulins have certain 
half l i ves . 
At occasions, there was elevation of antibodies immediately 
after drug therapy. Such a situation, in the past,has been explained 
on the basis of antigenic stimulation caused by the addit ional l i be ra -
tion of antigen from paralyzed worms (Menon and Bhopale, 1985). 
This hypothesis does not stand as the paralyzed worms are a l ive 
and lack active metabolism. The ES antigens released from such 
parasites would be insignif icant to stimulate antibody production. 
However, drugs which k i l l and disintegrate parasites are l i k e l y to 
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cause enhanced antibody production. The four drugs (Mebendazole, 
Albendazole, Pyrantel pamoate and Levamisole) used against A. 
ceylanicum have different modes of action. Mebendazole and Albenda-
zole cause death of the worms (Keystone and Murdoch , 1979), whi le 
Pyrantel pamoate and Levamisole paralyze them (Katz, 1982; Janssen, 
1976). In 3 drugs (Mebendazole, Albendazole and Pyrantel pamoate), 
there was no appreciable increase in antibody level whether the 
drugs k i l l ed parasites or paralyzed them. 
Visen et_ al^. (1987) observed that Mebendazole in i t iated 
anthelmintic action wi th in 12 h of medication and most of the worms 
migrated to rectum and were sluggishly moti le. The observations 
made at 18 h post medication revealed that worms were s t i l l a l ive 
and by 2A h a l l passed out allowing no time to parasites to d i s -
integrate. Since Albendazole is an analogue of Mebendazole, i t 
may be suggested that the rap id i t y of action of the two compounds 
is s imi lar . The in i t i a l f a l l in antibody level due to Levamisole 
therapy was in l ine wi th other anthelmintics used but the elevation 
observed at later dates corroborated the immunostimulatory action 
of the drug (Janssen, 1976). 
The administration of Comp. 81-470, considerably enhanced 
antibody t i t r e . This, being a benzimidazole compound, should 
have mechanism of anthelmintic action simi lar to Mebendazole and 
Albendazole. But since the compound is a newly discovered molecule, 
the precise mechanism of ac t iv i ty is not yet known. The possible 
explanation could be that the compound modulates the immune response 
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of the host, as i t has long prophylact ic action (Srivastava 
et^  al^., 1988). 
The present work provided clear evidence of humoral res-
ponse but fai led to demonstrate cel l mediated immunity during the 
course of infection. The results are in confirmation wi th those 
of Carrol l and Grove (1984). However, the study fa i led to establish 
any correlation between drug efficacy and antibody t i t r e and as 
such th is parameter cannot be used as one of the cr i ter ion to ascer-
tain the successful therapy in hookworm infect ion. 
S U M M A R Y 
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Ancylostomiasis, a disease caused by nematodes (ancylostomes) 
is of great public health importance, not only in India but in the 
whole of t ropica l and subtropical regions of the wor ld . 
The l i f e cycle of a l l hookworms is d i rec t . The infect ive 
stage larvae (L , ) enter the host ei ther through skin penetration 
or through mouth. After the entry (skin penetration) the larvae 
migrate through heart, lung, trachea and oesophagus and f ina l ly 
settle down in the intestine as adult parasites. The l i f e span 
of adult hookworms has been estimated to be from one year 
(Ancylostoma duodenale) to f i ve years (Necator americanus). 
Hookworms are voracious blood suckers causing severe anaemia, 
gastrointestinal disorders and creeping eruption. The other symptoms 
include physical and mental retardation and myocardial ailments. 
In pregnancy, these infections may be associated wi th changes in 
renal functions resulting in toxaemia and albuminuria. Chronic hook-
worm infection produces dullness, depression, confusion, poor memory, 
sexual retardation in chi ldren and par t ia l impotency in man. 
In the absence of any suitable control measures against 
ancylostomiasis, chemotherapy attained advantage in combating th is 
parasit ic scourge. But the current ly avai lable drugs are ei ther 
not fu l ly effective or have various side effects. Thus, i t is impera-
t i ve that ef fect ive, nontoxic, cheaper polyvalent antihookworm drugs 
be developed for the cure and control of the disease. 
For any biological investigation, the basic requirement 
is to have a re l iab le test model. The selection of a test parasite 
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should be based upon the probabi l i ty of s imi lar chemotherapeutic, 
biological and immunological responses in the organisms to that 
of the target parasite. Further, to obtain consistent therapeutic 
responses, i t is necessary to have a host of standard breed wi th 
minimum genetic var iat ions. On the other hand, parasite wi th short 
l i f e cycle is preferred for quick turnover of infected host and 
the parasit ic materials. 
The true human hookworms are A. duodenale and N|. americanus. 
Attempt to adapt N[. americanus in golden hamsters have been success-
f u l , however, i t necessitates the use of immunosuppressive drug 
and hydrocortisone. The forced parasitism is l i ke l y to change 
the genetic make up of the parasite resulting in altered immunological 
and chemotherapeutic responses and as such should be avoided. 
A. duodenale has been successfully maintained in beagle 
dogs but the model is not suitable for chemotherapeutic investigations 
because of large size and d i f f i cu l ty in handling of the host. 
A. ceylanicum, a hookworm parasite of dog, cat and man, having 
direct and short l i f e cycle and easy adapt ib i l i t y in small laboratory 
host-hamster, is an acceptable test parasite for experimentation 
on ancylostomiasis. Further, the existence of posi t ive correlation 
of chemotherapeutic and immunological responses between A. ceylanicum 
in hamster and target parasite add to i ts selection. 
The thesis has two dist inct aspects of studies: i ) Chemo-
therapy and i i ) Immunology. 
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a) CHEMOTHERAPEUTIC INVESTIGATIONS 
In search of highly effective and nontoxic, p lyvalent , an t i -
hookworm agents, a number of newly procured plant extracts and 
rat ional ly synthesized compounds were screened for the i r antihookworm 
ac t i v i t y . 
The synthetic compounds screened, belong to benzimidazole, 
>6-carboline, sa l icy lan i l ide , thiazole, py r ro le , isoxzoline and n i t ro -
imidazole groups. Amongst the benzimidazole series, 29 compounds 
were found effective and of these 4 have shown good promise and 
hence studied in de ta i l . The members of the /3-carboline, s a l i -
cy lan i l ide , thiazole and pyr ro le series showed poor eff icacy. In 
isoxzoline and nitroimidazole groups, none were found effective 
even at the i n i t i a l dose of 250 mg/kg x 1. 
None of the plant extracts showed any ac t i v i t y . I t is 
l i ke ly that inact iv i ty might be due to the process of extraction 
being different from that practiced in Ayurvedic system. 
A l l the four active compounds belonging to benzimidazole 
series, were evaluated against mature and metamorphic forms ( L , , 
L^ and L^ stages) of A. ceylanicum. 
Their efficacy was also investigated against other helminth 
parasites, Nippostrongylus brasi l iensis ( t r ichostrongyl id) in ra t , 
Syphacia obvelata ( t )xyur id) in mouse, Hymenolepis nana and 
H. diminuta (cestodes) in rats. 
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Among the four active benzimidazoles, Comp. 85-478 had 
weaker action. To achieve 100% clearance of A. ceylanicum, the 
required dose is 50 mg/kg x 1 per os. Developing larvae were 
also affected when the compound was administered in amount of 
100 mg/kg x 1. Even at th is dose a l l L^ were not k i l l e d . The 
compound has marginal ac t i v i t y against, S^ . obvelata and H. nana 
where as no action was observed against N_. brasi l iensis and 
H. diminuta even at the in i t i a l dose of 250 mg/kg x 3. 
Compound 85-479 had better ac t i v i t y and a single oral dose 
of 25 mg/kg x 1 was sufficient to remove a l l adult A. ceylanicum 
worms from treated hamsters. Though, the compound had 95-100% 
efficacy against L, and Lc stages of the parasite, the efficacy 
against L- was poor. In case of S^ . obvelata and H. nana, a dose 
of 100 mg/kg x I cured the respective host whereas, very l i t t l e 
ac t iv i ty was observed against H. diminuta and no efficacy was found 
against N. brasi l iensis. 
The other compound, 83-148 was found 100% effect ive against 
adult A. ceylanicum at an oral dose of 12.5 mg/kg x 1. By paren-
teral route the compound exhibi ted weak ac t i v i t y . This compound 
was though effective against a l l developing forms, the minimum 
required dose was 100 mg/kg x 1 to achieve almost 100% efficacy 
aginst the larvae. I t had good ac t i v i t y against S^ . obvelata and 
meager efficacy against cestode (IH. nana and H. diminuta). However, 
no anthelmintic action was detected against N. brasi l iensis. 
Among the lo t , compound 87-144 was found to be the most 
effect ive. The ED^Q value (based on worm reduction) against 
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A. ceylanicum is approximately 1.53 mg/kg x 1. The compound 
was also effective against a l l the metamorphic forms of th is parasite 
and against other helminths i . e . , N_. bras i l iensis, ^ . obvelata , 
H. nana and IH. diminuta also. However, the compound lacks chemo-
prophylact ic action. The compound has exceedingly high therapeutic 
index as the maximum tolerating dose is above A500 mg/kg x 1. 
b) IMMUNOLOGICAL INVESTIGATIONS 
Various antigens of A. ceylanicum (somatic and ES) were 
evaluated for the i r protect ive potential and the i r immunogenicity 
was assessed wi th challenge and iri v i t ro immunological tests. 
Fractionation of antigens was carr ied out wi th Sephadex 
G-200 column. The somatic and ES antigens of adult and la rva l 
parasites resolved into three major f ract ions. Adult somatic antigen 
engendered weaker immunity compared to ES products. Among somatic 
fractions, F- e l ic i ted better immunity and fraction 1 and 2 producted 
mild effects. Crude la rva l antigens also el ic i ted considerable immu-
nity at higher doses. 
A def ini te correlation in serum antibody t i t r e and the level 
of protection was observed. Animals immunized wi th somatic antigens 
and the i r fractions showed good antibody t i t r e , but that obtained 
wi th ES antigens was much higher. 
Humoral immune response during the course of A. ceylanicum 
infection was assessed wi th counter Immunoelectrophoresis (CIEP) 
and enzyme l inked immunosorbent assay (ELISA). Prec ip i t in antibody 
167 
t i t r e in infected hamster sera could be detected as early as on 
day 30 post infection ( p . i . ) and th is persisted for a longer period 
(250 days p . i . ) - ELISA test could detect serum antibody (IgG) 
as early as on day 3 post infection. A signif icant ly high antibody 
level was obtained on day 30 p . i . which further increased on day 
AO p . i . The antibodies persisted throughout the investigational 
period ( t i l l 300 days) wi th s l ight fluctuations at in terva ls . No 
cel l mediated immune (CMI) response was observed during the course 
of infection. 
In order to evaluate the impact of drug therapy on the 
immune status of infected hamsters, f i ve anthelmintics (Mebendazole, 
Albendazole, Levamisole, Pyrantel pamoate and CDRI Comp. 81-470) 
were evaluated for any alteration in serum antibody. Following 
therapy wi th Mebendazole and Pyrantel pamoate, no prec ip i t in an t i -
bodies were demonstrable on day 10 as observed by CIEP whi le 
in sera of Levamisole and Albendazole treated hamsters, the pre-
c ip i t i n antibodies were detectable t i l l day 20 and 30 post treatment, 
respect ively. Thereafter, th is test yielded negative resul ts. The 
hamsters, treated with comp. 81-470, demonstrated prec ip i t in an t i -
body t i l l day 40 post treatment ( p . t . ) and after that no antibodies 
were detected. 
ELISA results demonstrate that after Mebendazole therapy, 
there was sl ight elevation of the (IgG) antibody t i t r e on day 3 
followed by gradual decrease t i l l day 60 p. t . In Albendazole treated 
hamsters, there was percept ible reduction in antibody concentration 
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on day 3 post treatment. The antibody concentration was apprec i -
ably low on day 10 and further declined subsequently to a very 
low leve l . Levamisole treated hamsters, showed i n i t i a l decrease 
in antibody t i t r e followed by an elevation in the t i t r e which remained 
high t i l l day 60 p. t . 
Pyrantel pamoate sharply lowered antibody concentration 
on day 5 p. t . and th is antibody level was maintained t i l l the end 
of observation (60 days p . t . ) per iod. 
Comp. 81-A70 showed remarkable r ise in the serum antibody 
t i t r e after drug therapy (3-5 day p . t . ) . Thereafter a s l ight 
decrease in serum antibody was noticed but the t i t r e remained appre-
ciably higher than the untreated control throughout the observation 
per iod. 
Findings clearly demonstrated that A. ceylanicum is capable 
of evoking humoral response and sufficient antibody t i t res can be 
detected on day 30 p . i . However, the parasite does not stimulate 
CMI response atleast during the active infect ion. The antibodies 
so generated persisted for longer per iod. Thus, immunological 
parameters as such cannot serve an indication to evaluate ef fect iv i ty 
of drug against A. ceylanicum in hamster. ~ 
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